4hnp:E    (LYS61) to   (ILE181)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hnp:I    (LYS41) to   (ASP177)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hnp:J    (LYS34) to   (LYS170)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hnp:L    (LYS42) to   (ARG194)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hnp:M    (ARG41) to   (THR168)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hnp:N    (LYS33) to   (ASN141)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hnp:S    (LYS61) to   (ILE181)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hnp:T    (LYS62) to   (GLY182)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hnp:X    (LYS34) to   (MET172)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hnp:Z    (LYS42) to   (ARG194)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hnp:b    (LYS33) to   (ASN141)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4x6z:1    (LYS33) to   (ARG185)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4x6z:A    (TYR71) to   (ALA213)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4x6z:E    (LYS66) to   (GLU186)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4x6z:F    (LYS62) to   (ILE182)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4x6z:H    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4x6z:I    (LYS33) to   (ASP166)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4x6z:J    (LYS33) to   (ASP169)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4x6z:M    (LYS33) to   (ARG185)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4x6z:N    (ARG33) to   (ARG179)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4x6z:O    (TYR71) to   (ALA213)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4x6z:S    (LYS66) to   (LEU184)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4x6z:T    (LYS62) to   (ILE182)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4x6z:V    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4x6z:X    (LYS33) to   (ASP169)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4x6z:Y    (LYS33) to   (HIS146)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4hrc:C    (LYS61) to   (LEU198)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hrc:E    (LYS61) to   (ILE181)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hrc:I    (LYS41) to   (ASP177)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hrc:J    (LYS34) to   (MET172)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hrc:L    (LYS42) to   (ARG194)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hrc:N    (LYS33) to   (ASN141)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hrc:S    (LYS61) to   (ILE181)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hrc:T    (LYS62) to   (GLY182)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hrc:V    (LYS33) to   (TRP164)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hrc:X    (LYS34) to   (LYS170)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hrc:Z    (LYS42) to   (ARG194)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hrc:b    (LYS33) to   (ASN141)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hrd:E    (LYS61) to   (ILE181)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hrd:L    (LYS42) to   (ARG194)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hrd:M    (ARG41) to   (THR168)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hrd:N    (LYS33) to   (ASN141)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hrd:Q    (LYS61) to   (LEU198)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hrd:S    (LYS61) to   (ILE181)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hrd:Z    (LYS42) to   (ARG194)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hrd:b    (LYS33) to   (ASN141)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdi:E    (LYS66) to   (ILE180)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdi:I    (LYS33) to   (ASP166)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdi:L    (LYS33) to   (ARG165)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdi:N    (LYS33) to   (ASN141)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdi:S    (LYS66) to   (ILE180)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdi:T    (LYS66) to   (LYS206)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdi:U    (TYR66) to   (ALA200)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdi:W    (LYS33) to   (ASP166)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdi:Z    (LYS33) to   (ARG165)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdi:1    (LEU33) to   (ARG178)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdi:2    (LYS33) to   (ASN141)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdk:E    (SER59) to   (ILE180)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdk:G    (TYR66) to   (GLY202)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdk:I    (LYS33) to   (ASP166)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdk:J    (LYS33) to   (ARG165)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdk:L    (LYS33) to   (ARG165)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdk:M    (ARG33) to   (THR146)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdk:N    (LYS33) to   (ASN141)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdk:Q    (LYS66) to   (LEU198)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdk:R    (LYS66) to   (ASN178)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdk:S    (LYS66) to   (ILE182)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdk:W    (LYS33) to   (ASP166)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdk:X    (LYS33) to   (ARG165)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdk:Z    (LYS33) to   (ARG165)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdk:2    (LYS33) to   (ASN141)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
1ofi:G    (LYS33) to   (ASP158)  ASYMMETRIC COMPLEX BETWEEN HSLV AND I-DOMAIN DELETED HSLU (H. INFLUENZAE)  |   CHAPERONE, HYDROLASE, ATP-BINDING 
1ofi:H    (LYS33) to   (ILE159)  ASYMMETRIC COMPLEX BETWEEN HSLV AND I-DOMAIN DELETED HSLU (H. INFLUENZAE)  |   CHAPERONE, HYDROLASE, ATP-BINDING 
1ofi:I    (LYS33) to   (ILE159)  ASYMMETRIC COMPLEX BETWEEN HSLV AND I-DOMAIN DELETED HSLU (H. INFLUENZAE)  |   CHAPERONE, HYDROLASE, ATP-BINDING 
3shj:E    (LYS66) to    (ILE18)  PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10  |   UBIQUITIN, DRUG DEVELOPMENT, CANCER, IMMUNOLOGY, PROTEIN DEGRADATION, UNFOLDED PROTEIN SUBSTRATES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3shj:G    (TYR66) to   (LEU201)  PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10  |   UBIQUITIN, DRUG DEVELOPMENT, CANCER, IMMUNOLOGY, PROTEIN DEGRADATION, UNFOLDED PROTEIN SUBSTRATES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3shj:I    (LYS33) to   (ASP166)  PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10  |   UBIQUITIN, DRUG DEVELOPMENT, CANCER, IMMUNOLOGY, PROTEIN DEGRADATION, UNFOLDED PROTEIN SUBSTRATES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3shj:J    (LYS33) to   (HIS141)  PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10  |   UBIQUITIN, DRUG DEVELOPMENT, CANCER, IMMUNOLOGY, PROTEIN DEGRADATION, UNFOLDED PROTEIN SUBSTRATES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3shj:L    (LYS33) to   (ARG165)  PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10  |   UBIQUITIN, DRUG DEVELOPMENT, CANCER, IMMUNOLOGY, PROTEIN DEGRADATION, UNFOLDED PROTEIN SUBSTRATES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3shj:N    (LYS33) to   (ASN141)  PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10  |   UBIQUITIN, DRUG DEVELOPMENT, CANCER, IMMUNOLOGY, PROTEIN DEGRADATION, UNFOLDED PROTEIN SUBSTRATES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3shj:S    (LYS66) to    (ILE18)  PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10  |   UBIQUITIN, DRUG DEVELOPMENT, CANCER, IMMUNOLOGY, PROTEIN DEGRADATION, UNFOLDED PROTEIN SUBSTRATES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3shj:U    (TYR66) to   (LEU201)  PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10  |   UBIQUITIN, DRUG DEVELOPMENT, CANCER, IMMUNOLOGY, PROTEIN DEGRADATION, UNFOLDED PROTEIN SUBSTRATES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3shj:W    (LYS33) to   (ASP166)  PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10  |   UBIQUITIN, DRUG DEVELOPMENT, CANCER, IMMUNOLOGY, PROTEIN DEGRADATION, UNFOLDED PROTEIN SUBSTRATES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3shj:X    (LYS33) to   (HIS141)  PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10  |   UBIQUITIN, DRUG DEVELOPMENT, CANCER, IMMUNOLOGY, PROTEIN DEGRADATION, UNFOLDED PROTEIN SUBSTRATES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3shj:Z    (LYS33) to   (ARG165)  PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10  |   UBIQUITIN, DRUG DEVELOPMENT, CANCER, IMMUNOLOGY, PROTEIN DEGRADATION, UNFOLDED PROTEIN SUBSTRATES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3shj:2    (LYS33) to   (ASN141)  PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10  |   UBIQUITIN, DRUG DEVELOPMENT, CANCER, IMMUNOLOGY, PROTEIN DEGRADATION, UNFOLDED PROTEIN SUBSTRATES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4int:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4int:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4int:J    (LYS34) to   (MET172)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4int:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4int:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4int:S    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4int:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4int:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4int:a    (ARG41) to   (THR168)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4int:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inr:E    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inr:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inr:J    (LYS34) to   (LYS170)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inr:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inr:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inr:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inr:S    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inr:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inr:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inr:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inr:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inu:E    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inu:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inu:J    (LYS34) to   (LYS170)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inu:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inu:M    (ARG41) to   (THR168)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inu:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inu:S    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inu:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inu:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inu:a    (ARG41) to   (THR168)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inu:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
1pma:A    (LYS66) to   (SER200)  PROTEASOME FROM THERMOPLASMA ACIDOPHILUM  |   PROTEASE, PROTEASOME, HYDROLASE 
1pma:D    (LYS66) to   (SER200)  PROTEASOME FROM THERMOPLASMA ACIDOPHILUM  |   PROTEASE, PROTEASOME, HYDROLASE 
1pma:H    (LYS66) to   (SER200)  PROTEASOME FROM THERMOPLASMA ACIDOPHILUM  |   PROTEASE, PROTEASOME, HYDROLASE 
1pma:I    (LYS66) to   (SER200)  PROTEASOME FROM THERMOPLASMA ACIDOPHILUM  |   PROTEASE, PROTEASOME, HYDROLASE 
1pma:L    (LYS66) to   (SER200)  PROTEASOME FROM THERMOPLASMA ACIDOPHILUM  |   PROTEASE, PROTEASOME, HYDROLASE 
1pma:N    (LYS66) to   (SER200)  PROTEASOME FROM THERMOPLASMA ACIDOPHILUM  |   PROTEASE, PROTEASOME, HYDROLASE 
1pma:Q    (LYS33) to   (ARG165)  PROTEASOME FROM THERMOPLASMA ACIDOPHILUM  |   PROTEASE, PROTEASOME, HYDROLASE 
1pma:R    (LYS33) to   (ARG165)  PROTEASOME FROM THERMOPLASMA ACIDOPHILUM  |   PROTEASE, PROTEASOME, HYDROLASE 
1pma:S    (LYS33) to   (ARG165)  PROTEASOME FROM THERMOPLASMA ACIDOPHILUM  |   PROTEASE, PROTEASOME, HYDROLASE 
1pma:T    (LYS33) to   (ARG165)  PROTEASOME FROM THERMOPLASMA ACIDOPHILUM  |   PROTEASE, PROTEASOME, HYDROLASE 
1pma:V    (LYS33) to   (ARG165)  PROTEASOME FROM THERMOPLASMA ACIDOPHILUM  |   PROTEASE, PROTEASOME, HYDROLASE 
1pma:X    (LYS33) to   (ARG165)  PROTEASOME FROM THERMOPLASMA ACIDOPHILUM  |   PROTEASE, PROTEASOME, HYDROLASE 
1pma:1    (LYS33) to   (ARG165)  PROTEASOME FROM THERMOPLASMA ACIDOPHILUM  |   PROTEASE, PROTEASOME, HYDROLASE 
1pma:2    (LYS33) to   (ARG165)  PROTEASOME FROM THERMOPLASMA ACIDOPHILUM  |   PROTEASE, PROTEASOME, HYDROLASE 
3gpj:E    (LYS66) to    (ILE18)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B  |   PROTEASOME, VIRULENCE, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpj:G    (TYR66) to   (GLY202)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B  |   PROTEASOME, VIRULENCE, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpj:I    (LYS33) to   (ASP166)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B  |   PROTEASOME, VIRULENCE, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpj:L    (LYS33) to   (ARG165)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B  |   PROTEASOME, VIRULENCE, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpj:N    (LYS33) to   (ASN141)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B  |   PROTEASOME, VIRULENCE, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpj:S    (LYS66) to    (ILE18)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B  |   PROTEASOME, VIRULENCE, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpj:W    (LYS33) to   (ASP166)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B  |   PROTEASOME, VIRULENCE, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpj:Z    (LYS33) to   (ARG165)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B  |   PROTEASOME, VIRULENCE, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpj:1    (ARG33) to   (ARG165)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B  |   PROTEASOME, VIRULENCE, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpj:2    (LYS33) to   (ASN141)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B  |   PROTEASOME, VIRULENCE, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpw:E    (LYS66) to    (ILE18)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND  |   PROTEASOME, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, TIME- DEPENDENT ELIMINATION OF A DEFINED LEAVING GROUP, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpw:G    (TYR66) to   (GLY202)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND  |   PROTEASOME, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, TIME- DEPENDENT ELIMINATION OF A DEFINED LEAVING GROUP, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpw:I    (LYS33) to   (ASP166)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND  |   PROTEASOME, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, TIME- DEPENDENT ELIMINATION OF A DEFINED LEAVING GROUP, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpw:J    (LYS33) to   (HIS141)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND  |   PROTEASOME, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, TIME- DEPENDENT ELIMINATION OF A DEFINED LEAVING GROUP, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpw:L    (LYS33) to   (ARG165)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND  |   PROTEASOME, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, TIME- DEPENDENT ELIMINATION OF A DEFINED LEAVING GROUP, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpw:M    (ARG33) to   (ARG165)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND  |   PROTEASOME, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, TIME- DEPENDENT ELIMINATION OF A DEFINED LEAVING GROUP, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpw:N    (LYS33) to   (ASN141)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND  |   PROTEASOME, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, TIME- DEPENDENT ELIMINATION OF A DEFINED LEAVING GROUP, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpw:S    (LYS66) to    (ILE18)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND  |   PROTEASOME, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, TIME- DEPENDENT ELIMINATION OF A DEFINED LEAVING GROUP, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpw:U    (TYR66) to   (GLY202)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND  |   PROTEASOME, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, TIME- DEPENDENT ELIMINATION OF A DEFINED LEAVING GROUP, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpw:W    (LYS33) to   (ASP166)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND  |   PROTEASOME, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, TIME- DEPENDENT ELIMINATION OF A DEFINED LEAVING GROUP, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpw:X    (LYS33) to   (HIS141)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND  |   PROTEASOME, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, TIME- DEPENDENT ELIMINATION OF A DEFINED LEAVING GROUP, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpw:Z    (LYS33) to   (ARG165)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND  |   PROTEASOME, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, TIME- DEPENDENT ELIMINATION OF A DEFINED LEAVING GROUP, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpw:1    (ARG33) to   (ARG165)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND  |   PROTEASOME, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, TIME- DEPENDENT ELIMINATION OF A DEFINED LEAVING GROUP, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpw:2    (LYS33) to   (ASN141)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND  |   PROTEASOME, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, TIME- DEPENDENT ELIMINATION OF A DEFINED LEAVING GROUP, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
4y69:E    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y69:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y69:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y69:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y69:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y69:S    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y69:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y69:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y69:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y69:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6a:E    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6a:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6a:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6a:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6a:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6a:S    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6a:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6a:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6a:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6a:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6v:E    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6v:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6v:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6v:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6v:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6v:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6v:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6v:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6v:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6v:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6z:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y6z:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y6z:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y6z:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y6z:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y6z:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y6z:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y6z:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y6z:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y70:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y70:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y70:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y70:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y70:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y70:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y70:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y70:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y70:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y70:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y74:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y74:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y74:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y74:M    (ARG41) to   (THR168)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y74:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y74:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y74:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y74:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y74:a    (ARG41) to   (THR168)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y74:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y77:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y77:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y77:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y77:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y77:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y77:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y77:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y77:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y77:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y77:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y78:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y78:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y78:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y78:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y78:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y78:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y78:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y78:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y78:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y78:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4j70:E    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E  |   PROTEASOME, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, BETA-LACTONE, NTN HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4j70:J    (LYS34) to   (HIS147)  YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E  |   PROTEASOME, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, BETA-LACTONE, NTN HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4j70:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E  |   PROTEASOME, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, BETA-LACTONE, NTN HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4j70:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E  |   PROTEASOME, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, BETA-LACTONE, NTN HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4j70:S    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E  |   PROTEASOME, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, BETA-LACTONE, NTN HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4j70:X    (LYS34) to   (HIS147)  YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E  |   PROTEASOME, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, BETA-LACTONE, NTN HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4j70:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E  |   PROTEASOME, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, BETA-LACTONE, NTN HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4j70:a    (ARG41) to   (THR168)  YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E  |   PROTEASOME, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, BETA-LACTONE, NTN HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4j70:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E  |   PROTEASOME, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, BETA-LACTONE, NTN HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y7w:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7w:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7w:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7w:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7w:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7w:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7w:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7w:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7w:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7w:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7x:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7x:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7x:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7x:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7x:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7x:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7x:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7x:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7x:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7x:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7y:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7y:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7y:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7y:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7y:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7y:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7y:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7y:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7y:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7y:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y80:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y80:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y80:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y80:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y80:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y80:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y80:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y80:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y80:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y80:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y81:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y81:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y81:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y81:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y81:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y81:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y81:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y81:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y81:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y81:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y82:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y82:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y82:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y82:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y82:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y82:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y82:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y82:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y82:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y82:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y84:C    (LYS61) to   (LEU198)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(4,4-F2P)NLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y84:E    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(4,4-F2P)NLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y84:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(4,4-F2P)NLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y84:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(4,4-F2P)NLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y84:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(4,4-F2P)NLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y84:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(4,4-F2P)NLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y84:Q    (LYS61) to   (LEU198)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(4,4-F2P)NLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y84:S    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(4,4-F2P)NLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y84:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(4,4-F2P)NLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y84:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(4,4-F2P)NLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y84:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(4,4-F2P)NLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8g:C    (LYS61) to   (LEU198)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8g:E    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8g:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8g:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8g:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8g:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8g:Q    (LYS61) to   (LEU198)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8g:S    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8g:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8g:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8g:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8g:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8h:C    (LYS61) to   (LEU198)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8h:E    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8h:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8h:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8h:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8h:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8h:Q    (LYS61) to   (LEU198)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8h:S    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8h:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8h:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8h:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8h:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8j:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8j:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8j:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8j:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8j:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8j:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8j:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8j:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8j:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8j:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8l:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8l:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8l:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8l:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8l:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8l:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8l:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8l:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8l:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8l:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8m:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8m:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8m:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8m:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8m:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8m:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8m:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8m:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8m:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8m:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8n:E    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8n:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8n:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8n:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8n:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8n:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8n:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8n:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8n:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8n:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8o:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8o:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8o:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8o:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8o:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8o:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8o:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8o:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8o:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8o:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
1q5q:A    (LYS52) to   (GLN190)  THE RHODOCOCCUS 20S PROTEASOME  |   PROTEASOME ASSEMBLY, PRO-PEPTIDE, INTER-SUBUNIT CONTACTS, RHODOCOCCUS ERYTHROPOLIS, HYDROLASE 
1q5q:B    (LYS52) to   (GLN190)  THE RHODOCOCCUS 20S PROTEASOME  |   PROTEASOME ASSEMBLY, PRO-PEPTIDE, INTER-SUBUNIT CONTACTS, RHODOCOCCUS ERYTHROPOLIS, HYDROLASE 
1q5q:C    (LYS52) to   (GLN190)  THE RHODOCOCCUS 20S PROTEASOME  |   PROTEASOME ASSEMBLY, PRO-PEPTIDE, INTER-SUBUNIT CONTACTS, RHODOCOCCUS ERYTHROPOLIS, HYDROLASE 
1q5q:D    (LYS52) to   (GLN190)  THE RHODOCOCCUS 20S PROTEASOME  |   PROTEASOME ASSEMBLY, PRO-PEPTIDE, INTER-SUBUNIT CONTACTS, RHODOCOCCUS ERYTHROPOLIS, HYDROLASE 
1q5q:E    (LYS52) to   (GLN190)  THE RHODOCOCCUS 20S PROTEASOME  |   PROTEASOME ASSEMBLY, PRO-PEPTIDE, INTER-SUBUNIT CONTACTS, RHODOCOCCUS ERYTHROPOLIS, HYDROLASE 
1q5q:F    (LYS52) to   (GLN190)  THE RHODOCOCCUS 20S PROTEASOME  |   PROTEASOME ASSEMBLY, PRO-PEPTIDE, INTER-SUBUNIT CONTACTS, RHODOCOCCUS ERYTHROPOLIS, HYDROLASE 
1q5q:G    (LYS52) to   (GLN190)  THE RHODOCOCCUS 20S PROTEASOME  |   PROTEASOME ASSEMBLY, PRO-PEPTIDE, INTER-SUBUNIT CONTACTS, RHODOCOCCUS ERYTHROPOLIS, HYDROLASE 
4y8q:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8q:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8q:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8q:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8q:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8q:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8q:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8q:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8q:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8q:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8s:E    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8s:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8s:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8s:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8s:S    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8s:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8s:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8s:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8t:E    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8t:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8t:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8t:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8t:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8t:S    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8t:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8t:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8t:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8t:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8u:E    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8u:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8u:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8u:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8u:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8u:S    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8u:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8u:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8u:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8u:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y9y:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA2-H116E MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y9y:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA2-H116E MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y9y:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA2-H116E MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y9y:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA2-H116E MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y9y:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA2-H116E MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y9y:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA2-H116E MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y9y:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA2-H116E MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y9y:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA2-H116E MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y9y:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA2-H116E MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y9y:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA2-H116E MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y9z:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y9z:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y9z:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y9z:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y9z:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y9z:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y9z:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y9z:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y9z:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y9z:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya0:E    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya0:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya0:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya0:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya0:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya0:S    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya0:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya0:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya0:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya0:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya1:E    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME BETA2-H116N MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya1:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA2-H116N MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya1:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA2-H116N MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya1:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA2-H116N MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya1:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA2-H116N MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya1:S    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME BETA2-H116N MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya1:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA2-H116N MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya1:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA2-H116N MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya1:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA2-H116N MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya1:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA2-H116N MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya2:E    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya2:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya2:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya2:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya2:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya2:S    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya2:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya2:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya2:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya2:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya3:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya3:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya3:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya3:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya3:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya3:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya3:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya3:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya3:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya3:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya4:E    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME BETA2-H114D MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya4:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA2-H114D MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya4:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA2-H114D MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya4:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA2-H114D MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya4:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA2-H114D MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya4:S    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME BETA2-H114D MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya4:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA2-H114D MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya4:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA2-H114D MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya4:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA2-H114D MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya4:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA2-H114D MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya7:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya7:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya7:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya7:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya7:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya7:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya7:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya7:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya7:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya7:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya9:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya9:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya9:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya9:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya9:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya9:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya9:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya9:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya9:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya9:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
3h4p:E    (LYS67) to   (ASN202)  PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII  |   20S, PROTEASOME, CORE PARTICLE, HYDROLASE, PROTEASE, THREONINE PROTEASE 
3h4p:a    (LYS39) to   (ARG174)  PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII  |   20S, PROTEASOME, CORE PARTICLE, HYDROLASE, PROTEASE, THREONINE PROTEASE 
3h4p:b    (LYS39) to   (ASP175)  PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII  |   20S, PROTEASOME, CORE PARTICLE, HYDROLASE, PROTEASE, THREONINE PROTEASE 
3h4p:c    (LYS39) to   (ARG174)  PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII  |   20S, PROTEASOME, CORE PARTICLE, HYDROLASE, PROTEASE, THREONINE PROTEASE 
3h4p:d    (LYS39) to   (ARG174)  PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII  |   20S, PROTEASOME, CORE PARTICLE, HYDROLASE, PROTEASE, THREONINE PROTEASE 
3h4p:e    (LYS39) to   (ARG174)  PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII  |   20S, PROTEASOME, CORE PARTICLE, HYDROLASE, PROTEASE, THREONINE PROTEASE 
3h4p:f    (LYS39) to   (ARG174)  PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII  |   20S, PROTEASOME, CORE PARTICLE, HYDROLASE, PROTEASE, THREONINE PROTEASE 
3h4p:g    (LYS39) to   (ARG174)  PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII  |   20S, PROTEASOME, CORE PARTICLE, HYDROLASE, PROTEASE, THREONINE PROTEASE 
3h4p:H    (LYS67) to   (ASN202)  PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII  |   20S, PROTEASOME, CORE PARTICLE, HYDROLASE, PROTEASE, THREONINE PROTEASE 
3h4p:h    (LYS39) to   (ARG174)  PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII  |   20S, PROTEASOME, CORE PARTICLE, HYDROLASE, PROTEASE, THREONINE PROTEASE 
3h4p:i    (LYS39) to   (ARG174)  PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII  |   20S, PROTEASOME, CORE PARTICLE, HYDROLASE, PROTEASE, THREONINE PROTEASE 
3h4p:j    (LYS39) to   (ASP175)  PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII  |   20S, PROTEASOME, CORE PARTICLE, HYDROLASE, PROTEASE, THREONINE PROTEASE 
3h4p:k    (LYS39) to   (ARG174)  PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII  |   20S, PROTEASOME, CORE PARTICLE, HYDROLASE, PROTEASE, THREONINE PROTEASE 
3h4p:l    (LYS39) to   (ASP175)  PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII  |   20S, PROTEASOME, CORE PARTICLE, HYDROLASE, PROTEASE, THREONINE PROTEASE 
3h4p:m    (LYS39) to   (ARG174)  PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII  |   20S, PROTEASOME, CORE PARTICLE, HYDROLASE, PROTEASE, THREONINE PROTEASE 
3h4p:n    (LYS39) to   (ARG174)  PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII  |   20S, PROTEASOME, CORE PARTICLE, HYDROLASE, PROTEASE, THREONINE PROTEASE 
3h6f:C   (LYS333) to   (SER479)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME 
3h6f:E   (LYS333) to   (SER479)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME 
3h6f:G   (LYS333) to   (SER479)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME 
3h6f:H   (LYS333) to   (SER479)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME 
3h6f:J   (LYS333) to   (SER479)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME 
3h6f:L   (LYS333) to   (ASP476)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME 
3h6f:N   (LYS333) to   (SER479)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME 
3h6f:P   (LYS333) to   (ASP477)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME 
3h6f:R   (LYS333) to   (SER479)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME 
3h6f:T   (LYS333) to   (ASP477)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME 
3h6f:V   (LYS333) to   (SER479)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME 
3h6f:X   (LYS333) to   (SER479)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME 
3h6f:Z   (LYS333) to   (ASP476)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME 
3h6f:2   (LYS333) to   (ASP477)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME 
3h6i:C   (LYS333) to   (SER479)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME 
3h6i:E   (LYS333) to   (SER479)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME 
3h6i:G   (LYS333) to   (SER479)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME 
3h6i:H   (LYS333) to   (SER479)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME 
3h6i:J   (LYS333) to   (SER479)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME 
3h6i:L   (LYS333) to   (ASP477)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME 
3h6i:N   (LYS333) to   (ASP477)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME 
3h6i:P   (LYS333) to   (SER479)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME 
3h6i:R   (LYS333) to   (SER479)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME 
3h6i:T   (LYS333) to   (ASP477)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME 
3h6i:V   (LYS333) to   (SER479)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME 
3h6i:X   (LYS333) to   (SER479)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME 
3h6i:Z   (LYS333) to   (SER479)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME 
3h6i:2   (LYS333) to   (SER479)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME 
4jsq:E    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsq:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsq:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsq:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsq:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsq:S    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsq:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsq:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsq:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsq:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsu:E    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsu:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsu:J    (LYS34) to   (LYS170)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsu:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsu:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsu:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsu:S    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsu:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsu:X    (LYS34) to   (LYS170)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsu:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsu:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsu:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jt0:E    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jt0:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jt0:J    (LYS34) to   (LYS170)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jt0:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jt0:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jt0:S    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jt0:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jt0:X    (LYS34) to   (LYS170)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jt0:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jt0:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3hf9:H    (LYS33) to   (ASP176)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME 
3hf9:E    (LYS33) to   (ASP176)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME 
3hf9:G    (LYS33) to   (ASP176)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME 
3hf9:J    (LYS33) to   (ASP176)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME 
3hf9:N    (LYS33) to   (ASP176)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME 
3hf9:P    (LYS33) to   (ASP176)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME 
3hf9:R    (LYS33) to   (ASP176)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME 
3hf9:T    (LYS33) to   (ASP176)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME 
3hf9:V    (LYS33) to   (ASP176)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME 
3hf9:X    (LYS33) to   (ASP176)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME 
3hf9:Z    (LYS33) to   (ASP176)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME 
3hf9:2    (LYS33) to   (ASP176)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME 
3hf9:h   (LYS333) to   (ASP476)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME 
3hf9:c   (LYS333) to   (ASP476)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME 
3hf9:e   (LYS333) to   (ASP476)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME 
3hf9:g   (LYS333) to   (ASP476)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME 
3hf9:j   (LYS333) to   (ASP476)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME 
3hf9:l   (LYS333) to   (ASP476)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME 
3hf9:n   (LYS333) to   (ASP476)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME 
3hf9:p   (LYS333) to   (ASP476)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME 
3hf9:r   (LYS333) to   (ASP476)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME 
3hf9:t   (LYS333) to   (ASP476)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME 
3hf9:v   (LYS333) to   (ASP476)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME 
3hf9:x   (LYS333) to   (ASP476)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME 
3hf9:z   (LYS333) to   (ASP476)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME 
1fnt:E    (LYS66) to   (GLN206)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION  |   MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, PROTEASE, PROTEASOME ACTIVATOR, CELL ADHESION, INTERFERON INDUCTION, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX 
1fnt:F    (SER57) to   (ILE182)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION  |   MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, PROTEASE, PROTEASOME ACTIVATOR, CELL ADHESION, INTERFERON INDUCTION, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX 
1fnt:H    (LYS33) to   (TRP165)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION  |   MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, PROTEASE, PROTEASOME ACTIVATOR, CELL ADHESION, INTERFERON INDUCTION, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX 
1fnt:M    (LYS33) to   (ARG185)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION  |   MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, PROTEASE, PROTEASOME ACTIVATOR, CELL ADHESION, INTERFERON INDUCTION, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX 
1fnt:O    (TYR71) to   (ALA213)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION  |   MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, PROTEASE, PROTEASOME ACTIVATOR, CELL ADHESION, INTERFERON INDUCTION, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX 
1fnt:S    (LYS66) to   (GLN206)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION  |   MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, PROTEASE, PROTEASOME ACTIVATOR, CELL ADHESION, INTERFERON INDUCTION, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX 
1fnt:T    (SER57) to   (ILE182)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION  |   MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, PROTEASE, PROTEASOME ACTIVATOR, CELL ADHESION, INTERFERON INDUCTION, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX 
1fnt:a    (LYS33) to   (ARG185)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION  |   MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, PROTEASE, PROTEASOME ACTIVATOR, CELL ADHESION, INTERFERON INDUCTION, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX 
2f16:E    (LYS66) to    (ILE18)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB  |   BETA-SANDWICH FLANKED BY HELICES, COMPLEX STRUCTURE COVALENTLY BOUND TO THE SYNTHETIC INIHIBTOR BORTEZOMIB, HYDROLASE 
2f16:I    (LYS33) to   (ASP166)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB  |   BETA-SANDWICH FLANKED BY HELICES, COMPLEX STRUCTURE COVALENTLY BOUND TO THE SYNTHETIC INIHIBTOR BORTEZOMIB, HYDROLASE 
2f16:J    (LYS33) to   (LYS164)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB  |   BETA-SANDWICH FLANKED BY HELICES, COMPLEX STRUCTURE COVALENTLY BOUND TO THE SYNTHETIC INIHIBTOR BORTEZOMIB, HYDROLASE 
2f16:L    (LYS33) to   (ARG165)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB  |   BETA-SANDWICH FLANKED BY HELICES, COMPLEX STRUCTURE COVALENTLY BOUND TO THE SYNTHETIC INIHIBTOR BORTEZOMIB, HYDROLASE 
2f16:M    (ARG33) to   (ARG165)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB  |   BETA-SANDWICH FLANKED BY HELICES, COMPLEX STRUCTURE COVALENTLY BOUND TO THE SYNTHETIC INIHIBTOR BORTEZOMIB, HYDROLASE 
2f16:N    (LYS33) to   (ASN141)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB  |   BETA-SANDWICH FLANKED BY HELICES, COMPLEX STRUCTURE COVALENTLY BOUND TO THE SYNTHETIC INIHIBTOR BORTEZOMIB, HYDROLASE 
2f16:S    (LYS66) to    (ILE18)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB  |   BETA-SANDWICH FLANKED BY HELICES, COMPLEX STRUCTURE COVALENTLY BOUND TO THE SYNTHETIC INIHIBTOR BORTEZOMIB, HYDROLASE 
2f16:W    (LYS33) to   (ASP166)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB  |   BETA-SANDWICH FLANKED BY HELICES, COMPLEX STRUCTURE COVALENTLY BOUND TO THE SYNTHETIC INIHIBTOR BORTEZOMIB, HYDROLASE 
2f16:X    (LYS33) to   (LYS164)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB  |   BETA-SANDWICH FLANKED BY HELICES, COMPLEX STRUCTURE COVALENTLY BOUND TO THE SYNTHETIC INIHIBTOR BORTEZOMIB, HYDROLASE 
2f16:Z    (LYS33) to   (ARG165)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB  |   BETA-SANDWICH FLANKED BY HELICES, COMPLEX STRUCTURE COVALENTLY BOUND TO THE SYNTHETIC INIHIBTOR BORTEZOMIB, HYDROLASE 
2f16:1    (ARG33) to   (ARG165)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB  |   BETA-SANDWICH FLANKED BY HELICES, COMPLEX STRUCTURE COVALENTLY BOUND TO THE SYNTHETIC INIHIBTOR BORTEZOMIB, HYDROLASE 
2f16:2    (LYS33) to   (ASN141)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB  |   BETA-SANDWICH FLANKED BY HELICES, COMPLEX STRUCTURE COVALENTLY BOUND TO THE SYNTHETIC INIHIBTOR BORTEZOMIB, HYDROLASE 
3un4:E    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE -HYDROLASE-INHIBITOR COMPLEX, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
3un4:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE -HYDROLASE-INHIBITOR COMPLEX, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
3un4:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE -HYDROLASE-INHIBITOR COMPLEX, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
3un4:M    (ARG41) to   (THR168)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE -HYDROLASE-INHIBITOR COMPLEX, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
3un4:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE -HYDROLASE-INHIBITOR COMPLEX, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
3un4:S    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE -HYDROLASE-INHIBITOR COMPLEX, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
3un4:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE -HYDROLASE-INHIBITOR COMPLEX, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
3un4:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE -HYDROLASE-INHIBITOR COMPLEX, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
3un4:a    (ARG41) to   (THR168)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE -HYDROLASE-INHIBITOR COMPLEX, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
3un4:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE -HYDROLASE-INHIBITOR COMPLEX, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
3un8:E    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBTIOR COMPLEX 
3un8:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBTIOR COMPLEX 
3un8:K    (LYS33) to   (ASP168)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBTIOR COMPLEX 
3un8:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBTIOR COMPLEX 
3un8:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBTIOR COMPLEX 
3un8:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBTIOR COMPLEX 
3un8:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBTIOR COMPLEX 
3un8:X    (LYS34) to   (HIS147)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBTIOR COMPLEX 
3un8:Y    (LYS33) to   (ARG167)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBTIOR COMPLEX 
3un8:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBTIOR COMPLEX 
3un8:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBTIOR COMPLEX 
1g0u:E    (SER59) to   (ILE180)  A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE  |   PROTEASOME, UBIQUITIN, DEGRADATION, PROTEASE, NTN-HYDROLASE 
1g0u:G    (TYR66) to   (ALA200)  A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE  |   PROTEASOME, UBIQUITIN, DEGRADATION, PROTEASE, NTN-HYDROLASE 
1g0u:I    (LYS33) to   (ASP166)  A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE  |   PROTEASOME, UBIQUITIN, DEGRADATION, PROTEASE, NTN-HYDROLASE 
1g0u:J    (LYS33) to   (HIS141)  A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE  |   PROTEASOME, UBIQUITIN, DEGRADATION, PROTEASE, NTN-HYDROLASE 
1g0u:L    (LYS33) to   (ARG165)  A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE  |   PROTEASOME, UBIQUITIN, DEGRADATION, PROTEASE, NTN-HYDROLASE 
1g0u:N    (LYS33) to   (ASN141)  A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE  |   PROTEASOME, UBIQUITIN, DEGRADATION, PROTEASE, NTN-HYDROLASE 
1g0u:R    (LYS66) to   (GLU179)  A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE  |   PROTEASOME, UBIQUITIN, DEGRADATION, PROTEASE, NTN-HYDROLASE 
1g0u:S    (SER59) to   (ILE180)  A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE  |   PROTEASOME, UBIQUITIN, DEGRADATION, PROTEASE, NTN-HYDROLASE 
1g0u:W    (LYS33) to   (ASP166)  A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE  |   PROTEASOME, UBIQUITIN, DEGRADATION, PROTEASE, NTN-HYDROLASE 
1g0u:X    (LYS33) to   (HIS141)  A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE  |   PROTEASOME, UBIQUITIN, DEGRADATION, PROTEASE, NTN-HYDROLASE 
1g0u:Z    (LYS33) to   (ARG165)  A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE  |   PROTEASOME, UBIQUITIN, DEGRADATION, PROTEASE, NTN-HYDROLASE 
1g0u:1    (ARG33) to   (ASP166)  A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE  |   PROTEASOME, UBIQUITIN, DEGRADATION, PROTEASE, NTN-HYDROLASE 
1g0u:2    (LYS33) to   (ASN141)  A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE  |   PROTEASOME, UBIQUITIN, DEGRADATION, PROTEASE, NTN-HYDROLASE 
2fak:E    (SER59) to    (ILE18)  CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME  |   PROTEASOME, UBIQUITIN, DRUG DESIGN, INHIBITOR, PROTEASE, HYDROLASE 
2fak:I    (LYS33) to   (ASP166)  CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME  |   PROTEASOME, UBIQUITIN, DRUG DESIGN, INHIBITOR, PROTEASE, HYDROLASE 
2fak:J    (LYS33) to   (HIS141)  CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME  |   PROTEASOME, UBIQUITIN, DRUG DESIGN, INHIBITOR, PROTEASE, HYDROLASE 
2fak:L    (LYS33) to   (ARG165)  CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME  |   PROTEASOME, UBIQUITIN, DRUG DESIGN, INHIBITOR, PROTEASE, HYDROLASE 
2fak:M    (ARG33) to   (ARG165)  CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME  |   PROTEASOME, UBIQUITIN, DRUG DESIGN, INHIBITOR, PROTEASE, HYDROLASE 
2fak:N    (LYS33) to   (ASN141)  CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME  |   PROTEASOME, UBIQUITIN, DRUG DESIGN, INHIBITOR, PROTEASE, HYDROLASE 
2fak:S    (SER59) to    (ILE18)  CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME  |   PROTEASOME, UBIQUITIN, DRUG DESIGN, INHIBITOR, PROTEASE, HYDROLASE 
2fak:W    (LYS33) to   (ASP166)  CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME  |   PROTEASOME, UBIQUITIN, DRUG DESIGN, INHIBITOR, PROTEASE, HYDROLASE 
2fak:X    (LYS33) to   (HIS141)  CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME  |   PROTEASOME, UBIQUITIN, DRUG DESIGN, INHIBITOR, PROTEASE, HYDROLASE 
2fak:Z    (LYS33) to   (ARG165)  CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME  |   PROTEASOME, UBIQUITIN, DRUG DESIGN, INHIBITOR, PROTEASE, HYDROLASE 
2fak:1    (ARG33) to   (ARG165)  CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME  |   PROTEASOME, UBIQUITIN, DRUG DESIGN, INHIBITOR, PROTEASE, HYDROLASE 
2fak:2    (LYS33) to   (ASN141)  CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME  |   PROTEASOME, UBIQUITIN, DRUG DESIGN, INHIBITOR, PROTEASE, HYDROLASE 
3une:F    (ARG65) to   (HIS201)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:I    (LYS40) to   (ASP177)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:J    (LYS34) to   (LYS169)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:L    (LYS42) to   (ARG185)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:N    (LYS33) to   (THR142)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:O    (LYS63) to   (GLU196)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:T    (ARG65) to   (HIS201)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:W    (LYS40) to   (ASP177)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:X    (LYS34) to   (LYS169)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:Z    (LYS42) to   (ARG185)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:b    (LYS33) to   (THR142)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:h    (ARG65) to   (HIS201)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:k    (LYS40) to   (ASP177)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:n    (LYS42) to   (ARG185)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:o    (ARG41) to   (ARG179)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:p    (LYS33) to   (THR142)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:v    (ARG65) to   (HIS201)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:y    (LYS40) to   (ASP177)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:z    (LYS34) to   (LYS169)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:2    (LYS42) to   (ARG185)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:3    (ARG41) to   (ARG179)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:4    (LYS33) to   (THR142)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3unf:F    (ARG65) to   (HIS201)  MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unf:J    (LYS34) to   (LYS169)  MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unf:L    (LYS42) to   (ARG185)  MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unf:M    (ARG41) to   (ARG179)  MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unf:N    (LYS33) to   (ALA140)  MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unf:T    (ARG65) to   (HIS201)  MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unf:X    (LYS34) to   (LYS169)  MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unf:Z    (LYS42) to   (ARG185)  MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unf:a    (ARG41) to   (ARG179)  MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unf:b    (LYS33) to   (ALA140)  MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4z1l:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3  |   HYDROLASE, PROTEASOME, INHIBITOR, BINDING ANALYSIS, LEAD STRUCTURE MOTIF, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4z1l:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3  |   HYDROLASE, PROTEASOME, INHIBITOR, BINDING ANALYSIS, LEAD STRUCTURE MOTIF, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4z1l:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3  |   HYDROLASE, PROTEASOME, INHIBITOR, BINDING ANALYSIS, LEAD STRUCTURE MOTIF, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4z1l:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3  |   HYDROLASE, PROTEASOME, INHIBITOR, BINDING ANALYSIS, LEAD STRUCTURE MOTIF, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4z1l:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3  |   HYDROLASE, PROTEASOME, INHIBITOR, BINDING ANALYSIS, LEAD STRUCTURE MOTIF, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4z1l:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3  |   HYDROLASE, PROTEASOME, INHIBITOR, BINDING ANALYSIS, LEAD STRUCTURE MOTIF, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4z1l:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3  |   HYDROLASE, PROTEASOME, INHIBITOR, BINDING ANALYSIS, LEAD STRUCTURE MOTIF, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4z1l:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3  |   HYDROLASE, PROTEASOME, INHIBITOR, BINDING ANALYSIS, LEAD STRUCTURE MOTIF, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unh:F    (ARG65) to   (HIS201)  MOUSE 20S IMMUNOPROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3unh:I    (LYS40) to   (ASP177)  MOUSE 20S IMMUNOPROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3unh:J    (LYS34) to   (LYS169)  MOUSE 20S IMMUNOPROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3unh:L    (LYS42) to   (ARG185)  MOUSE 20S IMMUNOPROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3unh:M    (ARG41) to   (ARG179)  MOUSE 20S IMMUNOPROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3unh:N    (LYS33) to   (ALA140)  MOUSE 20S IMMUNOPROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3unh:T    (ARG65) to   (HIS201)  MOUSE 20S IMMUNOPROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3unh:V    (LYS33) to   (LEU164)  MOUSE 20S IMMUNOPROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3unh:W    (LYS40) to   (ASP177)  MOUSE 20S IMMUNOPROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3unh:X    (LYS34) to   (LYS169)  MOUSE 20S IMMUNOPROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3unh:Z    (LYS42) to   (ARG185)  MOUSE 20S IMMUNOPROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3unh:a    (ARG41) to   (ARG179)  MOUSE 20S IMMUNOPROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3unh:b    (LYS33) to   (ALA140)  MOUSE 20S IMMUNOPROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
1g3i:G    (LYS33) to   (ILE159)  CRYSTAL STRUCTURE OF THE HSLUV PROTEASE-CHAPERONE COMPLEX  |   CHAPERONE/HYDROLASE 
1g3i:H    (LYS33) to   (ILE159)  CRYSTAL STRUCTURE OF THE HSLUV PROTEASE-CHAPERONE COMPLEX  |   CHAPERONE/HYDROLASE 
1g3i:I    (LYS33) to   (ILE159)  CRYSTAL STRUCTURE OF THE HSLUV PROTEASE-CHAPERONE COMPLEX  |   CHAPERONE/HYDROLASE 
1g3i:J    (LYS33) to   (ILE159)  CRYSTAL STRUCTURE OF THE HSLUV PROTEASE-CHAPERONE COMPLEX  |   CHAPERONE/HYDROLASE 
1g3i:K    (LYS33) to   (ILE159)  CRYSTAL STRUCTURE OF THE HSLUV PROTEASE-CHAPERONE COMPLEX  |   CHAPERONE/HYDROLASE 
1g3i:L    (LYS33) to   (ILE159)  CRYSTAL STRUCTURE OF THE HSLUV PROTEASE-CHAPERONE COMPLEX  |   CHAPERONE/HYDROLASE 
1g3i:O    (LYS33) to   (ILE159)  CRYSTAL STRUCTURE OF THE HSLUV PROTEASE-CHAPERONE COMPLEX  |   CHAPERONE/HYDROLASE 
1g3i:P    (LYS33) to   (ILE159)  CRYSTAL STRUCTURE OF THE HSLUV PROTEASE-CHAPERONE COMPLEX  |   CHAPERONE/HYDROLASE 
1g3i:Q    (LYS33) to   (ILE159)  CRYSTAL STRUCTURE OF THE HSLUV PROTEASE-CHAPERONE COMPLEX  |   CHAPERONE/HYDROLASE 
1g3i:R    (LYS33) to   (ILE159)  CRYSTAL STRUCTURE OF THE HSLUV PROTEASE-CHAPERONE COMPLEX  |   CHAPERONE/HYDROLASE 
1g65:E    (SER59) to   (ILE180)  CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHA,BETA-EPOXYKETONE PROTEASOME INHIBITORS  |   PROTEASOME, EPOXOMICIN, UBIQUITIN, NTN-HYDOLASE, PROTEASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1g65:I    (LYS33) to   (ASP166)  CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHA,BETA-EPOXYKETONE PROTEASOME INHIBITORS  |   PROTEASOME, EPOXOMICIN, UBIQUITIN, NTN-HYDOLASE, PROTEASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1g65:J    (LYS33) to   (LYS164)  CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHA,BETA-EPOXYKETONE PROTEASOME INHIBITORS  |   PROTEASOME, EPOXOMICIN, UBIQUITIN, NTN-HYDOLASE, PROTEASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1g65:L    (LYS33) to   (ARG165)  CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHA,BETA-EPOXYKETONE PROTEASOME INHIBITORS  |   PROTEASOME, EPOXOMICIN, UBIQUITIN, NTN-HYDOLASE, PROTEASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1g65:N    (LYS33) to   (ASN141)  CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHA,BETA-EPOXYKETONE PROTEASOME INHIBITORS  |   PROTEASOME, EPOXOMICIN, UBIQUITIN, NTN-HYDOLASE, PROTEASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1g65:S    (LYS66) to   (ILE182)  CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHA,BETA-EPOXYKETONE PROTEASOME INHIBITORS  |   PROTEASOME, EPOXOMICIN, UBIQUITIN, NTN-HYDOLASE, PROTEASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1g65:U    (TYR66) to   (GLY202)  CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHA,BETA-EPOXYKETONE PROTEASOME INHIBITORS  |   PROTEASOME, EPOXOMICIN, UBIQUITIN, NTN-HYDOLASE, PROTEASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1g65:W    (LYS33) to   (ASP166)  CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHA,BETA-EPOXYKETONE PROTEASOME INHIBITORS  |   PROTEASOME, EPOXOMICIN, UBIQUITIN, NTN-HYDOLASE, PROTEASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1g65:X    (LYS33) to   (MET166)  CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHA,BETA-EPOXYKETONE PROTEASOME INHIBITORS  |   PROTEASOME, EPOXOMICIN, UBIQUITIN, NTN-HYDOLASE, PROTEASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1g65:Z    (LYS33) to   (ARG165)  CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHA,BETA-EPOXYKETONE PROTEASOME INHIBITORS  |   PROTEASOME, EPOXOMICIN, UBIQUITIN, NTN-HYDOLASE, PROTEASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1g65:1    (LEU34) to   (ASP166)  CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHA,BETA-EPOXYKETONE PROTEASOME INHIBITORS  |   PROTEASOME, EPOXOMICIN, UBIQUITIN, NTN-HYDOLASE, PROTEASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1g65:2    (LYS33) to   (ASN141)  CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHA,BETA-EPOXYKETONE PROTEASOME INHIBITORS  |   PROTEASOME, EPOXOMICIN, UBIQUITIN, NTN-HYDOLASE, PROTEASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1ryp:F    (LYS62) to   (ILE182)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION  |   MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, HYDROLASE, PROTEASE 
1ryp:H    (LYS33) to   (LYS164)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION  |   MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, HYDROLASE, PROTEASE 
1ryp:J    (LYS33) to   (ASP169)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION  |   MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, HYDROLASE, PROTEASE 
1ryp:K    (LYS33) to   (HIS146)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION  |   MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, HYDROLASE, PROTEASE 
1ryp:M    (LYS33) to   (ARG185)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION  |   MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, HYDROLASE, PROTEASE 
1ryp:T    (LYS62) to   (ILE182)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION  |   MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, HYDROLASE, PROTEASE 
1ryp:V    (LYS33) to   (ASN141)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION  |   MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, HYDROLASE, PROTEASE 
1ryp:X    (LYS33) to   (ASP169)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION  |   MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, HYDROLASE, PROTEASE 
1ryp:Y    (LYS33) to   (HIS146)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION  |   MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, HYDROLASE, PROTEASE 
1ryp:1    (LYS33) to   (ARG185)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION  |   MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, HYDROLASE, PROTEASE 
1ryp:2    (ARG33) to   (ARG179)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION  |   MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, HYDROLASE, PROTEASE 
3hye:E    (LYS66) to    (ILE18)  CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE  |   CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, PROTEASOME, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3hye:I    (LYS33) to   (ASP166)  CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE  |   CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, PROTEASOME, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3hye:J    (LYS33) to   (HIS141)  CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE  |   CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, PROTEASOME, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3hye:L    (LYS33) to   (ARG165)  CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE  |   CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, PROTEASOME, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3hye:M    (ARG33) to   (ARG165)  CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE  |   CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, PROTEASOME, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3hye:N    (LYS33) to   (ASN141)  CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE  |   CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, PROTEASOME, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3hye:S    (LYS66) to    (ILE18)  CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE  |   CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, PROTEASOME, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3hye:W    (LYS33) to   (ASP166)  CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE  |   CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, PROTEASOME, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3hye:X    (LYS33) to   (HIS141)  CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE  |   CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, PROTEASOME, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3hye:Z    (LYS33) to   (ARG165)  CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE  |   CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, PROTEASOME, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3hye:1    (ARG33) to   (ARG165)  CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE  |   CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, PROTEASOME, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3hye:2    (LYS33) to   (ASN141)  CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE  |   CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, PROTEASOME, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
2gpl:E    (LYS66) to    (ILE18)  TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS  |   PROTEASOMAL SUBUNIT FOLD REPRESENTS AN ANTIPARALLEL BETA- SHEET FLANKED BY HELICES; NTN-HYDROLASE 
2gpl:I    (LYS33) to   (ASP166)  TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS  |   PROTEASOMAL SUBUNIT FOLD REPRESENTS AN ANTIPARALLEL BETA- SHEET FLANKED BY HELICES; NTN-HYDROLASE 
2gpl:J    (LYS33) to   (HIS141)  TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS  |   PROTEASOMAL SUBUNIT FOLD REPRESENTS AN ANTIPARALLEL BETA- SHEET FLANKED BY HELICES; NTN-HYDROLASE 
2gpl:L    (LYS33) to   (ARG165)  TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS  |   PROTEASOMAL SUBUNIT FOLD REPRESENTS AN ANTIPARALLEL BETA- SHEET FLANKED BY HELICES; NTN-HYDROLASE 
2gpl:M    (ARG33) to   (ARG165)  TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS  |   PROTEASOMAL SUBUNIT FOLD REPRESENTS AN ANTIPARALLEL BETA- SHEET FLANKED BY HELICES; NTN-HYDROLASE 
2gpl:N    (LYS33) to   (ASN141)  TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS  |   PROTEASOMAL SUBUNIT FOLD REPRESENTS AN ANTIPARALLEL BETA- SHEET FLANKED BY HELICES; NTN-HYDROLASE 
2gpl:S    (LYS66) to    (ILE18)  TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS  |   PROTEASOMAL SUBUNIT FOLD REPRESENTS AN ANTIPARALLEL BETA- SHEET FLANKED BY HELICES; NTN-HYDROLASE 
2gpl:W    (LYS33) to   (ASP166)  TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS  |   PROTEASOMAL SUBUNIT FOLD REPRESENTS AN ANTIPARALLEL BETA- SHEET FLANKED BY HELICES; NTN-HYDROLASE 
2gpl:X    (LYS33) to   (HIS141)  TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS  |   PROTEASOMAL SUBUNIT FOLD REPRESENTS AN ANTIPARALLEL BETA- SHEET FLANKED BY HELICES; NTN-HYDROLASE 
2gpl:Z    (LYS33) to   (ARG165)  TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS  |   PROTEASOMAL SUBUNIT FOLD REPRESENTS AN ANTIPARALLEL BETA- SHEET FLANKED BY HELICES; NTN-HYDROLASE 
2gpl:1    (ARG33) to   (ARG165)  TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS  |   PROTEASOMAL SUBUNIT FOLD REPRESENTS AN ANTIPARALLEL BETA- SHEET FLANKED BY HELICES; NTN-HYDROLASE 
2gpl:2    (LYS33) to   (ASN141)  TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS  |   PROTEASOMAL SUBUNIT FOLD REPRESENTS AN ANTIPARALLEL BETA- SHEET FLANKED BY HELICES; NTN-HYDROLASE 
3ipm:G    (LYS66) to   (LEU201)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN  |   PROTEASOME, PROTEASOMAL ATPASE, PROTEIN DEGRADATION, AAA ATPASE, ELECTRON CRYOMICROSCOPY, HYDROLASE, PROTEASE, THREONINE PROTEASE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
2h6j:A    (LYS52) to   (GLN190)  CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)  |   20S PROTEASOME, HALF PROTEASOME, ASSEMBLY-DEPENDENT ACTIVATION, HYDROLASE 
2h6j:B    (LYS52) to   (GLN190)  CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)  |   20S PROTEASOME, HALF PROTEASOME, ASSEMBLY-DEPENDENT ACTIVATION, HYDROLASE 
2h6j:C    (LYS52) to   (GLN190)  CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)  |   20S PROTEASOME, HALF PROTEASOME, ASSEMBLY-DEPENDENT ACTIVATION, HYDROLASE 
2h6j:D    (LYS52) to   (GLN190)  CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)  |   20S PROTEASOME, HALF PROTEASOME, ASSEMBLY-DEPENDENT ACTIVATION, HYDROLASE 
2h6j:E    (LYS52) to   (GLN190)  CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)  |   20S PROTEASOME, HALF PROTEASOME, ASSEMBLY-DEPENDENT ACTIVATION, HYDROLASE 
2h6j:F    (LYS52) to   (GLN190)  CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)  |   20S PROTEASOME, HALF PROTEASOME, ASSEMBLY-DEPENDENT ACTIVATION, HYDROLASE 
4zzg:C    (LYS65) to   (THR200)  YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4zzg:E    (LYS66) to   (TRP187)  YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4zzg:F    (LYS62) to   (ILE182)  YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4zzg:H    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4zzg:I    (LYS33) to   (ASP166)  YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4zzg:K    (LYS33) to   (HIS146)  YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4zzg:M    (LYS33) to   (ARG185)  YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4zzg:N    (ARG33) to   (ARG179)  YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4zzg:O    (TYR71) to   (GLY215)  YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4zzg:V    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4zzg:W    (LYS33) to   (ASP166)  YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4zzg:X    (LYS33) to   (ASP169)  YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4zzg:Y    (LYS33) to   (LYS169)  YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4zzg:1    (LYS33) to   (ARG185)  YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4zzg:2    (ARG33) to   (THR160)  YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4lqi:E    (LYS66) to   (ILE180)  YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE  |   BETA-LACTONE, INHIBITOR, NATURAL PRODUCT, TARGET IDENTIFICATION, NTN- PROTEASE, CELLULAR PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4lqi:G    (TYR66) to   (GLY202)  YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE  |   BETA-LACTONE, INHIBITOR, NATURAL PRODUCT, TARGET IDENTIFICATION, NTN- PROTEASE, CELLULAR PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4lqi:I    (LYS33) to   (ASP166)  YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE  |   BETA-LACTONE, INHIBITOR, NATURAL PRODUCT, TARGET IDENTIFICATION, NTN- PROTEASE, CELLULAR PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4lqi:J    (LYS33) to   (HIS141)  YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE  |   BETA-LACTONE, INHIBITOR, NATURAL PRODUCT, TARGET IDENTIFICATION, NTN- PROTEASE, CELLULAR PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4lqi:L    (LYS32) to   (ARG184)  YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE  |   BETA-LACTONE, INHIBITOR, NATURAL PRODUCT, TARGET IDENTIFICATION, NTN- PROTEASE, CELLULAR PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4lqi:M    (ARG33) to   (THR146)  YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE  |   BETA-LACTONE, INHIBITOR, NATURAL PRODUCT, TARGET IDENTIFICATION, NTN- PROTEASE, CELLULAR PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4lqi:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE  |   BETA-LACTONE, INHIBITOR, NATURAL PRODUCT, TARGET IDENTIFICATION, NTN- PROTEASE, CELLULAR PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4lqi:S    (LYS66) to   (ILE180)  YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE  |   BETA-LACTONE, INHIBITOR, NATURAL PRODUCT, TARGET IDENTIFICATION, NTN- PROTEASE, CELLULAR PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4lqi:U    (TYR66) to   (GLY202)  YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE  |   BETA-LACTONE, INHIBITOR, NATURAL PRODUCT, TARGET IDENTIFICATION, NTN- PROTEASE, CELLULAR PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4lqi:W    (LYS33) to   (ASP166)  YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE  |   BETA-LACTONE, INHIBITOR, NATURAL PRODUCT, TARGET IDENTIFICATION, NTN- PROTEASE, CELLULAR PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4lqi:X    (LYS33) to   (HIS141)  YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE  |   BETA-LACTONE, INHIBITOR, NATURAL PRODUCT, TARGET IDENTIFICATION, NTN- PROTEASE, CELLULAR PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4lqi:Z    (LYS32) to   (ARG184)  YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE  |   BETA-LACTONE, INHIBITOR, NATURAL PRODUCT, TARGET IDENTIFICATION, NTN- PROTEASE, CELLULAR PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4lqi:a    (ARG33) to   (THR146)  YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE  |   BETA-LACTONE, INHIBITOR, NATURAL PRODUCT, TARGET IDENTIFICATION, NTN- PROTEASE, CELLULAR PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4lqi:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE  |   BETA-LACTONE, INHIBITOR, NATURAL PRODUCT, TARGET IDENTIFICATION, NTN- PROTEASE, CELLULAR PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ltc:E    (LYS61) to   (ILE181)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ltc:S    (LYS61) to   (ILE181)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ltc:J    (LYS34) to   (MET172)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ltc:L    (LYS42) to   (ARG194)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ltc:M    (ARG41) to   (THR168)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ltc:N    (LYS33) to   (ASN141)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ltc:Z    (LYS42) to   (ARG194)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ltc:a    (ARG41) to   (ARG187)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ltc:b    (LYS33) to   (ASN141)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
1iru:D    (LYS61) to   (GLU197)  CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION  |   20S PROTEASOME, CELL CYCLE, IMMUNE RESPONSE, PROTEOLYSIS, UBIQUITIN, HYDROLASE 
1iru:F    (LYS62) to   (CYS182)  CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION  |   20S PROTEASOME, CELL CYCLE, IMMUNE RESPONSE, PROTEOLYSIS, UBIQUITIN, HYDROLASE 
1iru:G    (ARG65) to   (ILE199)  CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION  |   20S PROTEASOME, CELL CYCLE, IMMUNE RESPONSE, PROTEOLYSIS, UBIQUITIN, HYDROLASE 
1iru:H    (LYS33) to   (THR142)  CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION  |   20S PROTEASOME, CELL CYCLE, IMMUNE RESPONSE, PROTEOLYSIS, UBIQUITIN, HYDROLASE 
1iru:J    (LYS41) to   (ASP178)  CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION  |   20S PROTEASOME, CELL CYCLE, IMMUNE RESPONSE, PROTEOLYSIS, UBIQUITIN, HYDROLASE 
1iru:R    (LYS61) to   (GLU197)  CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION  |   20S PROTEASOME, CELL CYCLE, IMMUNE RESPONSE, PROTEOLYSIS, UBIQUITIN, HYDROLASE 
1iru:U    (ARG65) to   (ILE199)  CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION  |   20S PROTEASOME, CELL CYCLE, IMMUNE RESPONSE, PROTEOLYSIS, UBIQUITIN, HYDROLASE 
1iru:V    (LYS33) to   (THR142)  CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION  |   20S PROTEASOME, CELL CYCLE, IMMUNE RESPONSE, PROTEOLYSIS, UBIQUITIN, HYDROLASE 
1iru:X    (LYS41) to   (ASP178)  CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION  |   20S PROTEASOME, CELL CYCLE, IMMUNE RESPONSE, PROTEOLYSIS, UBIQUITIN, HYDROLASE 
1iru:1    (LYS42) to   (ARG185)  CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION  |   20S PROTEASOME, CELL CYCLE, IMMUNE RESPONSE, PROTEOLYSIS, UBIQUITIN, HYDROLASE 
2x1d:A   (THR142) to   (LEU289)  THE CRYSTAL STRUCTURE OF MATURE ACYL COENZYME A:ISOPENICILLIN N ACYLTRANSFERASE FROM PENICILLIUM CHRYSOGENUM  |   ZYMOGEN, TRANSFERASE, NTN-HYDROLASE, PENICILLIN BIOSYNTHESIS, ANTIBIOTIC BIOSYNTHESIS 
2x1d:B   (VAL155) to   (LEU289)  THE CRYSTAL STRUCTURE OF MATURE ACYL COENZYME A:ISOPENICILLIN N ACYLTRANSFERASE FROM PENICILLIUM CHRYSOGENUM  |   ZYMOGEN, TRANSFERASE, NTN-HYDROLASE, PENICILLIN BIOSYNTHESIS, ANTIBIOTIC BIOSYNTHESIS 
5ahj:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A  |   HYDROLASE, PROTEASOME, NATURAL PRODUCT, TARGET IDENTIFICATION, INHIBITION, BINDING ANALYSIS 
5ahj:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A  |   HYDROLASE, PROTEASOME, NATURAL PRODUCT, TARGET IDENTIFICATION, INHIBITION, BINDING ANALYSIS 
5ahj:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A  |   HYDROLASE, PROTEASOME, NATURAL PRODUCT, TARGET IDENTIFICATION, INHIBITION, BINDING ANALYSIS 
5ahj:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A  |   HYDROLASE, PROTEASOME, NATURAL PRODUCT, TARGET IDENTIFICATION, INHIBITION, BINDING ANALYSIS 
5ahj:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A  |   HYDROLASE, PROTEASOME, NATURAL PRODUCT, TARGET IDENTIFICATION, INHIBITION, BINDING ANALYSIS 
5ahj:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A  |   HYDROLASE, PROTEASOME, NATURAL PRODUCT, TARGET IDENTIFICATION, INHIBITION, BINDING ANALYSIS 
5ahj:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A  |   HYDROLASE, PROTEASOME, NATURAL PRODUCT, TARGET IDENTIFICATION, INHIBITION, BINDING ANALYSIS 
5ahj:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A  |   HYDROLASE, PROTEASOME, NATURAL PRODUCT, TARGET IDENTIFICATION, INHIBITION, BINDING ANALYSIS 
5ahj:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A  |   HYDROLASE, PROTEASOME, NATURAL PRODUCT, TARGET IDENTIFICATION, INHIBITION, BINDING ANALYSIS 
5ahj:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A  |   HYDROLASE, PROTEASOME, NATURAL PRODUCT, TARGET IDENTIFICATION, INHIBITION, BINDING ANALYSIS 
1jd2:E    (LYS66) to   (ILE180)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR  |   BETA-SANDWICH, PROTEASOME:INHIBITOR COMPLEX, HYDROLASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1jd2:I    (LYS33) to   (ASP166)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR  |   BETA-SANDWICH, PROTEASOME:INHIBITOR COMPLEX, HYDROLASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1jd2:J    (LYS33) to   (ARG165)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR  |   BETA-SANDWICH, PROTEASOME:INHIBITOR COMPLEX, HYDROLASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1jd2:L    (LYS33) to   (ARG165)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR  |   BETA-SANDWICH, PROTEASOME:INHIBITOR COMPLEX, HYDROLASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1jd2:N    (LYS33) to   (ASN141)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR  |   BETA-SANDWICH, PROTEASOME:INHIBITOR COMPLEX, HYDROLASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1jd2:P    (LYS33) to   (ASP166)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR  |   BETA-SANDWICH, PROTEASOME:INHIBITOR COMPLEX, HYDROLASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1jd2:Q    (LYS33) to   (ARG165)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR  |   BETA-SANDWICH, PROTEASOME:INHIBITOR COMPLEX, HYDROLASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1jd2:S    (LYS33) to   (ARG165)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR  |   BETA-SANDWICH, PROTEASOME:INHIBITOR COMPLEX, HYDROLASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1jd2:U    (LYS33) to   (ASN141)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR  |   BETA-SANDWICH, PROTEASOME:INHIBITOR COMPLEX, HYDROLASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1jd2:Z    (LYS66) to   (ILE180)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR  |   BETA-SANDWICH, PROTEASOME:INHIBITOR COMPLEX, HYDROLASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
3wxr:D    (LYS63) to   (LEU200)  YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT  |   UPS, 20S PROTEASOME, HYDROLASE, PROTEASE, 19S REGULATORY PARTICLE, MULTICATALYTIC PROTEASE 
3wxr:F    (SER57) to   (ILE182)  YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT  |   UPS, 20S PROTEASOME, HYDROLASE, PROTEASE, 19S REGULATORY PARTICLE, MULTICATALYTIC PROTEASE 
3wxr:H    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT  |   UPS, 20S PROTEASOME, HYDROLASE, PROTEASE, 19S REGULATORY PARTICLE, MULTICATALYTIC PROTEASE 
3wxr:J    (LYS33) to   (ASP169)  YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT  |   UPS, 20S PROTEASOME, HYDROLASE, PROTEASE, 19S REGULATORY PARTICLE, MULTICATALYTIC PROTEASE 
3wxr:K    (LYS33) to   (HIS146)  YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT  |   UPS, 20S PROTEASOME, HYDROLASE, PROTEASE, 19S REGULATORY PARTICLE, MULTICATALYTIC PROTEASE 
3wxr:M    (LYS33) to   (ARG185)  YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT  |   UPS, 20S PROTEASOME, HYDROLASE, PROTEASE, 19S REGULATORY PARTICLE, MULTICATALYTIC PROTEASE 
3wxr:T    (LYS62) to   (ILE182)  YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT  |   UPS, 20S PROTEASOME, HYDROLASE, PROTEASE, 19S REGULATORY PARTICLE, MULTICATALYTIC PROTEASE 
3wxr:V    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT  |   UPS, 20S PROTEASOME, HYDROLASE, PROTEASE, 19S REGULATORY PARTICLE, MULTICATALYTIC PROTEASE 
3wxr:X    (LYS33) to   (ASP169)  YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT  |   UPS, 20S PROTEASOME, HYDROLASE, PROTEASE, 19S REGULATORY PARTICLE, MULTICATALYTIC PROTEASE 
3wxr:Y    (LYS33) to   (HIS146)  YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT  |   UPS, 20S PROTEASOME, HYDROLASE, PROTEASE, 19S REGULATORY PARTICLE, MULTICATALYTIC PROTEASE 
3wxr:1    (LYS33) to   (ARG185)  YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT  |   UPS, 20S PROTEASOME, HYDROLASE, PROTEASE, 19S REGULATORY PARTICLE, MULTICATALYTIC PROTEASE 
2ku1:A    (LYS66) to   (SER200)  DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR  |   PROTEASOME, PROTEOLYSIS, GATING RESIDUES, CYTOPLASM, HYDROLASE, PROTEASE, THREONINE PROTEASE 
2ku1:B    (LYS66) to   (SER200)  DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR  |   PROTEASOME, PROTEOLYSIS, GATING RESIDUES, CYTOPLASM, HYDROLASE, PROTEASE, THREONINE PROTEASE 
2ku1:C    (LYS66) to   (SER200)  DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR  |   PROTEASOME, PROTEOLYSIS, GATING RESIDUES, CYTOPLASM, HYDROLASE, PROTEASE, THREONINE PROTEASE 
2ku1:D    (LYS66) to   (SER200)  DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR  |   PROTEASOME, PROTEOLYSIS, GATING RESIDUES, CYTOPLASM, HYDROLASE, PROTEASE, THREONINE PROTEASE 
2ku1:E    (LYS66) to   (SER200)  DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR  |   PROTEASOME, PROTEOLYSIS, GATING RESIDUES, CYTOPLASM, HYDROLASE, PROTEASE, THREONINE PROTEASE 
2ku1:F    (LYS66) to   (SER200)  DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR  |   PROTEASOME, PROTEOLYSIS, GATING RESIDUES, CYTOPLASM, HYDROLASE, PROTEASE, THREONINE PROTEASE 
2ku1:G    (LYS66) to   (SER200)  DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR  |   PROTEASOME, PROTEOLYSIS, GATING RESIDUES, CYTOPLASM, HYDROLASE, PROTEASE, THREONINE PROTEASE 
2ku2:A    (LYS66) to   (SER200)  DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR  |   PROTEASOME, PROTEOLYSIS, GATING RESIDUES, CYTOPLASM, HYDROLASE, PROTEASE, THREONINE PROTEASE 
2ku2:B    (LYS66) to   (SER200)  DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR  |   PROTEASOME, PROTEOLYSIS, GATING RESIDUES, CYTOPLASM, HYDROLASE, PROTEASE, THREONINE PROTEASE 
2ku2:C    (LYS66) to   (SER200)  DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR  |   PROTEASOME, PROTEOLYSIS, GATING RESIDUES, CYTOPLASM, HYDROLASE, PROTEASE, THREONINE PROTEASE 
2ku2:D    (LYS66) to   (SER200)  DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR  |   PROTEASOME, PROTEOLYSIS, GATING RESIDUES, CYTOPLASM, HYDROLASE, PROTEASE, THREONINE PROTEASE 
2ku2:E    (LYS66) to   (SER200)  DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR  |   PROTEASOME, PROTEOLYSIS, GATING RESIDUES, CYTOPLASM, HYDROLASE, PROTEASE, THREONINE PROTEASE 
2ku2:F    (LYS66) to   (SER200)  DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR  |   PROTEASOME, PROTEOLYSIS, GATING RESIDUES, CYTOPLASM, HYDROLASE, PROTEASE, THREONINE PROTEASE 
2ku2:G    (LYS66) to   (SER200)  DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR  |   PROTEASOME, PROTEOLYSIS, GATING RESIDUES, CYTOPLASM, HYDROLASE, PROTEASE, THREONINE PROTEASE 
4nnn:E    (SER56) to   (ILE181)  YCP IN COMPLEX WITH MG132  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, ALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4nnn:I    (LYS41) to   (ASP177)  YCP IN COMPLEX WITH MG132  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, ALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4nnn:L    (LYS42) to   (ARG194)  YCP IN COMPLEX WITH MG132  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, ALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4nnn:M    (ARG41) to   (THR168)  YCP IN COMPLEX WITH MG132  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, ALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4nnn:N    (LYS33) to   (ASN141)  YCP IN COMPLEX WITH MG132  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, ALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4nnn:S    (SER56) to   (ILE181)  YCP IN COMPLEX WITH MG132  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, ALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4nnn:W    (LYS41) to   (ASP177)  YCP IN COMPLEX WITH MG132  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, ALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4nnn:Z    (LYS42) to   (ARG194)  YCP IN COMPLEX WITH MG132  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, ALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4nnn:a    (ARG41) to   (THR168)  YCP IN COMPLEX WITH MG132  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, ALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4nnn:b    (LYS33) to   (ASN141)  YCP IN COMPLEX WITH MG132  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, ALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4nnw:E    (SER56) to   (ILE181)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4nnw:I    (LYS41) to   (ASP177)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4nnw:L    (LYS42) to   (ARG194)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4nnw:N    (LYS33) to   (ASN141)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4nnw:S    (SER56) to   (ILE181)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4nnw:W    (LYS41) to   (ASP177)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4nnw:Z    (LYS42) to   (ARG194)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4nnw:b    (LYS33) to   (ASN141)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no1:E    (SER56) to   (ILE181)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, BORONIC ACID, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no1:L    (LYS42) to   (ARG194)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, BORONIC ACID, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no1:M    (ARG41) to   (ARG187)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, BORONIC ACID, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no1:N    (LYS33) to   (ASN141)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, BORONIC ACID, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no1:S    (SER56) to   (ILE181)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, BORONIC ACID, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no1:Z    (LYS42) to   (ARG194)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, BORONIC ACID, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no1:a    (ARG41) to   (ARG187)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, BORONIC ACID, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no1:b    (LYS33) to   (ASN141)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, BORONIC ACID, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no6:E    (SER56) to   (ILE181)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, VINYLSULFONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no6:I    (LYS41) to   (ASP177)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, VINYLSULFONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no6:L    (LYS42) to   (ARG194)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, VINYLSULFONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no6:S    (SER56) to   (ILE181)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, VINYLSULFONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no6:W    (LYS41) to   (ASP177)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, VINYLSULFONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no6:Z    (LYS42) to   (ARG194)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, VINYLSULFONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no8:E    (SER56) to   (ILE181)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOAMIDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no8:I    (LYS41) to   (ASP177)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOAMIDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no8:L    (LYS42) to   (ARG194)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOAMIDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no8:M    (ARG41) to   (ARG187)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOAMIDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no8:N    (LYS33) to   (ASN141)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOAMIDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no8:S    (SER56) to   (ILE181)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOAMIDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no8:W    (LYS41) to   (ASP177)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOAMIDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no8:Z    (LYS42) to   (ARG194)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOAMIDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no8:a    (ARG41) to   (ARG187)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOAMIDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no8:b    (LYS33) to   (ASN141)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOAMIDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
1kuu:A    (CYS61) to   (THR180)  CRYSTAL STRUCTURE OF METHANOBACTERIUM THERMOAUTOTROPHICUM CONSERVED PROTEIN MTH1020 REVEALS AN NTN-HYDROLASE FOLD  |   STRUCTURAL GENOMICS, CONSERVED PROTEIN, NTN-HYDROLASE FOLD, UNKNOWN FUNCTION 
1kyi:G    (LYS33) to   (ILE159)  HSLUV (H. INFLUENZAE)-NLVS VINYL SULFONE INHIBITOR COMPLEX  |   PROKARYOTIC PROTEASOME, PROTEASE, AAA-PROTEIN, ATP-DEPENDENT CHAPERONE; CLP/HSP100, VINYL SULFONE INHIBITOR, CHAPERONE-HYDROLASE COMPLEX 
1kyi:H    (LYS33) to   (ILE159)  HSLUV (H. INFLUENZAE)-NLVS VINYL SULFONE INHIBITOR COMPLEX  |   PROKARYOTIC PROTEASOME, PROTEASE, AAA-PROTEIN, ATP-DEPENDENT CHAPERONE; CLP/HSP100, VINYL SULFONE INHIBITOR, CHAPERONE-HYDROLASE COMPLEX 
1kyi:I    (LYS33) to   (ILE159)  HSLUV (H. INFLUENZAE)-NLVS VINYL SULFONE INHIBITOR COMPLEX  |   PROKARYOTIC PROTEASOME, PROTEASE, AAA-PROTEIN, ATP-DEPENDENT CHAPERONE; CLP/HSP100, VINYL SULFONE INHIBITOR, CHAPERONE-HYDROLASE COMPLEX 
1kyi:J    (LYS33) to   (ILE159)  HSLUV (H. INFLUENZAE)-NLVS VINYL SULFONE INHIBITOR COMPLEX  |   PROKARYOTIC PROTEASOME, PROTEASE, AAA-PROTEIN, ATP-DEPENDENT CHAPERONE; CLP/HSP100, VINYL SULFONE INHIBITOR, CHAPERONE-HYDROLASE COMPLEX 
1kyi:K    (LYS33) to   (ILE159)  HSLUV (H. INFLUENZAE)-NLVS VINYL SULFONE INHIBITOR COMPLEX  |   PROKARYOTIC PROTEASOME, PROTEASE, AAA-PROTEIN, ATP-DEPENDENT CHAPERONE; CLP/HSP100, VINYL SULFONE INHIBITOR, CHAPERONE-HYDROLASE COMPLEX 
1kyi:L    (LYS33) to   (ILE159)  HSLUV (H. INFLUENZAE)-NLVS VINYL SULFONE INHIBITOR COMPLEX  |   PROKARYOTIC PROTEASOME, PROTEASE, AAA-PROTEIN, ATP-DEPENDENT CHAPERONE; CLP/HSP100, VINYL SULFONE INHIBITOR, CHAPERONE-HYDROLASE COMPLEX 
1kyi:M    (LYS33) to   (CYS160)  HSLUV (H. INFLUENZAE)-NLVS VINYL SULFONE INHIBITOR COMPLEX  |   PROKARYOTIC PROTEASOME, PROTEASE, AAA-PROTEIN, ATP-DEPENDENT CHAPERONE; CLP/HSP100, VINYL SULFONE INHIBITOR, CHAPERONE-HYDROLASE COMPLEX 
1kyi:N    (LYS33) to   (CYS160)  HSLUV (H. INFLUENZAE)-NLVS VINYL SULFONE INHIBITOR COMPLEX  |   PROKARYOTIC PROTEASOME, PROTEASE, AAA-PROTEIN, ATP-DEPENDENT CHAPERONE; CLP/HSP100, VINYL SULFONE INHIBITOR, CHAPERONE-HYDROLASE COMPLEX 
1kyi:O    (LYS33) to   (ILE159)  HSLUV (H. INFLUENZAE)-NLVS VINYL SULFONE INHIBITOR COMPLEX  |   PROKARYOTIC PROTEASOME, PROTEASE, AAA-PROTEIN, ATP-DEPENDENT CHAPERONE; CLP/HSP100, VINYL SULFONE INHIBITOR, CHAPERONE-HYDROLASE COMPLEX 
1kyi:P    (LYS33) to   (CYS160)  HSLUV (H. INFLUENZAE)-NLVS VINYL SULFONE INHIBITOR COMPLEX  |   PROKARYOTIC PROTEASOME, PROTEASE, AAA-PROTEIN, ATP-DEPENDENT CHAPERONE; CLP/HSP100, VINYL SULFONE INHIBITOR, CHAPERONE-HYDROLASE COMPLEX 
1kyi:Q    (LYS33) to   (ILE159)  HSLUV (H. INFLUENZAE)-NLVS VINYL SULFONE INHIBITOR COMPLEX  |   PROKARYOTIC PROTEASOME, PROTEASE, AAA-PROTEIN, ATP-DEPENDENT CHAPERONE; CLP/HSP100, VINYL SULFONE INHIBITOR, CHAPERONE-HYDROLASE COMPLEX 
1kyi:R    (LYS33) to   (CYS160)  HSLUV (H. INFLUENZAE)-NLVS VINYL SULFONE INHIBITOR COMPLEX  |   PROKARYOTIC PROTEASOME, PROTEASE, AAA-PROTEIN, ATP-DEPENDENT CHAPERONE; CLP/HSP100, VINYL SULFONE INHIBITOR, CHAPERONE-HYDROLASE COMPLEX 
3jse:B    (LYS66) to   (LEU201)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR  |   20S PROTEASOME, PA26, PROTEASOME ACTIVATION, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX 
3jse:E    (LYS66) to   (LEU201)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR  |   20S PROTEASOME, PA26, PROTEASOME ACTIVATION, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX 
3jse:F    (LYS66) to   (LEU201)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR  |   20S PROTEASOME, PA26, PROTEASOME ACTIVATION, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX 
3jse:H    (LYS33) to   (GLN164)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR  |   20S PROTEASOME, PA26, PROTEASOME ACTIVATION, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX 
3jse:I    (LYS33) to   (GLN164)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR  |   20S PROTEASOME, PA26, PROTEASOME ACTIVATION, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX 
3jse:J    (LYS33) to   (GLN164)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR  |   20S PROTEASOME, PA26, PROTEASOME ACTIVATION, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX 
3jse:K    (LYS33) to   (GLN164)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR  |   20S PROTEASOME, PA26, PROTEASOME ACTIVATION, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX 
3jse:L    (LYS33) to   (GLN164)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR  |   20S PROTEASOME, PA26, PROTEASOME ACTIVATION, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX 
3jse:M    (LYS33) to   (GLN164)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR  |   20S PROTEASOME, PA26, PROTEASOME ACTIVATION, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX 
3jse:N    (LYS33) to   (GLN164)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR  |   20S PROTEASOME, PA26, PROTEASOME ACTIVATION, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX 
2ntk:A    (CYS61) to   (THR180)  CRYSTAL STRUCTURE OF PURO/IMP FROM METHANOTHERMOBACTER THERMOAUTOTROPHICUS  |   ALPHA-BETA-BETA-ALPHA NTN HYDROLASE FOLD 
2ntk:B    (CYS61) to   (THR180)  CRYSTAL STRUCTURE OF PURO/IMP FROM METHANOTHERMOBACTER THERMOAUTOTROPHICUS  |   ALPHA-BETA-BETA-ALPHA NTN HYDROLASE FOLD 
2ntk:C    (CYS61) to   (THR180)  CRYSTAL STRUCTURE OF PURO/IMP FROM METHANOTHERMOBACTER THERMOAUTOTROPHICUS  |   ALPHA-BETA-BETA-ALPHA NTN HYDROLASE FOLD 
2ntk:D    (CYS61) to   (THR180)  CRYSTAL STRUCTURE OF PURO/IMP FROM METHANOTHERMOBACTER THERMOAUTOTROPHICUS  |   ALPHA-BETA-BETA-ALPHA NTN HYDROLASE FOLD 
2ntl:A    (CYS61) to   (THR180)  CRYSTAL STRUCTURE OF PURO/AICAR FROM METHANOTHERMOBACTER THERMOAUTOTROPHICUS  |   ALPHA-BETA-BETA-ALPHA NTN HYDROLASE FOLD 
2ntl:B    (CYS61) to   (THR180)  CRYSTAL STRUCTURE OF PURO/AICAR FROM METHANOTHERMOBACTER THERMOAUTOTROPHICUS  |   ALPHA-BETA-BETA-ALPHA NTN HYDROLASE FOLD 
2ntl:C    (CYS61) to   (THR180)  CRYSTAL STRUCTURE OF PURO/AICAR FROM METHANOTHERMOBACTER THERMOAUTOTROPHICUS  |   ALPHA-BETA-BETA-ALPHA NTN HYDROLASE FOLD 
2ntl:D    (CYS61) to   (THR180)  CRYSTAL STRUCTURE OF PURO/AICAR FROM METHANOTHERMOBACTER THERMOAUTOTROPHICUS  |   ALPHA-BETA-BETA-ALPHA NTN HYDROLASE FOLD 
2ntm:A    (CYS61) to   (THR180)  CRYSTAL STRUCTURE OF PURO FROM METHANOTHERMOBACTER THERMOAUTOTROPHICUS  |   ALPHA-BETA-BETA-ALPHA NTN HYDROLASE FOLD 
2ntm:B    (CYS61) to   (THR180)  CRYSTAL STRUCTURE OF PURO FROM METHANOTHERMOBACTER THERMOAUTOTROPHICUS  |   ALPHA-BETA-BETA-ALPHA NTN HYDROLASE FOLD 
2ntm:C    (CYS61) to   (THR180)  CRYSTAL STRUCTURE OF PURO FROM METHANOTHERMOBACTER THERMOAUTOTROPHICUS  |   ALPHA-BETA-BETA-ALPHA NTN HYDROLASE FOLD 
2ntm:D    (CYS61) to   (THR180)  CRYSTAL STRUCTURE OF PURO FROM METHANOTHERMOBACTER THERMOAUTOTROPHICUS  |   ALPHA-BETA-BETA-ALPHA NTN HYDROLASE FOLD 
3jtl:H    (LYS33) to   (ASP166)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR  |   20S PROTEASOME, PA26, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3jtl:I    (LYS33) to   (ASP166)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR  |   20S PROTEASOME, PA26, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3jtl:M    (LYS33) to   (ASP166)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR  |   20S PROTEASOME, PA26, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3jtl:N    (LYS33) to   (ASP166)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR  |   20S PROTEASOME, PA26, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
5cgg:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgg:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgg:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgg:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgg:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgg:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgg:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgg:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgg:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgg:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgh:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgh:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgh:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgh:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgh:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgh:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgh:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgh:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgh:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgh:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgi:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgi:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgi:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgi:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgi:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgi:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgi:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgi:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
2z3b:F    (LYS39) to   (ILE166)  CRYSTAL STRUCTURE OF BACILLUS SUBTILIS CODW, A NON- CANONICAL HSLV-LIKE PEPTIDASE WITH AN IMPAIRED CATALYTIC APPARATUS  |   N-TERMINAL NUCLEOPHILE HYDROLASE 
2zcy:E    (LYS66) to    (ILE18)  YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX  |   ALPHA/BETA SANDWICH, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
2zcy:F    (ILE67) to   (LYS206)  YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX  |   ALPHA/BETA SANDWICH, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
2zcy:I    (LYS33) to   (ASP166)  YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX  |   ALPHA/BETA SANDWICH, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
2zcy:L    (LYS33) to   (ARG165)  YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX  |   ALPHA/BETA SANDWICH, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
2zcy:M    (ARG33) to   (ARG165)  YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX  |   ALPHA/BETA SANDWICH, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
2zcy:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX  |   ALPHA/BETA SANDWICH, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
2zcy:S    (LYS66) to    (ILE18)  YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX  |   ALPHA/BETA SANDWICH, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
2zcy:T    (ILE67) to   (LYS206)  YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX  |   ALPHA/BETA SANDWICH, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
2zcy:W    (LYS33) to   (ASP166)  YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX  |   ALPHA/BETA SANDWICH, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
2zcy:Z    (LYS33) to   (ARG165)  YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX  |   ALPHA/BETA SANDWICH, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
2zcy:0    (ARG33) to   (ARG165)  YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX  |   ALPHA/BETA SANDWICH, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
2zcy:1    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX  |   ALPHA/BETA SANDWICH, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
5cz6:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A, PROPEPTIDE EXPRESSED IN TRANS  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz6:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A, PROPEPTIDE EXPRESSED IN TRANS  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz6:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A, PROPEPTIDE EXPRESSED IN TRANS  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz6:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A, PROPEPTIDE EXPRESSED IN TRANS  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz6:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A, PROPEPTIDE EXPRESSED IN TRANS  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz6:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A, PROPEPTIDE EXPRESSED IN TRANS  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz6:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A, PROPEPTIDE EXPRESSED IN TRANS  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz6:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A, PROPEPTIDE EXPRESSED IN TRANS  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz6:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A, PROPEPTIDE EXPRESSED IN TRANS  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz6:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A, PROPEPTIDE EXPRESSED IN TRANS  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz5:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz5:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz5:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz5:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz5:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz5:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz5:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz5:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz5:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz5:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cza:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA5-D166N MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5cza:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA5-D166N MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5cza:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA5-D166N MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5cza:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA5-D166N MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5cza:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA5-D166N MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5cza:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA5-D166N MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5cza:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA5-D166N MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5cza:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA5-D166N MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5cza:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA5-D166N MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5cza:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA5-D166N MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5d0s:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0s:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0s:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0s:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0s:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0s:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0s:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0s:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0s:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0s:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0t:E    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0t:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0t:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0t:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0t:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0t:S    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0t:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0t:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0t:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0t:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0v:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0v:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0v:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0v:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0v:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0v:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0v:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0v:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0v:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0v:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0w:E    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME BETA5-T1S MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5d0w:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA5-T1S MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5d0w:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA5-T1S MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5d0w:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA5-T1S MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5d0w:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA5-T1S MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5d0w:S    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME BETA5-T1S MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5d0w:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA5-T1S MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5d0w:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA5-T1S MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5d0w:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA5-T1S MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5d0w:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA5-T1S MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5d0x:E    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0x:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0x:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0x:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0x:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0x:S    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0x:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0x:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0x:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0x:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0z:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0z:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0z:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0z:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0z:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0z:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0z:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0z:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
1ya7:A    (LYS66) to   (LEU201)  IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX  |   ARCHAEAL PROTEASOME, PA26, COPMLEX, OPEN GATE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1ya7:H    (LYS33) to   (ARG165)  IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX  |   ARCHAEAL PROTEASOME, PA26, COPMLEX, OPEN GATE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1ya7:I    (LYS33) to   (ARG165)  IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX  |   ARCHAEAL PROTEASOME, PA26, COPMLEX, OPEN GATE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1ya7:J    (LYS33) to   (ARG165)  IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX  |   ARCHAEAL PROTEASOME, PA26, COPMLEX, OPEN GATE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1ya7:K    (LYS33) to   (ARG165)  IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX  |   ARCHAEAL PROTEASOME, PA26, COPMLEX, OPEN GATE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1ya7:L    (LYS33) to   (ARG165)  IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX  |   ARCHAEAL PROTEASOME, PA26, COPMLEX, OPEN GATE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1ya7:M    (LYS33) to   (ARG165)  IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX  |   ARCHAEAL PROTEASOME, PA26, COPMLEX, OPEN GATE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1ya7:N    (LYS33) to   (ARG165)  IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX  |   ARCHAEAL PROTEASOME, PA26, COPMLEX, OPEN GATE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1yau:A    (LYS66) to   (LEU201)  STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX  |   PROTEASOME 20S, PA26 PROTEASOME ACTIVATOR 11S, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1yau:B    (LYS66) to   (LEU201)  STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX  |   PROTEASOME 20S, PA26 PROTEASOME ACTIVATOR 11S, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1yau:H    (LYS33) to   (ARG165)  STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX  |   PROTEASOME 20S, PA26 PROTEASOME ACTIVATOR 11S, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1yau:I    (LYS33) to   (ARG165)  STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX  |   PROTEASOME 20S, PA26 PROTEASOME ACTIVATOR 11S, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1yau:J    (LYS33) to   (ARG165)  STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX  |   PROTEASOME 20S, PA26 PROTEASOME ACTIVATOR 11S, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1yau:K    (LYS33) to   (ARG165)  STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX  |   PROTEASOME 20S, PA26 PROTEASOME ACTIVATOR 11S, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1yau:L    (LYS33) to   (ARG165)  STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX  |   PROTEASOME 20S, PA26 PROTEASOME ACTIVATOR 11S, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1yau:M    (LYS33) to   (ARG165)  STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX  |   PROTEASOME 20S, PA26 PROTEASOME ACTIVATOR 11S, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1yau:N    (LYS33) to   (ARG165)  STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX  |   PROTEASOME 20S, PA26 PROTEASOME ACTIVATOR 11S, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
3krd:M    (LYS52) to   (ALA190)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B  |   BINDING SITES, MYCOBACTERIUM TUBERCULOSIS, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME, FELLUTAMIDE B, INHIBITION, PROTEASE, THREONINE PROTEASE, VIRULENCE, AUTOCATALYTIC CLEAVAGE, ZYMOGEN 
3krd:Q    (LYS52) to   (GLY191)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B  |   BINDING SITES, MYCOBACTERIUM TUBERCULOSIS, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME, FELLUTAMIDE B, INHIBITION, PROTEASE, THREONINE PROTEASE, VIRULENCE, AUTOCATALYTIC CLEAVAGE, ZYMOGEN 
5dki:E    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5dki:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5dki:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5dki:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5dki:S    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5dki:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5dki:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5dki:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5dkj:E    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5dkj:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5dkj:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5dkj:S    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5dkj:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5dkj:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
1z7q:B    (LYS63) to   (ARG178)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION  |   20S, PROTEASOME, PA26, ACTIVATOR, MULTI-CATALYTIC PROTEASE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1z7q:E    (LYS66) to   (GLN206)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION  |   20S, PROTEASOME, PA26, ACTIVATOR, MULTI-CATALYTIC PROTEASE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1z7q:F    (SER57) to   (ILE182)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION  |   20S, PROTEASOME, PA26, ACTIVATOR, MULTI-CATALYTIC PROTEASE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1z7q:H    (LYS33) to   (ASN141)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION  |   20S, PROTEASOME, PA26, ACTIVATOR, MULTI-CATALYTIC PROTEASE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1z7q:M    (LYS42) to   (ARG194)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION  |   20S, PROTEASOME, PA26, ACTIVATOR, MULTI-CATALYTIC PROTEASE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1z7q:P    (LYS63) to   (ARG178)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION  |   20S, PROTEASOME, PA26, ACTIVATOR, MULTI-CATALYTIC PROTEASE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1z7q:S    (LYS66) to   (GLN206)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION  |   20S, PROTEASOME, PA26, ACTIVATOR, MULTI-CATALYTIC PROTEASE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1z7q:T    (SER57) to   (ILE182)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION  |   20S, PROTEASOME, PA26, ACTIVATOR, MULTI-CATALYTIC PROTEASE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1z7q:V    (LYS33) to   (ASN141)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION  |   20S, PROTEASOME, PA26, ACTIVATOR, MULTI-CATALYTIC PROTEASE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1z7q:X    (LYS41) to   (ASP177)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION  |   20S, PROTEASOME, PA26, ACTIVATOR, MULTI-CATALYTIC PROTEASE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1z7q:a    (LYS42) to   (ARG194)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION  |   20S, PROTEASOME, PA26, ACTIVATOR, MULTI-CATALYTIC PROTEASE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
5dsv:A    (ARG65) to   (VAL200)  CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER  |   PROTEASOME, HYDROLASE 
5dsv:B    (ARG65) to   (VAL200)  CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER  |   PROTEASOME, HYDROLASE 
5dsv:C    (ARG65) to   (HIS201)  CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER  |   PROTEASOME, HYDROLASE 
5dsv:D    (ARG65) to   (VAL200)  CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER  |   PROTEASOME, HYDROLASE 
5dsv:E    (ARG65) to   (HIS201)  CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER  |   PROTEASOME, HYDROLASE 
5dsv:F    (ARG65) to   (HIS201)  CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER  |   PROTEASOME, HYDROLASE 
5dsv:G    (ARG65) to   (HIS201)  CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER  |   PROTEASOME, HYDROLASE 
5dsv:H    (ARG65) to   (HIS201)  CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER  |   PROTEASOME, HYDROLASE 
5dsv:I    (ARG65) to   (HIS201)  CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER  |   PROTEASOME, HYDROLASE 
5dsv:J    (ARG65) to   (HIS201)  CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER  |   PROTEASOME, HYDROLASE 
5dsv:K    (ARG65) to   (HIS201)  CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER  |   PROTEASOME, HYDROLASE 
5dsv:L    (ARG65) to   (VAL200)  CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER  |   PROTEASOME, HYDROLASE 
5dsv:M    (ARG65) to   (HIS201)  CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER  |   PROTEASOME, HYDROLASE 
5dsv:N    (ARG65) to   (HIS201)  CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER  |   PROTEASOME, HYDROLASE 
4q1s:E    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN  |   PROTEASOME, NATURAL PRODUCT, QUINONE METHIDE, COVALENT BINDING, EXOSITE, HYDROLASE-TOXIN COMPLEX 
4q1s:G    (TYR62) to   (GLY206)  YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN  |   PROTEASOME, NATURAL PRODUCT, QUINONE METHIDE, COVALENT BINDING, EXOSITE, HYDROLASE-TOXIN COMPLEX 
4q1s:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN  |   PROTEASOME, NATURAL PRODUCT, QUINONE METHIDE, COVALENT BINDING, EXOSITE, HYDROLASE-TOXIN COMPLEX 
4q1s:N    (LYS33) to   (LYS164)  YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN  |   PROTEASOME, NATURAL PRODUCT, QUINONE METHIDE, COVALENT BINDING, EXOSITE, HYDROLASE-TOXIN COMPLEX 
4q1s:S    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN  |   PROTEASOME, NATURAL PRODUCT, QUINONE METHIDE, COVALENT BINDING, EXOSITE, HYDROLASE-TOXIN COMPLEX 
4q1s:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN  |   PROTEASOME, NATURAL PRODUCT, QUINONE METHIDE, COVALENT BINDING, EXOSITE, HYDROLASE-TOXIN COMPLEX 
4q1s:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN  |   PROTEASOME, NATURAL PRODUCT, QUINONE METHIDE, COVALENT BINDING, EXOSITE, HYDROLASE-TOXIN COMPLEX 
4q1s:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN  |   PROTEASOME, NATURAL PRODUCT, QUINONE METHIDE, COVALENT BINDING, EXOSITE, HYDROLASE-TOXIN COMPLEX 
4q1s:b    (LYS33) to   (LYS164)  YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN  |   PROTEASOME, NATURAL PRODUCT, QUINONE METHIDE, COVALENT BINDING, EXOSITE, HYDROLASE-TOXIN COMPLEX 
4qls:E    (LYS61) to   (ILE181)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qls:I    (LYS41) to   (ASP177)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qls:L    (LYS42) to   (ARG194)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qls:M    (ARG41) to   (ARG187)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qls:N    (LYS33) to   (LYS164)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qls:S    (LYS61) to   (ILE181)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qls:W    (LYS41) to   (ASP177)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qls:Z    (LYS42) to   (ARG194)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qls:a    (ARG41) to   (ARG187)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qls:b    (LYS33) to   (LYS164)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlq:C    (LYS61) to   (GLU199)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlq:E    (SER56) to   (ILE181)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlq:L    (LYS42) to   (ARG194)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlq:M    (ARG41) to   (ARG187)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlq:N    (LYS33) to   (ASN141)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlq:Q    (LYS61) to   (GLU199)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlq:S    (SER56) to   (ILE181)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlq:Z    (LYS42) to   (ARG194)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlq:a    (ARG41) to   (ARG187)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlq:b    (LYS33) to   (ASN141)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlt:E    (SER56) to   (ILE181)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlt:I    (LYS41) to   (ASP177)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlt:L    (LYS42) to   (ARG194)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlt:M    (ARG41) to   (ARG187)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlt:N    (LYS33) to   (LYS164)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlt:S    (SER56) to   (ILE181)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlt:W    (LYS41) to   (ASP177)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlt:Z    (LYS42) to   (ARG194)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlt:a    (ARG41) to   (ARG187)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlt:b    (LYS33) to   (ASN141)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlu:F    (ILE63) to   (LYS204)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlu:I    (LYS41) to   (ASP177)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlu:L    (LYS42) to   (ARG194)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlu:N    (LYS33) to   (ASN141)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlu:T    (ILE63) to   (LYS204)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlu:W    (LYS41) to   (ASP177)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlu:Z    (LYS42) to   (ARG194)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlu:b    (LYS33) to   (ASN141)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3mfe:H   (LYS333) to   (SER479)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT  |   CATALYTIC DOMAIN, HYDROGEN BONDING, MYCOBACTERIUM TUBERCULOSIS, OXAZOLIDINONES, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN CARBONYLATION, PROTEIN CONFORMATION, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, THIAZOLES, HELIX MOVEMENT, HYDROLASE 
3mfe:A    (LYS52) to   (GLY191)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT  |   CATALYTIC DOMAIN, HYDROGEN BONDING, MYCOBACTERIUM TUBERCULOSIS, OXAZOLIDINONES, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN CARBONYLATION, PROTEIN CONFORMATION, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, THIAZOLES, HELIX MOVEMENT, HYDROLASE 
3mfe:W    (LYS52) to   (SER192)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT  |   CATALYTIC DOMAIN, HYDROGEN BONDING, MYCOBACTERIUM TUBERCULOSIS, OXAZOLIDINONES, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN CARBONYLATION, PROTEIN CONFORMATION, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, THIAZOLES, HELIX MOVEMENT, HYDROLASE 
3mg0:E    (LYS66) to    (ILE18)  STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB  |   20S PROTEASOME, HYDROLASE 
3mg0:F    (ILE67) to    (GLY18)  STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB  |   20S PROTEASOME, HYDROLASE 
3mg0:I    (LYS33) to   (ASP166)  STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB  |   20S PROTEASOME, HYDROLASE 
3mg0:L    (LYS33) to   (ARG165)  STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB  |   20S PROTEASOME, HYDROLASE 
3mg0:N    (LYS33) to   (ASN141)  STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB  |   20S PROTEASOME, HYDROLASE 
3mg0:S    (LYS66) to    (ILE18)  STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB  |   20S PROTEASOME, HYDROLASE 
3mg0:Z    (LYS33) to   (ARG165)  STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB  |   20S PROTEASOME, HYDROLASE 
3mg0:2    (LYS33) to   (ASN141)  STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB  |   20S PROTEASOME, HYDROLASE 
3mg4:I    (LYS33) to   (ASP166)  STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1  |   20S PROTEASOME, HYDROLASE 
3mg4:J    (LYS33) to   (LYS164)  STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1  |   20S PROTEASOME, HYDROLASE 
3mg4:L    (LYS33) to   (ARG165)  STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1  |   20S PROTEASOME, HYDROLASE 
3mg4:N    (LYS33) to   (LYS164)  STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1  |   20S PROTEASOME, HYDROLASE 
3mg4:S    (LYS66) to   (ILE182)  STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1  |   20S PROTEASOME, HYDROLASE 
3mg4:W    (LYS33) to   (ASP166)  STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1  |   20S PROTEASOME, HYDROLASE 
3mg4:X    (LYS33) to   (LYS164)  STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1  |   20S PROTEASOME, HYDROLASE 
3mg4:Z    (LYS33) to   (ARG165)  STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1  |   20S PROTEASOME, HYDROLASE 
3mg4:1    (ARG33) to   (ARG165)  STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1  |   20S PROTEASOME, HYDROLASE 
3mg4:2    (LYS33) to   (ASN141)  STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1  |   20S PROTEASOME, HYDROLASE 
3mg6:E    (SER59) to   (ILE180)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6  |   20S PROTEASOME, HYDROLASE 
3mg6:F    (LYS66) to   (HIS180)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6  |   20S PROTEASOME, HYDROLASE 
3mg6:G    (TYR66) to   (ALA200)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6  |   20S PROTEASOME, HYDROLASE 
3mg6:I    (LYS33) to   (ASP166)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6  |   20S PROTEASOME, HYDROLASE 
3mg6:L    (LYS33) to   (ARG165)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6  |   20S PROTEASOME, HYDROLASE 
3mg6:M    (ARG33) to   (ARG165)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6  |   20S PROTEASOME, HYDROLASE 
3mg6:N    (LYS33) to   (ASN141)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6  |   20S PROTEASOME, HYDROLASE 
3mg6:S    (LYS66) to   (ILE182)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6  |   20S PROTEASOME, HYDROLASE 
3mg6:U    (TYR66) to   (ALA200)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6  |   20S PROTEASOME, HYDROLASE 
3mg6:W    (LYS33) to   (ASP166)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6  |   20S PROTEASOME, HYDROLASE 
3mg6:X    (LYS33) to   (ARG165)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6  |   20S PROTEASOME, HYDROLASE 
3mg6:Z    (LYS33) to   (ARG165)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6  |   20S PROTEASOME, HYDROLASE 
3mg6:1    (ARG33) to   (ARG165)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6  |   20S PROTEASOME, HYDROLASE 
3mg6:2    (LYS33) to   (ASN141)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6  |   20S PROTEASOME, HYDROLASE 
3mg7:E    (SER59) to   (ILE180)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8  |   20S PROTEASOME, HYDROLASE 
3mg7:I    (LYS33) to   (ASP166)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8  |   20S PROTEASOME, HYDROLASE 
3mg7:L    (LYS33) to   (ARG165)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8  |   20S PROTEASOME, HYDROLASE 
3mg7:M    (ARG33) to   (ARG165)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8  |   20S PROTEASOME, HYDROLASE 
3mg7:N    (LYS33) to   (ASN141)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8  |   20S PROTEASOME, HYDROLASE 
3mg7:S    (SER59) to   (ILE182)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8  |   20S PROTEASOME, HYDROLASE 
3mg7:W    (LYS33) to   (ASP166)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8  |   20S PROTEASOME, HYDROLASE 
3mg7:Z    (LYS33) to   (ARG165)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8  |   20S PROTEASOME, HYDROLASE 
3mg7:1    (ARG33) to   (ARG165)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8  |   20S PROTEASOME, HYDROLASE 
3mg7:2    (LYS33) to   (ASN141)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8  |   20S PROTEASOME, HYDROLASE 
3mg8:E    (SER59) to   (ILE180)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16  |   20S PROTEASOME, HYDROLASE 
3mg8:L    (LYS33) to   (ARG165)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16  |   20S PROTEASOME, HYDROLASE 
3mg8:M    (ARG33) to   (ARG165)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16  |   20S PROTEASOME, HYDROLASE 
3mg8:N    (LYS33) to   (ASN141)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16  |   20S PROTEASOME, HYDROLASE 
3mg8:Q    (LYS66) to   (LEU198)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16  |   20S PROTEASOME, HYDROLASE 
3mg8:S    (LYS66) to   (ILE182)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16  |   20S PROTEASOME, HYDROLASE 
3mg8:U    (TYR66) to   (LEU201)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16  |   20S PROTEASOME, HYDROLASE 
3mg8:Z    (LYS33) to   (ARG165)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16  |   20S PROTEASOME, HYDROLASE 
3mg8:2    (LYS33) to   (ASN141)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16  |   20S PROTEASOME, HYDROLASE 
3mka:A    (LYS52) to   (ALA190)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT  |   MYCOBACTERIUM TUBERCULOSIS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, PROPEPTIDE, PROTEIN MATURATION, PROTEASOME ASSEMBLY, HYDROLASE 
3mka:D    (LYS52) to   (ALA190)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT  |   MYCOBACTERIUM TUBERCULOSIS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, PROPEPTIDE, PROTEIN MATURATION, PROTEASOME ASSEMBLY, HYDROLASE 
3mka:I    (LYS52) to   (SER192)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT  |   MYCOBACTERIUM TUBERCULOSIS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, PROPEPTIDE, PROTEIN MATURATION, PROTEASOME ASSEMBLY, HYDROLASE 
3mka:K    (LYS52) to   (SER192)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT  |   MYCOBACTERIUM TUBERCULOSIS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, PROPEPTIDE, PROTEIN MATURATION, PROTEASOME ASSEMBLY, HYDROLASE 
3mka:Q    (LYS52) to   (SER192)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT  |   MYCOBACTERIUM TUBERCULOSIS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, PROPEPTIDE, PROTEIN MATURATION, PROTEASOME ASSEMBLY, HYDROLASE 
3mka:1    (LYS52) to   (ARG189)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT  |   MYCOBACTERIUM TUBERCULOSIS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, PROPEPTIDE, PROTEIN MATURATION, PROTEASOME ASSEMBLY, HYDROLASE 
4qux:E    (LYS61) to   (ILE181)  YCP BETA5-A49T-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qux:I    (LYS41) to   (ASP177)  YCP BETA5-A49T-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qux:L    (LYS42) to   (ARG194)  YCP BETA5-A49T-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qux:M    (ARG41) to   (ARG187)  YCP BETA5-A49T-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qux:N    (LYS33) to   (ASN141)  YCP BETA5-A49T-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qux:S    (LYS61) to   (ILE181)  YCP BETA5-A49T-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qux:W    (LYS41) to   (ASP177)  YCP BETA5-A49T-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qux:Z    (LYS42) to   (ARG194)  YCP BETA5-A49T-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qux:a    (ARG41) to   (ARG187)  YCP BETA5-A49T-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qux:b    (LYS33) to   (ASN141)  YCP BETA5-A49T-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv1:E    (LYS61) to   (ILE181)  YCP BETA5-M45A MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qv1:I    (LYS41) to   (ASP177)  YCP BETA5-M45A MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qv1:L    (LYS42) to   (ARG194)  YCP BETA5-M45A MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qv1:M    (ARG41) to   (ARG187)  YCP BETA5-M45A MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qv1:N    (LYS33) to   (ASN141)  YCP BETA5-M45A MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qv1:S    (LYS61) to   (ILE181)  YCP BETA5-M45A MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qv1:W    (LYS41) to   (ASP177)  YCP BETA5-M45A MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qv1:Z    (LYS42) to   (ARG194)  YCP BETA5-M45A MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qv1:a    (ARG41) to   (ARG187)  YCP BETA5-M45A MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qv1:b    (LYS33) to   (ASN141)  YCP BETA5-M45A MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4quy:E    (LYS61) to   (ILE181)  YCP BETA5-A49S-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4quy:I    (LYS41) to   (ASP177)  YCP BETA5-A49S-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4quy:L    (LYS42) to   (ARG194)  YCP BETA5-A49S-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4quy:M    (ARG41) to   (ARG187)  YCP BETA5-A49S-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4quy:N    (LYS33) to   (ASN141)  YCP BETA5-A49S-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4quy:S    (LYS61) to   (ILE181)  YCP BETA5-A49S-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4quy:W    (LYS41) to   (ASP177)  YCP BETA5-A49S-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4quy:Z    (LYS42) to   (ARG194)  YCP BETA5-A49S-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4quy:a    (ARG41) to   (ARG187)  YCP BETA5-A49S-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4quy:b    (LYS33) to   (ASN141)  YCP BETA5-A49S-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv0:E    (LYS61) to   (ILE181)  YCP BETA5-A49T-A50V-DOUBLE MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv0:I    (LYS41) to   (ASP177)  YCP BETA5-A49T-A50V-DOUBLE MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv0:L    (LYS42) to   (ARG194)  YCP BETA5-A49T-A50V-DOUBLE MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv0:M    (ARG41) to   (ARG187)  YCP BETA5-A49T-A50V-DOUBLE MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv0:N    (LYS33) to   (ASN141)  YCP BETA5-A49T-A50V-DOUBLE MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv0:S    (LYS61) to   (ILE181)  YCP BETA5-A49T-A50V-DOUBLE MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv0:W    (LYS41) to   (ASP177)  YCP BETA5-A49T-A50V-DOUBLE MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv0:Z    (LYS42) to   (ARG194)  YCP BETA5-A49T-A50V-DOUBLE MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv0:a    (ARG41) to   (ARG187)  YCP BETA5-A49T-A50V-DOUBLE MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv0:b    (LYS33) to   (ASN141)  YCP BETA5-A49T-A50V-DOUBLE MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv3:E    (LYS61) to   (ILE181)  YCP BETA5-M45V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv3:I    (LYS41) to   (ASP177)  YCP BETA5-M45V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv3:L    (LYS42) to   (ARG194)  YCP BETA5-M45V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv3:M    (ARG41) to   (ARG187)  YCP BETA5-M45V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv3:N    (LYS33) to   (ASN141)  YCP BETA5-M45V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv3:S    (LYS61) to   (ILE181)  YCP BETA5-M45V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv3:W    (LYS41) to   (ASP177)  YCP BETA5-M45V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv3:Z    (LYS42) to   (ARG194)  YCP BETA5-M45V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv3:a    (ARG41) to   (ARG187)  YCP BETA5-M45V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv3:b    (LYS33) to   (ASN141)  YCP BETA5-M45V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv4:E    (LYS61) to   (ILE181)  YCP BETA5-M45T MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv4:I    (LYS41) to   (ASP177)  YCP BETA5-M45T MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv4:L    (LYS42) to   (ARG194)  YCP BETA5-M45T MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv4:M    (ARG41) to   (ARG187)  YCP BETA5-M45T MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv4:N    (LYS33) to   (ASN141)  YCP BETA5-M45T MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv4:S    (LYS61) to   (ILE181)  YCP BETA5-M45T MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv4:W    (LYS41) to   (ASP177)  YCP BETA5-M45T MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv4:Z    (LYS42) to   (ARG194)  YCP BETA5-M45T MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv4:a    (ARG41) to   (ARG187)  YCP BETA5-M45T MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv4:b    (LYS33) to   (ASN141)  YCP BETA5-M45T MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv5:E    (LYS61) to   (ILE181)  YCP BETA5-M45I MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv5:I    (LYS41) to   (ASP177)  YCP BETA5-M45I MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv5:L    (LYS42) to   (ARG194)  YCP BETA5-M45I MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv5:M    (ARG41) to   (ARG187)  YCP BETA5-M45I MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv5:N    (LYS33) to   (ASN141)  YCP BETA5-M45I MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv5:S    (LYS61) to   (ILE181)  YCP BETA5-M45I MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv5:W    (LYS41) to   (ASP177)  YCP BETA5-M45I MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv5:Z    (LYS42) to   (ARG194)  YCP BETA5-M45I MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv5:a    (ARG41) to   (ARG187)  YCP BETA5-M45I MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv5:b    (LYS33) to   (ASN141)  YCP BETA5-M45I MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv6:E    (LYS61) to   (ILE181)  YCP BETA5-A49V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv6:I    (LYS41) to   (ASP177)  YCP BETA5-A49V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv6:L    (LYS42) to   (ARG194)  YCP BETA5-A49V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv6:M    (ARG41) to   (ARG187)  YCP BETA5-A49V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv6:N    (LYS33) to   (ASN141)  YCP BETA5-A49V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv6:S    (LYS61) to   (ILE181)  YCP BETA5-A49V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv6:W    (LYS41) to   (ASP177)  YCP BETA5-A49V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv6:Z    (LYS42) to   (ARG194)  YCP BETA5-A49V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv6:a    (ARG41) to   (ARG187)  YCP BETA5-A49V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv6:b    (LYS33) to   (ASN141)  YCP BETA5-A49V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv7:E    (LYS61) to   (ILE181)  YCP BETA5-A50V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv7:I    (LYS41) to   (ASP177)  YCP BETA5-A50V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv7:L    (LYS42) to   (ARG194)  YCP BETA5-A50V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv7:M    (ARG41) to   (ARG187)  YCP BETA5-A50V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv7:N    (LYS33) to   (ASN141)  YCP BETA5-A50V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv7:S    (LYS61) to   (ILE181)  YCP BETA5-A50V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv7:W    (LYS41) to   (ASP177)  YCP BETA5-A50V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv7:Z    (LYS42) to   (ARG194)  YCP BETA5-A50V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv7:a    (ARG41) to   (ARG187)  YCP BETA5-A50V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv7:b    (LYS33) to   (ASN141)  YCP BETA5-A50V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv8:E    (LYS61) to   (ILE181)  YCP BETA5-C52F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv8:I    (LYS41) to   (ASP177)  YCP BETA5-C52F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv8:L    (LYS42) to   (ARG194)  YCP BETA5-C52F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv8:M    (ARG41) to   (ARG187)  YCP BETA5-C52F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv8:N    (LYS33) to   (ASN141)  YCP BETA5-C52F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv8:S    (LYS61) to   (ILE181)  YCP BETA5-C52F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv8:W    (LYS41) to   (ASP177)  YCP BETA5-C52F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv8:Z    (LYS42) to   (ARG194)  YCP BETA5-C52F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv8:a    (ARG41) to   (ARG187)  YCP BETA5-C52F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv8:b    (LYS33) to   (ASN141)  YCP BETA5-C52F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv9:E    (LYS61) to   (ILE181)  YCP BETA5-C63F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv9:I    (LYS41) to   (ASP177)  YCP BETA5-C63F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv9:L    (LYS42) to   (ARG194)  YCP BETA5-C63F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv9:M    (ARG41) to   (ARG187)  YCP BETA5-C63F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv9:N    (LYS33) to   (ASN141)  YCP BETA5-C63F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv9:S    (LYS61) to   (ILE181)  YCP BETA5-C63F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv9:W    (LYS41) to   (ASP177)  YCP BETA5-C63F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv9:Z    (LYS42) to   (ARG194)  YCP BETA5-C63F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv9:a    (ARG41) to   (ARG187)  YCP BETA5-C63F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv9:b    (LYS33) to   (ASN141)  YCP BETA5-C63F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qvl:E    (LYS61) to   (ILE181)  YCP IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvl:I    (LYS41) to   (ASP177)  YCP IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvl:L    (LYS42) to   (ARG194)  YCP IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvl:M    (ARG41) to   (ARG187)  YCP IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvl:N    (LYS33) to   (ASN141)  YCP IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvl:S    (LYS61) to   (ILE181)  YCP IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvl:W    (LYS41) to   (ASP177)  YCP IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvl:Z    (LYS42) to   (ARG194)  YCP IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvl:a    (ARG41) to   (ARG187)  YCP IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvl:b    (LYS33) to   (ASN141)  YCP IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvm:E    (LYS61) to   (ILE181)  YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvm:I    (LYS41) to   (ASP177)  YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvm:L    (LYS42) to   (ARG194)  YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvm:M    (ARG41) to   (THR168)  YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvm:N    (LYS33) to   (ASN141)  YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvm:S    (LYS61) to   (ILE181)  YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvm:W    (LYS41) to   (ASP177)  YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvm:Z    (LYS42) to   (ARG194)  YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvm:a    (ARG41) to   (ARG187)  YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvm:b    (LYS33) to   (ASN141)  YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvn:E    (LYS61) to   (ILE181)  YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvn:I    (LYS41) to   (ASP177)  YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvn:L    (LYS42) to   (ARG194)  YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvn:M    (ARG41) to   (ARG187)  YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvn:N    (LYS33) to   (ASN141)  YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvn:S    (LYS61) to   (ILE181)  YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvn:W    (LYS41) to   (ASP177)  YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvn:Z    (LYS42) to   (ARG194)  YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvn:a    (ARG41) to   (ARG187)  YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvn:b    (LYS33) to   (ASN141)  YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvp:E    (LYS61) to   (ILE181)  YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvp:I    (LYS41) to   (ASP177)  YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvp:L    (LYS42) to   (ARG194)  YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvp:M    (ARG41) to   (ARG187)  YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvp:N    (LYS33) to   (ASN141)  YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvp:S    (LYS61) to   (ILE181)  YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvp:W    (LYS41) to   (ASP177)  YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvp:Z    (LYS42) to   (ARG194)  YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvp:a    (ARG41) to   (ARG187)  YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvp:b    (LYS33) to   (ASN141)  YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvq:E    (LYS61) to   (ILE181)  YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvq:I    (LYS41) to   (ASP177)  YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvq:L    (LYS42) to   (ARG194)  YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvq:M    (ARG41) to   (ARG187)  YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvq:N    (LYS33) to   (ASN141)  YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvq:S    (LYS61) to   (ILE181)  YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvq:W    (LYS41) to   (ASP177)  YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvq:Z    (LYS42) to   (ARG194)  YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvq:a    (ARG41) to   (ARG187)  YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvq:b    (LYS33) to   (ASN141)  YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvv:E    (SER56) to   (ILE181)  YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvv:I    (LYS41) to   (ASP177)  YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvv:M    (ARG41) to   (ARG187)  YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvv:N    (LYS33) to   (ASN141)  YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvv:S    (SER56) to   (ILE181)  YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvv:W    (LYS41) to   (ASP177)  YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvv:a    (ARG41) to   (ARG187)  YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvv:b    (LYS33) to   (ASN141)  YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvw:E    (LYS61) to   (ILE181)  YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvw:I    (LYS41) to   (ASP177)  YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvw:L    (LYS42) to   (ARG194)  YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvw:M    (ARG41) to   (ARG187)  YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvw:N    (LYS33) to   (ASN141)  YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvw:S    (LYS61) to   (ILE181)  YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvw:W    (LYS41) to   (ASP177)  YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvw:Z    (LYS42) to   (ARG194)  YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvw:a    (ARG41) to   (ARG187)  YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvw:b    (LYS33) to   (ASN141)  YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvy:E    (SER56) to   (ILE181)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvy:I    (LYS41) to   (ASP177)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvy:L    (LYS42) to   (ARG194)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvy:M    (ARG41) to   (ARG187)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvy:N    (LYS33) to   (ASN141)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvy:S    (SER56) to   (ILE181)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvy:W    (LYS41) to   (ASP177)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvy:Z    (LYS42) to   (ARG194)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvy:a    (ARG41) to   (ARG187)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvy:b    (LYS33) to   (ASN141)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw0:E    (LYS61) to   (ILE181)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw0:I    (LYS41) to   (ASP177)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw0:L    (LYS42) to   (ARG194)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw0:M    (ARG41) to   (ARG187)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw0:N    (LYS33) to   (ASN141)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw0:S    (LYS61) to   (ILE181)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw0:W    (LYS41) to   (ASP177)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw0:Z    (LYS42) to   (ARG194)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw0:a    (ARG41) to   (ARG187)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw0:b    (LYS33) to   (ASN141)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw1:E    (LYS61) to   (ILE181)  YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw1:I    (LYS41) to   (ASP177)  YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw1:L    (LYS42) to   (ARG194)  YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw1:M    (ARG41) to   (ARG187)  YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw1:N    (LYS33) to   (ASN141)  YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw1:S    (LYS61) to   (ILE181)  YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw1:W    (LYS41) to   (ASP177)  YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw1:Z    (LYS42) to   (ARG194)  YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw1:a    (ARG41) to   (ARG187)  YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw1:b    (LYS33) to   (ASN141)  YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw5:E    (SER56) to   (ILE181)  YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw5:I    (LYS41) to   (ASP177)  YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw5:L    (LYS42) to   (ARG194)  YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw5:M    (ARG41) to   (ARG187)  YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw5:N    (LYS33) to   (ASN141)  YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw5:S    (SER56) to   (ILE181)  YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw5:W    (LYS41) to   (ASP177)  YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw5:Z    (LYS42) to   (ARG194)  YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw5:a    (ARG41) to   (ARG187)  YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw5:b    (LYS33) to   (ASN141)  YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw4:E    (SER56) to   (ILE181)  YCP IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw4:I    (LYS41) to   (ASP177)  YCP IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw4:L    (LYS42) to   (ARG194)  YCP IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw4:M    (ARG41) to   (ARG187)  YCP IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw4:N    (LYS33) to   (ASN141)  YCP IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw4:S    (SER56) to   (ILE181)  YCP IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw4:W    (LYS41) to   (ASP177)  YCP IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw4:Z    (LYS42) to   (ARG194)  YCP IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw4:a    (ARG41) to   (ARG187)  YCP IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw4:b    (LYS33) to   (ASN141)  YCP IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw6:E    (SER56) to   (ILE181)  YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw6:I    (LYS41) to   (ASP177)  YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw6:L    (LYS42) to   (ARG194)  YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw6:M    (ARG41) to   (ARG187)  YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw6:N    (LYS33) to   (ASN141)  YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw6:S    (SER56) to   (ILE181)  YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw6:W    (LYS41) to   (ASP177)  YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw6:Z    (LYS42) to   (ARG194)  YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw6:a    (ARG41) to   (ARG187)  YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw6:b    (LYS33) to   (ASN141)  YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwj:E    (SER56) to   (ILE181)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwj:I    (LYS41) to   (ASP177)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwj:L    (LYS42) to   (ARG194)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwj:M    (ARG41) to   (ARG187)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwj:N    (LYS33) to   (ASN141)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwj:S    (SER56) to   (ILE181)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwj:W    (LYS41) to   (ASP177)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwj:Z    (LYS42) to   (ARG194)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwj:a    (ARG41) to   (ARG187)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwj:b    (LYS33) to   (ASN141)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwf:E    (SER56) to   (ILE181)  YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwf:I    (LYS41) to   (ASP177)  YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwf:L    (LYS42) to   (ARG194)  YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwf:M    (ARG41) to   (ARG187)  YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwf:N    (LYS33) to   (ASN141)  YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwf:S    (SER56) to   (ILE181)  YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwf:W    (LYS41) to   (ASP177)  YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwf:Z    (LYS42) to   (ARG194)  YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwf:a    (ARG41) to   (ARG187)  YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwf:b    (LYS33) to   (ASN141)  YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwg:E    (SER56) to   (ILE181)  YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwg:M    (ARG41) to   (ARG187)  YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwg:N    (LYS33) to   (ASN141)  YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwg:S    (SER56) to   (ILE181)  YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwg:a    (ARG41) to   (ARG187)  YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwg:b    (LYS33) to   (ASN141)  YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwk:E    (SER56) to   (ILE181)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwk:I    (LYS41) to   (ASP177)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwk:L    (LYS42) to   (ARG194)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwk:M    (ARG41) to   (ARG187)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwk:N    (LYS33) to   (ASN141)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwk:S    (SER56) to   (ILE181)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwk:W    (LYS41) to   (ASP177)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwk:Z    (LYS42) to   (ARG194)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwk:a    (ARG41) to   (ARG187)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwk:b    (LYS33) to   (ASN141)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwl:E    (SER56) to   (ILE181)  YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwl:I    (LYS41) to   (ASP177)  YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwl:L    (LYS42) to   (ARG194)  YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwl:M    (ARG41) to   (ARG187)  YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwl:N    (LYS33) to   (ASN141)  YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwl:S    (SER56) to   (ILE181)  YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwl:W    (LYS41) to   (ASP177)  YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwl:Z    (LYS42) to   (ARG194)  YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwl:a    (ARG41) to   (ARG187)  YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwl:b    (LYS33) to   (ASN141)  YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwr:E    (SER56) to   (ILE181)  YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwr:I    (LYS41) to   (ASP177)  YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwr:L    (LYS42) to   (ARG194)  YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwr:M    (ARG41) to   (ARG187)  YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwr:N    (LYS33) to   (ASN141)  YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwr:S    (SER56) to   (ILE181)  YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwr:W    (LYS41) to   (ASP177)  YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwr:Z    (LYS42) to   (ARG194)  YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwr:a    (ARG41) to   (ARG187)  YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qws:E    (SER56) to   (ILE181)  YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qws:J    (LYS34) to   (ARG171)  YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qws:L    (LYS42) to   (ARG194)  YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qws:M    (ARG41) to   (ARG187)  YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qws:N    (LYS33) to   (ASN141)  YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qws:S    (SER56) to   (ILE181)  YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qws:X    (LYS34) to   (ARG171)  YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qws:Z    (LYS42) to   (ARG194)  YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qws:a    (ARG41) to   (ARG187)  YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qws:b    (LYS33) to   (ASN141)  YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwu:E    (LYS61) to   (ILE181)  YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwu:I    (LYS41) to   (ASP177)  YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwu:L    (LYS42) to   (ARG194)  YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwu:M    (ARG41) to   (ARG187)  YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwu:N    (LYS33) to   (ASN141)  YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwu:S    (LYS61) to   (ILE181)  YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwu:W    (LYS41) to   (ASP177)  YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwu:a    (ARG41) to   (ARG187)  YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwu:b    (LYS33) to   (ASN141)  YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwx:E    (SER56) to   (ILE181)  YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwx:I    (LYS41) to   (ASP177)  YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwx:L    (LYS42) to   (ARG194)  YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwx:M    (ARG41) to   (ARG187)  YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwx:N    (LYS33) to   (LYS164)  YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwx:S    (SER56) to   (ILE181)  YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwx:W    (LYS41) to   (ASP177)  YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwx:Z    (LYS42) to   (ARG194)  YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwx:a    (ARG41) to   (ARG187)  YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwx:b    (LYS33) to   (LYS164)  YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qxj:E    (SER56) to   (ILE181)  YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qxj:I    (LYS41) to   (ASP177)  YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qxj:L    (LYS42) to   (ARG194)  YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qxj:M    (ARG41) to   (ARG187)  YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qxj:N    (LYS33) to   (ASN141)  YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qxj:S    (SER56) to   (ILE181)  YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qxj:W    (LYS41) to   (ASP177)  YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qxj:Z    (LYS42) to   (ARG194)  YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qxj:a    (ARG41) to   (ARG187)  YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qxj:b    (LYS33) to   (ASN141)  YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz0:E    (SER56) to   (ILE181)  YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz0:I    (LYS41) to   (ASP177)  YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz0:L    (LYS42) to   (ARG194)  YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz0:M    (ARG41) to   (ARG187)  YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz0:N    (LYS33) to   (TRP165)  YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz0:S    (SER56) to   (ILE181)  YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz0:W    (LYS41) to   (ASP177)  YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz0:Z    (LYS42) to   (ARG194)  YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz0:a    (ARG41) to   (ARG187)  YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz0:b    (LYS33) to   (TRP165)  YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz2:E    (SER56) to   (ILE181)  YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz2:I    (LYS41) to   (ASP177)  YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz2:L    (LYS42) to   (ARG194)  YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz2:M    (ARG41) to   (ARG187)  YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz2:N    (LYS33) to   (TRP165)  YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz2:S    (SER56) to   (ILE181)  YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz2:W    (LYS41) to   (ASP177)  YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz2:Z    (LYS42) to   (ARG194)  YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz2:a    (ARG41) to   (ARG187)  YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz2:b    (LYS33) to   (TRP165)  YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz3:E    (SER56) to   (ILE181)  YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz3:I    (LYS41) to   (ASP177)  YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz3:L    (LYS42) to   (ARG194)  YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz3:M    (ARG41) to   (ARG187)  YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz3:N    (LYS33) to   (ASN141)  YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz3:S    (SER56) to   (ILE181)  YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz3:W    (LYS41) to   (ASP177)  YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz3:Z    (LYS42) to   (ARG194)  YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz3:a    (ARG41) to   (ARG187)  YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz3:b    (LYS33) to   (ASN141)  YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz4:E    (SER56) to   (ILE181)  YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz4:I    (LYS41) to   (ASP177)  YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz4:L    (LYS42) to   (ARG194)  YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz4:M    (ARG41) to   (ARG187)  YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz4:S    (SER56) to   (ILE181)  YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz4:W    (LYS41) to   (ASP177)  YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz4:Z    (LYS42) to   (ARG194)  YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz4:a    (ARG41) to   (ARG187)  YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz5:E    (SER56) to   (ILE181)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz5:I    (LYS41) to   (ASP177)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz5:L    (LYS42) to   (ARG194)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz5:M    (ARG41) to   (ARG187)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz5:N    (LYS33) to   (ASN141)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz5:S    (SER56) to   (ILE181)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz5:W    (LYS41) to   (ASP177)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz5:Z    (LYS42) to   (ARG194)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz5:a    (ARG41) to   (ARG187)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz5:b    (LYS33) to   (ASN141)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz6:E    (SER56) to   (ILE181)  YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz6:I    (LYS41) to   (ASP177)  YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz6:L    (LYS42) to   (ARG194)  YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz6:M    (ARG41) to   (THR168)  YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz6:N    (LYS33) to   (ASN141)  YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz6:S    (SER56) to   (ILE181)  YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz6:W    (LYS41) to   (ASP177)  YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz6:Z    (LYS42) to   (ARG194)  YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz6:a    (ARG41) to   (THR168)  YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz6:b    (LYS33) to   (ASN141)  YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzw:E    (SER56) to   (ILE181)  YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzw:I    (LYS41) to   (ASP177)  YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzw:J    (LYS34) to   (LYS170)  YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzw:L    (LYS42) to   (ARG194)  YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzw:M    (ARG41) to   (ARG187)  YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzw:S    (SER56) to   (ILE181)  YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzw:W    (LYS41) to   (ASP177)  YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzw:X    (LYS34) to   (LYS170)  YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzw:Z    (LYS42) to   (ARG194)  YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzw:a    (ARG41) to   (ARG187)  YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzx:E    (SER56) to   (ILE181)  YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzx:I    (LYS41) to   (ASP177)  YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzx:L    (LYS42) to   (ARG194)  YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzx:M    (ARG41) to   (ARG187)  YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzx:S    (SER56) to   (ILE181)  YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzx:W    (LYS41) to   (ASP177)  YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzx:Z    (LYS42) to   (ARG194)  YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzx:a    (ARG41) to   (ARG187)  YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r00:E    (LYS61) to   (ILE181)  YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r00:I    (LYS41) to   (ASP177)  YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r00:L    (LYS42) to   (ARG194)  YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r00:M    (ARG41) to   (ARG187)  YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r00:N    (LYS33) to   (ASN141)  YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r00:S    (LYS61) to   (ILE181)  YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r00:W    (LYS41) to   (ASP177)  YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r00:Z    (LYS42) to   (ARG194)  YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r00:a    (ARG41) to   (ARG187)  YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r00:b    (LYS33) to   (ASN141)  YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzz:E    (LYS61) to   (ILE181)  YCP IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzz:I    (LYS41) to   (ASP177)  YCP IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzz:L    (LYS42) to   (ARG194)  YCP IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzz:M    (ARG41) to   (ARG187)  YCP IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzz:N    (LYS33) to   (ASN141)  YCP IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzz:S    (LYS61) to   (ILE181)  YCP IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzz:W    (LYS41) to   (ASP177)  YCP IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzz:Z    (LYS42) to   (ARG194)  YCP IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzz:a    (ARG41) to   (ARG187)  YCP IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzz:b    (LYS33) to   (ASN141)  YCP IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r02:C    (LYS61) to   (LEU198)  YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)  |   CANCER, PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, REVERSIBLE COVALENT LIGAND, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r02:E    (LYS61) to   (ILE181)  YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)  |   CANCER, PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, REVERSIBLE COVALENT LIGAND, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r02:I    (LYS41) to   (ASP177)  YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)  |   CANCER, PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, REVERSIBLE COVALENT LIGAND, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r02:J    (LYS34) to   (MET172)  YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)  |   CANCER, PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, REVERSIBLE COVALENT LIGAND, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r02:L    (LYS42) to   (ARG194)  YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)  |   CANCER, PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, REVERSIBLE COVALENT LIGAND, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r02:M    (ARG41) to   (ARG187)  YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)  |   CANCER, PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, REVERSIBLE COVALENT LIGAND, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r02:N    (LYS33) to   (ASN141)  YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)  |   CANCER, PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, REVERSIBLE COVALENT LIGAND, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r02:S    (SER56) to   (ILE181)  YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)  |   CANCER, PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, REVERSIBLE COVALENT LIGAND, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r02:Z    (LYS42) to   (ARG194)  YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)  |   CANCER, PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, REVERSIBLE COVALENT LIGAND, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r02:a    (ARG41) to   (ARG187)  YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)  |   CANCER, PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, REVERSIBLE COVALENT LIGAND, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r02:b    (LYS33) to   (ASN141)  YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)  |   CANCER, PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, REVERSIBLE COVALENT LIGAND, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r17:E    (LYS61) to   (ILE181)  LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r17:L    (LYS42) to   (ARG194)  LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r17:M    (ARG41) to   (ARG187)  LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r17:N    (LYS33) to   (ASN141)  LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r17:S    (LYS61) to   (ILE181)  LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r17:Z    (LYS42) to   (ARG194)  LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r17:a    (ARG41) to   (ARG187)  LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r17:b    (LYS33) to   (ASN141)  LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r18:E    (LYS61) to   (ILE181)  LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r18:I    (LYS41) to   (ASP177)  LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r18:L    (LYS42) to   (ARG194)  LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r18:M    (ARG41) to   (ARG187)  LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r18:N    (LYS33) to   (ASN141)  LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r18:S    (LYS61) to   (ILE181)  LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r18:W    (LYS41) to   (ASP177)  LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r18:Z    (LYS42) to   (ARG194)  LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r18:a    (ARG41) to   (ARG187)  LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r18:b    (LYS33) to   (ASN141)  LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r3o:A    (HIS68) to   (LEU206)  HUMAN CONSTITUTIVE 20S PROTEASOME  |   HYDROLASE 
4r3o:B    (LYS63) to   (GLU196)  HUMAN CONSTITUTIVE 20S PROTEASOME  |   HYDROLASE 
4r3o:F    (LYS62) to   (CYS182)  HUMAN CONSTITUTIVE 20S PROTEASOME  |   HYDROLASE 
4r3o:G    (ARG65) to   (ILE199)  HUMAN CONSTITUTIVE 20S PROTEASOME  |   HYDROLASE 
4r3o:J    (LYS41) to   (ASP178)  HUMAN CONSTITUTIVE 20S PROTEASOME  |   HYDROLASE 
4r3o:K    (LYS34) to   (LYS169)  HUMAN CONSTITUTIVE 20S PROTEASOME  |   HYDROLASE 
4r3o:M    (LYS42) to   (ARG185)  HUMAN CONSTITUTIVE 20S PROTEASOME  |   HYDROLASE 
4r3o:O    (HIS68) to   (SER207)  HUMAN CONSTITUTIVE 20S PROTEASOME  |   HYDROLASE 
4r3o:P    (LYS63) to   (GLU196)  HUMAN CONSTITUTIVE 20S PROTEASOME  |   HYDROLASE 
4r3o:R    (LYS61) to   (GLU197)  HUMAN CONSTITUTIVE 20S PROTEASOME  |   HYDROLASE 
4r3o:T    (LYS62) to   (CYS182)  HUMAN CONSTITUTIVE 20S PROTEASOME  |   HYDROLASE 
4r3o:U    (ARG65) to   (ILE199)  HUMAN CONSTITUTIVE 20S PROTEASOME  |   HYDROLASE 
4r3o:X    (LYS41) to   (ASP178)  HUMAN CONSTITUTIVE 20S PROTEASOME  |   HYDROLASE 
4r3o:Y    (LYS34) to   (LYS169)  HUMAN CONSTITUTIVE 20S PROTEASOME  |   HYDROLASE 
4r3o:1    (LYS42) to   (ARG185)  HUMAN CONSTITUTIVE 20S PROTEASOME  |   HYDROLASE 
5fgd:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgd:J    (LYS34) to   (LYS170)  YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgd:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgd:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgd:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgd:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgd:X    (LYS34) to   (LYS170)  YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgd:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgd:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgd:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fg7:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA2-T1A MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg7:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA2-T1A MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg7:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA2-T1A MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg7:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA2-T1A MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg7:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA2-T1A MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg7:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA2-T1A MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg7:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA2-T1A MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg7:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA2-T1A MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg7:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA2-T1A MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg7:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA2-T1A MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg9:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg9:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg9:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg9:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg9:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg9:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg9:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg9:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg9:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg9:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fge:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fge:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fge:J    (LYS34) to   (MET172)  YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fge:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fge:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fge:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fge:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fge:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fge:X    (LYS34) to   (MET172)  YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fge:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fge:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fge:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgf:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgf:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgf:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgf:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgf:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgf:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgf:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgf:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgf:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgf:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fhs:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fhs:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fhs:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fhs:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fhs:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fhs:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fhs:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fhs:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
3nzj:E    (LYS66) to    (ILE18)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzj:G    (TYR66) to   (ALA200)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzj:I    (LYS33) to   (ASP166)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzj:J    (LYS33) to   (LYS164)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzj:L    (LYS33) to   (ARG165)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzj:M    (ARG33) to   (ARG165)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzj:N    (LYS33) to   (ASN141)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzj:S    (LYS66) to    (ILE18)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzj:U    (TYR66) to   (ALA200)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzj:W    (LYS33) to   (ASP166)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzj:X    (LYS33) to   (LYS164)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzj:Z    (LYS33) to   (ARG165)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzj:1    (ARG33) to   (ARG165)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzj:2    (LYS33) to   (ASN141)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzw:E    (LYS66) to    (ILE18)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzw:I    (LYS33) to   (ASP166)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzw:L    (LYS33) to   (ARG165)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzw:M    (ARG33) to   (ARG165)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzw:N    (LYS33) to   (ASN141)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzw:S    (LYS66) to    (ILE18)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzw:W    (LYS33) to   (ASP166)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzw:Z    (LYS33) to   (ARG165)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzw:1    (ARG33) to   (ARG165)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzw:2    (LYS33) to   (ASN141)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3d29:E    (LYS66) to    (ILE18)  PROTEASOME INHIBITION BY FELLUTAMIDE B  |   ANTI-PARALLEL BETA-SHEET STRUCTURE FLANKED BY ALPHA-HELICES, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3d29:F    (ILE67) to   (ASN205)  PROTEASOME INHIBITION BY FELLUTAMIDE B  |   ANTI-PARALLEL BETA-SHEET STRUCTURE FLANKED BY ALPHA-HELICES, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3d29:I    (LYS33) to   (ASP166)  PROTEASOME INHIBITION BY FELLUTAMIDE B  |   ANTI-PARALLEL BETA-SHEET STRUCTURE FLANKED BY ALPHA-HELICES, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3d29:L    (LYS33) to   (ARG165)  PROTEASOME INHIBITION BY FELLUTAMIDE B  |   ANTI-PARALLEL BETA-SHEET STRUCTURE FLANKED BY ALPHA-HELICES, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3d29:M    (ARG33) to   (ARG165)  PROTEASOME INHIBITION BY FELLUTAMIDE B  |   ANTI-PARALLEL BETA-SHEET STRUCTURE FLANKED BY ALPHA-HELICES, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3d29:N    (LYS33) to   (ASN141)  PROTEASOME INHIBITION BY FELLUTAMIDE B  |   ANTI-PARALLEL BETA-SHEET STRUCTURE FLANKED BY ALPHA-HELICES, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3d29:S    (LYS66) to    (ILE18)  PROTEASOME INHIBITION BY FELLUTAMIDE B  |   ANTI-PARALLEL BETA-SHEET STRUCTURE FLANKED BY ALPHA-HELICES, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3d29:T    (ILE67) to   (ASN205)  PROTEASOME INHIBITION BY FELLUTAMIDE B  |   ANTI-PARALLEL BETA-SHEET STRUCTURE FLANKED BY ALPHA-HELICES, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3d29:W    (LYS33) to   (ASP166)  PROTEASOME INHIBITION BY FELLUTAMIDE B  |   ANTI-PARALLEL BETA-SHEET STRUCTURE FLANKED BY ALPHA-HELICES, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3d29:Z    (LYS33) to   (ARG165)  PROTEASOME INHIBITION BY FELLUTAMIDE B  |   ANTI-PARALLEL BETA-SHEET STRUCTURE FLANKED BY ALPHA-HELICES, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3d29:1    (ARG33) to   (ARG165)  PROTEASOME INHIBITION BY FELLUTAMIDE B  |   ANTI-PARALLEL BETA-SHEET STRUCTURE FLANKED BY ALPHA-HELICES, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3d29:2    (LYS33) to   (ASN141)  PROTEASOME INHIBITION BY FELLUTAMIDE B  |   ANTI-PARALLEL BETA-SHEET STRUCTURE FLANKED BY ALPHA-HELICES, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
4cr3:3    (LYS33) to   (ASP169)  DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME  |   HYDROLASE, AAA-ATPASE, ATP-ANALOG, CLASSIFICATION 
4cr3:6    (LYS33) to   (HIS186)  DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME  |   HYDROLASE, AAA-ATPASE, ATP-ANALOG, CLASSIFICATION 
4cr3:7    (ARG33) to   (ALA181)  DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME  |   HYDROLASE, AAA-ATPASE, ATP-ANALOG, CLASSIFICATION 
4cr3:A    (TYR71) to   (ALA213)  DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME  |   HYDROLASE, AAA-ATPASE, ATP-ANALOG, CLASSIFICATION 
4cr3:B    (LYS63) to   (SER199)  DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME  |   HYDROLASE, AAA-ATPASE, ATP-ANALOG, CLASSIFICATION 
4cr3:C    (LYS65) to   (THR201)  DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME  |   HYDROLASE, AAA-ATPASE, ATP-ANALOG, CLASSIFICATION 
4cr3:D    (LYS63) to   (GLN204)  DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME  |   HYDROLASE, AAA-ATPASE, ATP-ANALOG, CLASSIFICATION 
4cr3:F    (LYS62) to   (ILE182)  DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME  |   HYDROLASE, AAA-ATPASE, ATP-ANALOG, CLASSIFICATION 
4cr4:2    (LYS33) to   (LEU167)  DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME  |   HYDROLASE, AAA-ATPASE, ATP-ANALOG, CLASSIFICATION 
4cr4:3    (LYS33) to   (ASP169)  DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME  |   HYDROLASE, AAA-ATPASE, ATP-ANALOG, CLASSIFICATION 
4cr4:4    (LYS33) to   (LYS169)  DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME  |   HYDROLASE, AAA-ATPASE, ATP-ANALOG, CLASSIFICATION 
4cr4:7    (ARG33) to   (THR160)  DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME  |   HYDROLASE, AAA-ATPASE, ATP-ANALOG, CLASSIFICATION 
4cr4:B    (LYS63) to   (SER199)  DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME  |   HYDROLASE, AAA-ATPASE, ATP-ANALOG, CLASSIFICATION 
4cr4:D    (LYS63) to   (GLN204)  DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME  |   HYDROLASE, AAA-ATPASE, ATP-ANALOG, CLASSIFICATION 
4cr4:E    (LYS66) to   (TRP187)  DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME  |   HYDROLASE, AAA-ATPASE, ATP-ANALOG, CLASSIFICATION 
4cr4:F    (LYS62) to   (ILE182)  DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME  |   HYDROLASE, AAA-ATPASE, ATP-ANALOG, CLASSIFICATION 
3oeu:E    (SER59) to   (ILE180)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oeu:I    (LYS33) to   (ASP166)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oeu:L    (LYS33) to   (ARG165)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oeu:M    (ARG33) to   (THR146)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oeu:N    (LYS33) to   (ASN141)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oeu:U    (TYR66) to   (ALA200)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oeu:W    (LYS33) to   (ASP166)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oeu:Z    (LYS33) to   (ARG165)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oeu:1    (ARG33) to   (ARG165)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oeu:2    (LYS33) to   (ASN141)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oev:E    (LYS66) to   (ILE180)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oev:I    (LYS33) to   (ASP166)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oev:L    (LYS33) to   (ARG165)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oev:M    (ARG33) to   (THR146)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oev:N    (LYS33) to   (ASN141)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oev:S    (LYS66) to   (ILE182)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oev:T    (LYS66) to   (LYS206)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oev:W    (LYS33) to   (ASP166)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oev:Z    (LYS33) to   (ARG165)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oev:1    (ARG33) to   (THR146)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oev:2    (LYS33) to   (LYS164)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3dy3:E    (LYS66) to    (ILE18)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN  |   PROTEASOME, INHIBITOR, PROTEIN DEGRADATION, UBIQUITIN- PROTEASOME-PATHWAY, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3dy3:J    (LYS33) to   (HIS141)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN  |   PROTEASOME, INHIBITOR, PROTEIN DEGRADATION, UBIQUITIN- PROTEASOME-PATHWAY, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3dy3:L    (LYS33) to   (ARG165)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN  |   PROTEASOME, INHIBITOR, PROTEIN DEGRADATION, UBIQUITIN- PROTEASOME-PATHWAY, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3dy3:M    (ARG33) to   (ARG165)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN  |   PROTEASOME, INHIBITOR, PROTEIN DEGRADATION, UBIQUITIN- PROTEASOME-PATHWAY, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3dy3:N    (LYS33) to   (ASN141)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN  |   PROTEASOME, INHIBITOR, PROTEIN DEGRADATION, UBIQUITIN- PROTEASOME-PATHWAY, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3dy3:S    (LYS66) to    (ILE18)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN  |   PROTEASOME, INHIBITOR, PROTEIN DEGRADATION, UBIQUITIN- PROTEASOME-PATHWAY, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3dy3:X    (LYS33) to   (HIS141)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN  |   PROTEASOME, INHIBITOR, PROTEIN DEGRADATION, UBIQUITIN- PROTEASOME-PATHWAY, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3dy3:Z    (LYS33) to   (ARG165)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN  |   PROTEASOME, INHIBITOR, PROTEIN DEGRADATION, UBIQUITIN- PROTEASOME-PATHWAY, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3dy3:1    (ARG33) to   (ARG165)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN  |   PROTEASOME, INHIBITOR, PROTEIN DEGRADATION, UBIQUITIN- PROTEASOME-PATHWAY, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3dy3:2    (LYS33) to   (ASN141)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN  |   PROTEASOME, INHIBITOR, PROTEIN DEGRADATION, UBIQUITIN- PROTEASOME-PATHWAY, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3e47:B    (LYS66) to   (THR200)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C  |   PROTEASOME, UBIQUITIN, PROTEIN DEGRADATION, INHIBITOR, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, ZYMOGEN 
3e47:E    (LYS66) to    (ILE18)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C  |   PROTEASOME, UBIQUITIN, PROTEIN DEGRADATION, INHIBITOR, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, ZYMOGEN 
3e47:I    (LYS33) to   (ASP166)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C  |   PROTEASOME, UBIQUITIN, PROTEIN DEGRADATION, INHIBITOR, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, ZYMOGEN 
3e47:J    (LYS33) to   (HIS141)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C  |   PROTEASOME, UBIQUITIN, PROTEIN DEGRADATION, INHIBITOR, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, ZYMOGEN 
3e47:L    (LYS33) to   (ARG165)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C  |   PROTEASOME, UBIQUITIN, PROTEIN DEGRADATION, INHIBITOR, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, ZYMOGEN 
3e47:M    (ARG33) to   (ARG165)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C  |   PROTEASOME, UBIQUITIN, PROTEIN DEGRADATION, INHIBITOR, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, ZYMOGEN 
3e47:N    (LYS33) to   (ASN141)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C  |   PROTEASOME, UBIQUITIN, PROTEIN DEGRADATION, INHIBITOR, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, ZYMOGEN 
3e47:P    (LYS66) to   (THR200)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C  |   PROTEASOME, UBIQUITIN, PROTEIN DEGRADATION, INHIBITOR, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, ZYMOGEN 
3e47:S    (LYS66) to    (ILE18)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C  |   PROTEASOME, UBIQUITIN, PROTEIN DEGRADATION, INHIBITOR, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, ZYMOGEN 
3e47:W    (LYS33) to   (ASP166)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C  |   PROTEASOME, UBIQUITIN, PROTEIN DEGRADATION, INHIBITOR, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, ZYMOGEN 
3e47:X    (LYS33) to   (HIS141)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C  |   PROTEASOME, UBIQUITIN, PROTEIN DEGRADATION, INHIBITOR, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, ZYMOGEN 
3e47:Z    (LYS33) to   (ARG165)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C  |   PROTEASOME, UBIQUITIN, PROTEIN DEGRADATION, INHIBITOR, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, ZYMOGEN 
3e47:1    (ARG33) to   (ARG165)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C  |   PROTEASOME, UBIQUITIN, PROTEIN DEGRADATION, INHIBITOR, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, ZYMOGEN 
3e47:2    (LYS33) to   (ASN141)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C  |   PROTEASOME, UBIQUITIN, PROTEIN DEGRADATION, INHIBITOR, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, ZYMOGEN 
4eu2:F    (LYS62) to   (ILE182)  CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174  |   PROTEASOME INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4eu2:H    (LYS33) to   (ASN141)  CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174  |   PROTEASOME INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4eu2:I    (LYS33) to   (ALA161)  CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174  |   PROTEASOME INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4eu2:J    (LYS33) to   (ASP169)  CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174  |   PROTEASOME INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4eu2:K    (LYS33) to   (HIS146)  CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174  |   PROTEASOME INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4eu2:T    (LYS62) to   (ILE182)  CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174  |   PROTEASOME INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4eu2:V    (LYS33) to   (ASN141)  CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174  |   PROTEASOME INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4eu2:X    (LYS33) to   (ASP169)  CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174  |   PROTEASOME INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4eu2:Y    (LYS33) to   (HIS146)  CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174  |   PROTEASOME INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4eu2:1    (LYS33) to   (ARG185)  CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174  |   PROTEASOME INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
5jhr:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5jhr:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5jhr:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5jhr:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5jhr:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5jhr:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5jhr:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5jhr:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5jhr:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5jhr:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5jhs:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5jhs:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5jhs:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5jhs:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5jhs:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5jhs:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5jhs:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5jhs:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4fzc:E    (SER56) to   (ILE181)  20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I  |   UBIQUITIN, PROTEASOME, DRUG DEVELOPMENT, INHIBITOR, NATURAL PRODUCT, N-TERMINAL NUCLEOPHILIC HYDROLASE, PROTEIN DEGRADATION, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4fzc:I    (LYS41) to   (ASP177)  20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I  |   UBIQUITIN, PROTEASOME, DRUG DEVELOPMENT, INHIBITOR, NATURAL PRODUCT, N-TERMINAL NUCLEOPHILIC HYDROLASE, PROTEIN DEGRADATION, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4fzc:J    (LYS34) to   (HIS147)  20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I  |   UBIQUITIN, PROTEASOME, DRUG DEVELOPMENT, INHIBITOR, NATURAL PRODUCT, N-TERMINAL NUCLEOPHILIC HYDROLASE, PROTEIN DEGRADATION, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4fzc:L    (LYS42) to   (ARG194)  20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I  |   UBIQUITIN, PROTEASOME, DRUG DEVELOPMENT, INHIBITOR, NATURAL PRODUCT, N-TERMINAL NUCLEOPHILIC HYDROLASE, PROTEIN DEGRADATION, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4fzc:N    (LYS33) to   (ASN141)  20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I  |   UBIQUITIN, PROTEASOME, DRUG DEVELOPMENT, INHIBITOR, NATURAL PRODUCT, N-TERMINAL NUCLEOPHILIC HYDROLASE, PROTEIN DEGRADATION, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4fzc:S    (SER56) to   (ILE181)  20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I  |   UBIQUITIN, PROTEASOME, DRUG DEVELOPMENT, INHIBITOR, NATURAL PRODUCT, N-TERMINAL NUCLEOPHILIC HYDROLASE, PROTEIN DEGRADATION, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4fzc:W    (LYS41) to   (ASP177)  20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I  |   UBIQUITIN, PROTEASOME, DRUG DEVELOPMENT, INHIBITOR, NATURAL PRODUCT, N-TERMINAL NUCLEOPHILIC HYDROLASE, PROTEIN DEGRADATION, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4fzc:X    (LYS34) to   (HIS147)  20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I  |   UBIQUITIN, PROTEASOME, DRUG DEVELOPMENT, INHIBITOR, NATURAL PRODUCT, N-TERMINAL NUCLEOPHILIC HYDROLASE, PROTEIN DEGRADATION, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4fzc:Z    (LYS42) to   (ARG194)  20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I  |   UBIQUITIN, PROTEASOME, DRUG DEVELOPMENT, INHIBITOR, NATURAL PRODUCT, N-TERMINAL NUCLEOPHILIC HYDROLASE, PROTEIN DEGRADATION, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4fzc:b    (LYS33) to   (ASN141)  20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I  |   UBIQUITIN, PROTEASOME, DRUG DEVELOPMENT, INHIBITOR, NATURAL PRODUCT, N-TERMINAL NUCLEOPHILIC HYDROLASE, PROTEIN DEGRADATION, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4g4s:B    (LYS63) to   (LYS177)  STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX  |   ALPHA BETA, NTN-HYDROLASE, PEPTIDE BINDING, HYDROLASE-CHAPERONE COMPLEX 
4g4s:E    (LYS66) to   (TRP187)  STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX  |   ALPHA BETA, NTN-HYDROLASE, PEPTIDE BINDING, HYDROLASE-CHAPERONE COMPLEX 
4g4s:F    (LYS62) to   (ILE182)  STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX  |   ALPHA BETA, NTN-HYDROLASE, PEPTIDE BINDING, HYDROLASE-CHAPERONE COMPLEX 
4g4s:G    (LYS66) to   (LYS208)  STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX  |   ALPHA BETA, NTN-HYDROLASE, PEPTIDE BINDING, HYDROLASE-CHAPERONE COMPLEX 
4g4s:H    (LYS33) to   (ASN141)  STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX  |   ALPHA BETA, NTN-HYDROLASE, PEPTIDE BINDING, HYDROLASE-CHAPERONE COMPLEX 
4g4s:J    (LYS42) to   (ASP178)  STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX  |   ALPHA BETA, NTN-HYDROLASE, PEPTIDE BINDING, HYDROLASE-CHAPERONE COMPLEX 
4g4s:M    (LYS32) to   (ARG184)  STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX  |   ALPHA BETA, NTN-HYDROLASE, PEPTIDE BINDING, HYDROLASE-CHAPERONE COMPLEX 
4g4s:N    (ARG33) to   (ARG179)  STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX  |   ALPHA BETA, NTN-HYDROLASE, PEPTIDE BINDING, HYDROLASE-CHAPERONE COMPLEX 
5l52:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l52:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l52:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l52:M    (ARG41) to   (THR168)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l52:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l52:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l52:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l52:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l52:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l52:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l54:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l54:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l54:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l54:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l54:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l54:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l54:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l54:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l55:E    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l55:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l55:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l55:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l55:N    (LYS33) to   (LYS164)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l55:S    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l55:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l55:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l55:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l55:b    (LYS33) to   (LYS164)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l5a:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5a:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5a:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5a:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5a:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5a:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5a:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5a:X    (LYS34) to   (HIS147)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5a:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5a:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5a:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5b:E    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5b:J    (LYS34) to   (HIS147)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5b:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5b:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5b:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5b:S    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5b:X    (LYS34) to   (HIS147)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5b:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5b:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5b:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5d:E    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5d:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5d:J    (LYS34) to   (HIS147)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5d:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5d:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5d:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5d:S    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5d:X    (LYS34) to   (HIS147)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5d:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5d:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5d:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5h:E    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5h:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5h:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5h:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5h:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5h:S    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5h:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5h:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5h:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5h:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5i:E    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5i:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5i:J    (LYS34) to   (HIS147)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5i:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5i:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5i:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5i:S    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5i:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5i:X    (LYS34) to   (HIS147)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5i:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5i:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5i:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5j:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5j:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5j:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5j:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5j:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5j:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5j:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5j:X    (LYS34) to   (HIS147)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5j:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5j:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5j:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5o:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5o:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5o:J    (LYS34) to   (HIS147)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5o:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5o:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5o:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5o:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5o:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5o:X    (LYS34) to   (HIS147)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5o:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5o:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5o:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5p:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5p:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5p:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5p:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5p:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5p:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5p:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5p:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5p:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5p:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5q:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5q:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5q:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5q:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5q:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5q:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5q:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5q:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5q:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5q:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5s:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5s:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5s:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5s:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5s:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5s:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5s:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5s:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5u:E    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5u:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5u:J    (LYS34) to   (HIS147)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5u:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5u:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5u:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5u:S    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5u:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5u:X    (LYS34) to   (HIS147)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5u:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5u:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5u:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5v:E    (SER56) to   (ILE181)  'YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5v:L    (LYS42) to   (ARG194)  'YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5v:N    (LYS33) to   (ASN141)  'YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5v:S    (SER56) to   (ILE181)  'YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5v:Z    (LYS42) to   (ARG194)  'YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5v:b    (LYS33) to   (ASN141)  'YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5w:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5w:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5w:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5w:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5w:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5w:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5w:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5w:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5w:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5w:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5x:E    (SER56) to   (ILE181)  'YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5x:K    (LYS33) to   (ASP167)  'YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5x:L    (LYS42) to   (ARG194)  'YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5x:M    (ARG41) to   (ARG187)  'YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5x:N    (LYS33) to   (ASN141)  'YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5x:S    (SER56) to   (ILE181)  'YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5x:Y    (LYS33) to   (ASP167)  'YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5x:Z    (LYS42) to   (ARG194)  'YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5x:a    (ARG41) to   (ARG187)  'YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5x:b    (LYS33) to   (ASN141)  'YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5y:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5y:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5y:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5y:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5y:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5y:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5y:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5z:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5z:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5z:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5z:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5z:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5z:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5z:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5z:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5z:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5z:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l60:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l60:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l60:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l60:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l60:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l60:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l60:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l60:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l60:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l61:E    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l61:K    (LYS33) to   (ASP167)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l61:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l61:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l61:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l61:S    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l61:Y    (LYS33) to   (ASP167)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l61:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l61:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l61:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l62:E    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l62:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l62:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l62:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l62:S    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l62:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l62:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l62:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l64:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l64:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l64:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l64:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l64:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l64:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l64:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l64:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l65:E    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l65:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l65:K    (LYS33) to   (ARG166)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l65:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l65:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l65:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l65:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l65:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l65:Y    (LYS33) to   (ASP167)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l65:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l65:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l65:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l66:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l66:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l66:K    (LYS33) to   (ASP167)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l66:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l66:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l66:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l66:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l66:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l66:Y    (LYS33) to   (ASP167)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l66:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l66:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l66:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l67:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l67:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l67:K    (LYS33) to   (ARG166)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l67:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l67:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l67:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l67:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l67:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l67:Y    (LYS33) to   (ARG166)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l67:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l67:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l67:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l68:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l68:K    (LYS33) to   (ARG166)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l68:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l68:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l68:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l68:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l68:Y    (LYS33) to   (ARG166)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l68:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l68:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l68:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l69:E    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l69:K    (LYS33) to   (ARG166)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l69:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l69:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l69:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l69:S    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l69:Y    (LYS33) to   (ARG166)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l69:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l69:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l69:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l6a:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l6a:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l6a:J    (LYS34) to   (HIS147)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l6a:K    (LYS33) to   (ARG166)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l6a:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l6a:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l6a:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l6a:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l6a:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l6a:X    (LYS34) to   (HIS147)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l6a:Y    (LYS33) to   (ARG166)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l6a:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l6a:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l6a:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l6b:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l6b:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l6b:K    (LYS33) to   (ARG166)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l6b:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l6b:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l6b:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l6b:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l6b:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l6b:X    (LYS34) to   (HIS147)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l6b:Y    (LYS33) to   (ARG166)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l6b:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l6b:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l6b:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l6c:E    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l6c:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l6c:K    (LYS33) to   (ARG166)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l6c:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l6c:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l6c:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l6c:S    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l6c:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l6c:Y    (LYS33) to   (ARG166)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l6c:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l6c:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l6c:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5le5:E    (LYS62) to   (CYS182)  NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5le5:F    (ARG65) to   (ILE199)  NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5le5:I    (LYS40) to   (ASP177)  NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5le5:J    (LYS34) to   (LYS169)  NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5le5:L    (LYS42) to   (ARG185)  NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5le5:N    (LYS33) to   (THR142)  NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5le5:O    (LYS63) to   (GLU196)  NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5le5:S    (LYS62) to   (CYS182)  NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5le5:T    (ARG65) to   (ILE199)  NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5le5:W    (LYS40) to   (ASP177)  NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5le5:X    (LYS34) to   (LYS169)  NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5le5:Z    (LYS42) to   (ARG185)  NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5le5:b    (LYS33) to   (THR142)  NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lex:A    (LYS63) to   (GLU196)  NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lex:B    (LYS64) to   (LYS199)  NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lex:E    (LYS62) to   (CYS182)  NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lex:F    (ARG65) to   (ILE199)  NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lex:I    (LYS40) to   (ASP177)  NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lex:J    (LYS34) to   (LYS169)  NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lex:L    (LYS42) to   (ARG185)  NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lex:M    (ARG41) to   (ARG179)  NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lex:O    (LYS63) to   (GLU196)  NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lex:T    (ARG65) to   (ILE199)  NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lex:W    (LYS40) to   (ASP177)  NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lex:X    (LYS34) to   (LYS169)  NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lex:Z    (LYS42) to   (ARG185)  NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lex:a    (ARG41) to   (ARG179)  NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5ley:B    (LYS64) to   (LYS199)  HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5ley:E    (LYS62) to   (CYS182)  HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5ley:F    (ARG65) to   (ILE199)  HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5ley:I    (LYS40) to   (ASP177)  HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5ley:J    (LYS34) to   (LYS169)  HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5ley:L    (LYS42) to   (ARG185)  HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5ley:M    (ARG41) to   (ARG179)  HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5ley:O    (LYS63) to   (GLU196)  HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5ley:T    (ARG65) to   (ILE199)  HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5ley:W    (LYS40) to   (ASP177)  HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5ley:X    (LYS34) to   (LYS169)  HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5ley:Z    (LYS42) to   (ARG185)  HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lez:A    (LYS63) to   (GLU196)  HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lez:B    (LYS64) to   (LYS199)  HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lez:E    (LYS62) to   (CYS182)  HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lez:F    (ARG65) to   (ILE199)  HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lez:H    (LYS33) to   (ASP166)  HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lez:I    (LYS40) to   (ASP177)  HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lez:J    (LYS34) to   (LYS169)  HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lez:L    (LYS42) to   (ARG185)  HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lez:M    (ARG41) to   (ARG179)  HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lez:O    (LYS63) to   (GLU196)  HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lez:T    (ARG65) to   (ILE199)  HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lez:X    (LYS34) to   (LYS169)  HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lez:Z    (LYS42) to   (ARG185)  HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf0:A    (LYS63) to   (GLU196)  HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf0:B    (LYS64) to   (LYS199)  HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf0:E    (LYS62) to   (CYS182)  HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf0:F    (ARG65) to   (ILE199)  HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf0:I    (LYS40) to   (ASP177)  HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf0:J    (LYS34) to   (LYS169)  HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf0:L    (LYS42) to   (ARG185)  HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf0:N    (LYS33) to   (THR142)  HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf0:S    (LYS62) to   (CYS182)  HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf0:T    (ARG65) to   (ILE199)  HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf0:W    (LYS40) to   (ASP177)  HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf0:X    (LYS34) to   (LYS169)  HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf0:Z    (LYS42) to   (ARG185)  HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf0:b    (LYS33) to   (THR142)  HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf1:A    (LYS63) to   (GLU196)  HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf1:B    (LYS64) to   (LYS199)  HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf1:E    (LYS62) to   (CYS182)  HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf1:F    (ARG65) to   (ILE199)  HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf1:I    (LYS40) to   (ASP177)  HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf1:J    (LYS34) to   (LYS169)  HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf1:L    (LYS42) to   (ARG185)  HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf1:O    (LYS63) to   (GLU196)  HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf1:S    (LYS62) to   (CYS182)  HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf1:T    (ARG65) to   (ILE199)  HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf1:W    (LYS40) to   (ASP177)  HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf1:X    (LYS34) to   (LYS169)  HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf1:Z    (LYS42) to   (ARG185)  HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf3:A    (LYS63) to   (GLU196)  HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf3:B    (LYS64) to   (LYS199)  HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf3:E    (LYS62) to   (CYS182)  HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf3:F    (ARG65) to   (HIS201)  HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf3:I    (LYS40) to   (ASP177)  HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf3:J    (LYS34) to   (LYS169)  HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf3:L    (LYS42) to   (ARG185)  HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf3:O    (LYS63) to   (GLU196)  HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf3:S    (LYS62) to   (CYS182)  HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf3:T    (ARG65) to   (ILE199)  HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf3:W    (LYS40) to   (ASP177)  HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf3:X    (LYS34) to   (LYS169)  HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf3:Z    (LYS42) to   (ARG185)  HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf4:A    (LYS63) to   (GLU196)  HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf4:B    (LYS64) to   (LYS199)  HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf4:E    (LYS62) to   (CYS182)  HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf4:F    (ARG65) to   (ILE199)  HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf4:I    (LYS40) to   (ASP177)  HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf4:J    (LYS34) to   (LYS169)  HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf4:L    (LYS42) to   (ARG185)  HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf4:O    (LYS63) to   (GLU196)  HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf4:S    (LYS62) to   (CYS182)  HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf4:T    (ARG65) to   (ILE199)  HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf4:W    (LYS40) to   (ASP177)  HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf4:X    (LYS34) to   (LYS169)  HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf4:Z    (LYS42) to   (ARG185)  HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf7:A    (LYS63) to   (GLU196)  HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf7:B    (LYS64) to   (LYS199)  HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf7:E    (LYS62) to   (CYS182)  HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf7:F    (ARG65) to   (ILE199)  HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf7:I    (LYS40) to   (ASP177)  HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf7:J    (LYS34) to   (LYS169)  HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf7:L    (LYS42) to   (ARG185)  HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf7:O    (LYS63) to   (GLU196)  HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf7:T    (ARG65) to   (ILE199)  HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf7:W    (LYS40) to   (ASP177)  HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf7:X    (LYS34) to   (LYS169)  HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5lf7:Z    (LYS42) to   (ARG185)  HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5ltt:E    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5ltt:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5ltt:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5ltt:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5ltt:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5ltt:S    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5ltt:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5ltt:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5ltt:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5ltt:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5t0h:G    (HIS68) to   (THR204)  STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME  |   UBIQUITIN-PROTEASOME SYSTEM, AAA-ATPASE, HYDROLASE 
5t0h:J    (LYS61) to   (THR183)  STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME  |   UBIQUITIN-PROTEASOME SYSTEM, AAA-ATPASE, HYDROLASE 
5t0h:K    (LYS66) to   (MET206)  STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME  |   UBIQUITIN-PROTEASOME SYSTEM, AAA-ATPASE, HYDROLASE 
5t0h:L    (HIS43) to   (MET180)  STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME  |   UBIQUITIN-PROTEASOME SYSTEM, AAA-ATPASE, HYDROLASE 
5t0h:M    (ARG65) to   (VAL200)  STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME  |   UBIQUITIN-PROTEASOME SYSTEM, AAA-ATPASE, HYDROLASE 
5t0h:O    (LYS33) to   (PHE142)  STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME  |   UBIQUITIN-PROTEASOME SYSTEM, AAA-ATPASE, HYDROLASE 
5t0h:P    (LYS41) to   (ALA179)  STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME  |   UBIQUITIN-PROTEASOME SYSTEM, AAA-ATPASE, HYDROLASE 
5t0h:S    (LYS42) to   (PHE155)  STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME  |   UBIQUITIN-PROTEASOME SYSTEM, AAA-ATPASE, HYDROLASE 
5t0i:G    (HIS68) to   (THR204)  STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME  |   UBIQUITIN-PROTEASOME SYSTEM, AAA-ATPASE, HYDROLASE 
5t0i:L    (HIS43) to   (MET180)  STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME  |   UBIQUITIN-PROTEASOME SYSTEM, AAA-ATPASE, HYDROLASE 
5t0i:O    (LYS33) to   (ASP166)  STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME  |   UBIQUITIN-PROTEASOME SYSTEM, AAA-ATPASE, HYDROLASE 
5t0i:P    (LYS41) to   (ASP178)  STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME  |   UBIQUITIN-PROTEASOME SYSTEM, AAA-ATPASE, HYDROLASE 
5t0i:S    (LYS42) to   (PHE155)  STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME  |   UBIQUITIN-PROTEASOME SYSTEM, AAA-ATPASE, HYDROLASE 
5t0i:T    (ARG41) to   (ARG179)  STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME  |   UBIQUITIN-PROTEASOME SYSTEM, AAA-ATPASE, HYDROLASE 
5t0j:H    (LYS64) to   (GLU197)  STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME  |   UBIQUITIN-PROTEASOME SYSTEM, AAA-ATPASE, HYDROLASE 
5t0j:J    (LYS61) to   (ASP184)  STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME  |   UBIQUITIN-PROTEASOME SYSTEM, AAA-ATPASE, HYDROLASE 
5t0j:O    (LYS33) to   (PHE142)  STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME  |   UBIQUITIN-PROTEASOME SYSTEM, AAA-ATPASE, HYDROLASE 
5t0j:P    (LYS41) to   (ALA179)  STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME  |   UBIQUITIN-PROTEASOME SYSTEM, AAA-ATPASE, HYDROLASE 
5t0j:S    (LYS42) to   (GLN152)  STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME  |   UBIQUITIN-PROTEASOME SYSTEM, AAA-ATPASE, HYDROLASE 
5t0j:T    (ARG41) to   (ARG179)  STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME  |   UBIQUITIN-PROTEASOME SYSTEM, AAA-ATPASE, HYDROLASE 
2pk0:D    (GLN17) to   (HIS156)  STRUCTURE OF THE S. AGALACTIAE SERINE/THREONINE PHOSPHATASE AT 2.65 RESOLUTION  |   STREPTOCOCCUS AGALACTIAE, SERINE, THREONINE, PHOSPHATASE, SIGNALING MOTIF, SIGNALING PROTEIN 
1ofh:H    (LYS33) to   (ILE159)  ASYMMETRIC COMPLEX BETWEEN HSLV AND I-DOMAIN DELETED HSLU (H. INFLUENZAE)  |   CHAPERONE, HYDROLASE, ATP-BINDING 
1ofh:I    (LYS33) to   (ILE159)  ASYMMETRIC COMPLEX BETWEEN HSLV AND I-DOMAIN DELETED HSLU (H. INFLUENZAE)  |   CHAPERONE, HYDROLASE, ATP-BINDING 
1ofh:N    (LYS33) to   (ILE159)  ASYMMETRIC COMPLEX BETWEEN HSLV AND I-DOMAIN DELETED HSLU (H. INFLUENZAE)  |   CHAPERONE, HYDROLASE, ATP-BINDING 
3gpt:E    (LYS66) to    (ILE18)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND  |   PROTEASOME, UBIQUITIN, CANCER THERAPY, INHIBITOR, IMMUNOLOGY, TIME DEPENDENT LEAVING GROUP ELIMINATION, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpt:K    (LYS33) to   (ASP166)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND  |   PROTEASOME, UBIQUITIN, CANCER THERAPY, INHIBITOR, IMMUNOLOGY, TIME DEPENDENT LEAVING GROUP ELIMINATION, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpt:L    (LYS33) to   (ARG165)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND  |   PROTEASOME, UBIQUITIN, CANCER THERAPY, INHIBITOR, IMMUNOLOGY, TIME DEPENDENT LEAVING GROUP ELIMINATION, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpt:M    (ARG33) to   (ARG165)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND  |   PROTEASOME, UBIQUITIN, CANCER THERAPY, INHIBITOR, IMMUNOLOGY, TIME DEPENDENT LEAVING GROUP ELIMINATION, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpt:N    (LYS33) to   (ASN141)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND  |   PROTEASOME, UBIQUITIN, CANCER THERAPY, INHIBITOR, IMMUNOLOGY, TIME DEPENDENT LEAVING GROUP ELIMINATION, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpt:S    (LYS66) to    (ILE18)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND  |   PROTEASOME, UBIQUITIN, CANCER THERAPY, INHIBITOR, IMMUNOLOGY, TIME DEPENDENT LEAVING GROUP ELIMINATION, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpt:Y    (LYS33) to   (ASP166)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND  |   PROTEASOME, UBIQUITIN, CANCER THERAPY, INHIBITOR, IMMUNOLOGY, TIME DEPENDENT LEAVING GROUP ELIMINATION, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpt:Z    (LYS33) to   (ARG165)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND  |   PROTEASOME, UBIQUITIN, CANCER THERAPY, INHIBITOR, IMMUNOLOGY, TIME DEPENDENT LEAVING GROUP ELIMINATION, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpt:1    (ARG33) to   (ARG165)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND  |   PROTEASOME, UBIQUITIN, CANCER THERAPY, INHIBITOR, IMMUNOLOGY, TIME DEPENDENT LEAVING GROUP ELIMINATION, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpt:2    (LYS33) to   (ASN141)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND  |   PROTEASOME, UBIQUITIN, CANCER THERAPY, INHIBITOR, IMMUNOLOGY, TIME DEPENDENT LEAVING GROUP ELIMINATION, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3tdd:E    (LYS66) to    (ILE18)  CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C  |   UBIQUITIN, INHIBITOR, PROTEASOME, DRUG DEVELOPMENT, PRIMED SUBSTRATE BINDING CHANNEL, BETA-SANDWICH FLANKED BY ALPHA-HELICES, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3tdd:I    (LYS33) to   (ASP166)  CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C  |   UBIQUITIN, INHIBITOR, PROTEASOME, DRUG DEVELOPMENT, PRIMED SUBSTRATE BINDING CHANNEL, BETA-SANDWICH FLANKED BY ALPHA-HELICES, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3tdd:L    (LYS33) to   (ARG165)  CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C  |   UBIQUITIN, INHIBITOR, PROTEASOME, DRUG DEVELOPMENT, PRIMED SUBSTRATE BINDING CHANNEL, BETA-SANDWICH FLANKED BY ALPHA-HELICES, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3tdd:M    (ARG33) to   (ARG165)  CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C  |   UBIQUITIN, INHIBITOR, PROTEASOME, DRUG DEVELOPMENT, PRIMED SUBSTRATE BINDING CHANNEL, BETA-SANDWICH FLANKED BY ALPHA-HELICES, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3tdd:N    (LYS33) to   (ASN141)  CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C  |   UBIQUITIN, INHIBITOR, PROTEASOME, DRUG DEVELOPMENT, PRIMED SUBSTRATE BINDING CHANNEL, BETA-SANDWICH FLANKED BY ALPHA-HELICES, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3tdd:S    (LYS66) to    (ILE18)  CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C  |   UBIQUITIN, INHIBITOR, PROTEASOME, DRUG DEVELOPMENT, PRIMED SUBSTRATE BINDING CHANNEL, BETA-SANDWICH FLANKED BY ALPHA-HELICES, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3tdd:W    (LYS33) to   (ASP166)  CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C  |   UBIQUITIN, INHIBITOR, PROTEASOME, DRUG DEVELOPMENT, PRIMED SUBSTRATE BINDING CHANNEL, BETA-SANDWICH FLANKED BY ALPHA-HELICES, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3tdd:Z    (LYS33) to   (ARG165)  CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C  |   UBIQUITIN, INHIBITOR, PROTEASOME, DRUG DEVELOPMENT, PRIMED SUBSTRATE BINDING CHANNEL, BETA-SANDWICH FLANKED BY ALPHA-HELICES, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3tdd:1    (ARG33) to   (THR146)  CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C  |   UBIQUITIN, INHIBITOR, PROTEASOME, DRUG DEVELOPMENT, PRIMED SUBSTRATE BINDING CHANNEL, BETA-SANDWICH FLANKED BY ALPHA-HELICES, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3tdd:2    (LYS33) to   (ASN141)  CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C  |   UBIQUITIN, INHIBITOR, PROTEASOME, DRUG DEVELOPMENT, PRIMED SUBSTRATE BINDING CHANNEL, BETA-SANDWICH FLANKED BY ALPHA-HELICES, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y75:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y75:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y75:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y75:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y75:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y75:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y75:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y75:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y75:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y75:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8i:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8i:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8i:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8i:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8i:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8i:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8i:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8i:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8i:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8i:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8k:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8k:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8k:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8k:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8k:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8k:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8k:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8k:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8p:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8p:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8p:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8p:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8p:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8p:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8p:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8p:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8p:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8p:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8r:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA2-H116D MUTANT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS 
4y8r:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA2-H116D MUTANT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS 
4y8r:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA2-H116D MUTANT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS 
4y8r:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA2-H116D MUTANT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS 
4y8r:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA2-H116D MUTANT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS 
4y8r:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA2-H116D MUTANT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS 
4y8r:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA2-H116D MUTANT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS 
4y8r:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA2-H116D MUTANT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS 
4y8r:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA2-H116D MUTANT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS 
4y8r:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA2-H116D MUTANT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS 
4ya5:E    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya5:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya5:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya5:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya5:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya5:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya5:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya5:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya5:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya5:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
3unb:C    (LYS60) to   (LEU195)  MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957  |   20S PROTEASOME COMPRISES 28 SUBUNITS; EACH SUBUNIT ADOPTS THE FOLD OF AN ANTIPARALLEL BETA-SHEET FLANKED BY HELICES, PROTEASE, REGULATORY COMPLEXES, COVALENT BINDING OF PR-957 TO ALL ACTIVE SITES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unb:F    (ARG65) to   (ILE199)  MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957  |   20S PROTEASOME COMPRISES 28 SUBUNITS; EACH SUBUNIT ADOPTS THE FOLD OF AN ANTIPARALLEL BETA-SHEET FLANKED BY HELICES, PROTEASE, REGULATORY COMPLEXES, COVALENT BINDING OF PR-957 TO ALL ACTIVE SITES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unb:I    (LYS40) to   (ASP177)  MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957  |   20S PROTEASOME COMPRISES 28 SUBUNITS; EACH SUBUNIT ADOPTS THE FOLD OF AN ANTIPARALLEL BETA-SHEET FLANKED BY HELICES, PROTEASE, REGULATORY COMPLEXES, COVALENT BINDING OF PR-957 TO ALL ACTIVE SITES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unb:J    (LYS34) to   (LYS169)  MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957  |   20S PROTEASOME COMPRISES 28 SUBUNITS; EACH SUBUNIT ADOPTS THE FOLD OF AN ANTIPARALLEL BETA-SHEET FLANKED BY HELICES, PROTEASE, REGULATORY COMPLEXES, COVALENT BINDING OF PR-957 TO ALL ACTIVE SITES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unb:L    (LYS42) to   (ARG185)  MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957  |   20S PROTEASOME COMPRISES 28 SUBUNITS; EACH SUBUNIT ADOPTS THE FOLD OF AN ANTIPARALLEL BETA-SHEET FLANKED BY HELICES, PROTEASE, REGULATORY COMPLEXES, COVALENT BINDING OF PR-957 TO ALL ACTIVE SITES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unb:N    (LYS33) to   (THR142)  MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957  |   20S PROTEASOME COMPRISES 28 SUBUNITS; EACH SUBUNIT ADOPTS THE FOLD OF AN ANTIPARALLEL BETA-SHEET FLANKED BY HELICES, PROTEASE, REGULATORY COMPLEXES, COVALENT BINDING OF PR-957 TO ALL ACTIVE SITES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unb:T    (ARG65) to   (HIS201)  MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957  |   20S PROTEASOME COMPRISES 28 SUBUNITS; EACH SUBUNIT ADOPTS THE FOLD OF AN ANTIPARALLEL BETA-SHEET FLANKED BY HELICES, PROTEASE, REGULATORY COMPLEXES, COVALENT BINDING OF PR-957 TO ALL ACTIVE SITES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unb:W    (LYS40) to   (ASP177)  MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957  |   20S PROTEASOME COMPRISES 28 SUBUNITS; EACH SUBUNIT ADOPTS THE FOLD OF AN ANTIPARALLEL BETA-SHEET FLANKED BY HELICES, PROTEASE, REGULATORY COMPLEXES, COVALENT BINDING OF PR-957 TO ALL ACTIVE SITES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unb:X    (LYS34) to   (LYS169)  MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957  |   20S PROTEASOME COMPRISES 28 SUBUNITS; EACH SUBUNIT ADOPTS THE FOLD OF AN ANTIPARALLEL BETA-SHEET FLANKED BY HELICES, PROTEASE, REGULATORY COMPLEXES, COVALENT BINDING OF PR-957 TO ALL ACTIVE SITES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unb:Z    (LYS42) to   (ARG185)  MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957  |   20S PROTEASOME COMPRISES 28 SUBUNITS; EACH SUBUNIT ADOPTS THE FOLD OF AN ANTIPARALLEL BETA-SHEET FLANKED BY HELICES, PROTEASE, REGULATORY COMPLEXES, COVALENT BINDING OF PR-957 TO ALL ACTIVE SITES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unb:b    (LYS33) to   (THR142)  MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957  |   20S PROTEASOME COMPRISES 28 SUBUNITS; EACH SUBUNIT ADOPTS THE FOLD OF AN ANTIPARALLEL BETA-SHEET FLANKED BY HELICES, PROTEASE, REGULATORY COMPLEXES, COVALENT BINDING OF PR-957 TO ALL ACTIVE SITES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unb:c    (LYS63) to   (GLU196)  MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957  |   20S PROTEASOME COMPRISES 28 SUBUNITS; EACH SUBUNIT ADOPTS THE FOLD OF AN ANTIPARALLEL BETA-SHEET FLANKED BY HELICES, PROTEASE, REGULATORY COMPLEXES, COVALENT BINDING OF PR-957 TO ALL ACTIVE SITES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unb:e    (LYS60) to   (LEU195)  MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957  |   20S PROTEASOME COMPRISES 28 SUBUNITS; EACH SUBUNIT ADOPTS THE FOLD OF AN ANTIPARALLEL BETA-SHEET FLANKED BY HELICES, PROTEASE, REGULATORY COMPLEXES, COVALENT BINDING OF PR-957 TO ALL ACTIVE SITES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unb:h    (ARG65) to   (HIS201)  MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957  |   20S PROTEASOME COMPRISES 28 SUBUNITS; EACH SUBUNIT ADOPTS THE FOLD OF AN ANTIPARALLEL BETA-SHEET FLANKED BY HELICES, PROTEASE, REGULATORY COMPLEXES, COVALENT BINDING OF PR-957 TO ALL ACTIVE SITES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unb:k    (LYS40) to   (ASP177)  MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957  |   20S PROTEASOME COMPRISES 28 SUBUNITS; EACH SUBUNIT ADOPTS THE FOLD OF AN ANTIPARALLEL BETA-SHEET FLANKED BY HELICES, PROTEASE, REGULATORY COMPLEXES, COVALENT BINDING OF PR-957 TO ALL ACTIVE SITES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unb:l    (LYS34) to   (LYS169)  MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957  |   20S PROTEASOME COMPRISES 28 SUBUNITS; EACH SUBUNIT ADOPTS THE FOLD OF AN ANTIPARALLEL BETA-SHEET FLANKED BY HELICES, PROTEASE, REGULATORY COMPLEXES, COVALENT BINDING OF PR-957 TO ALL ACTIVE SITES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unb:n    (LYS42) to   (ARG185)  MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957  |   20S PROTEASOME COMPRISES 28 SUBUNITS; EACH SUBUNIT ADOPTS THE FOLD OF AN ANTIPARALLEL BETA-SHEET FLANKED BY HELICES, PROTEASE, REGULATORY COMPLEXES, COVALENT BINDING OF PR-957 TO ALL ACTIVE SITES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unb:p    (LYS33) to   (THR142)  MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957  |   20S PROTEASOME COMPRISES 28 SUBUNITS; EACH SUBUNIT ADOPTS THE FOLD OF AN ANTIPARALLEL BETA-SHEET FLANKED BY HELICES, PROTEASE, REGULATORY COMPLEXES, COVALENT BINDING OF PR-957 TO ALL ACTIVE SITES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unb:v    (ARG65) to   (HIS201)  MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957  |   20S PROTEASOME COMPRISES 28 SUBUNITS; EACH SUBUNIT ADOPTS THE FOLD OF AN ANTIPARALLEL BETA-SHEET FLANKED BY HELICES, PROTEASE, REGULATORY COMPLEXES, COVALENT BINDING OF PR-957 TO ALL ACTIVE SITES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unb:2    (LYS42) to   (ARG185)  MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957  |   20S PROTEASOME COMPRISES 28 SUBUNITS; EACH SUBUNIT ADOPTS THE FOLD OF AN ANTIPARALLEL BETA-SHEET FLANKED BY HELICES, PROTEASE, REGULATORY COMPLEXES, COVALENT BINDING OF PR-957 TO ALL ACTIVE SITES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unb:4    (LYS33) to   (THR142)  MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957  |   20S PROTEASOME COMPRISES 28 SUBUNITS; EACH SUBUNIT ADOPTS THE FOLD OF AN ANTIPARALLEL BETA-SHEET FLANKED BY HELICES, PROTEASE, REGULATORY COMPLEXES, COVALENT BINDING OF PR-957 TO ALL ACTIVE SITES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
1g4a:B    (LYS33) to   (THR140)  CRYSTAL STRUCTURES OF THE HSLVU PEPTIDASE-ATPASE COMPLEX REVEAL AN ATP-DEPENDENT PROTEOLYSIS MECHANISM  |   HSLVU, PEPTIDASE-ATPASE COMPLEX, CHAPERONE/HYDROLASE COMPLEX 
1g4a:D    (LYS33) to   (ILE158)  CRYSTAL STRUCTURES OF THE HSLVU PEPTIDASE-ATPASE COMPLEX REVEAL AN ATP-DEPENDENT PROTEOLYSIS MECHANISM  |   HSLVU, PEPTIDASE-ATPASE COMPLEX, CHAPERONE/HYDROLASE COMPLEX 
2fhh:D    (LYS52) to   (SER192)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273  |   MULTI-SUBUNIT PROTEIN ASSEMBLY, INHIBITOR-COMPLEX, HYDROLASE 
5a0q:A    (LEU69) to   (SER207)  CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE  |   HYDROLASE, PROTEASOME, 20S, ADAAHX3L3VS, LIGAND, INHIBITOR, DRUG DESIGN 
5a0q:B    (LYS63) to   (LYS175)  CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE  |   HYDROLASE, PROTEASOME, 20S, ADAAHX3L3VS, LIGAND, INHIBITOR, DRUG DESIGN 
5a0q:F    (LYS62) to   (HIS175)  CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE  |   HYDROLASE, PROTEASOME, 20S, ADAAHX3L3VS, LIGAND, INHIBITOR, DRUG DESIGN 
5a0q:O    (LEU69) to   (SER207)  CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE  |   HYDROLASE, PROTEASOME, 20S, ADAAHX3L3VS, LIGAND, INHIBITOR, DRUG DESIGN 
5a0q:P    (LYS63) to   (LYS175)  CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE  |   HYDROLASE, PROTEASOME, 20S, ADAAHX3L3VS, LIGAND, INHIBITOR, DRUG DESIGN 
5a0q:T    (LYS62) to   (HIS175)  CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE  |   HYDROLASE, PROTEASOME, 20S, ADAAHX3L3VS, LIGAND, INHIBITOR, DRUG DESIGN 
5a5b:3    (LYS33) to   (ASP169)  STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX  |   HYDROLASE, CONFORMATIONAL SWITCHING, PROTEIN DEGRADATION, PROTEOSTASIS, QUALITY CONTROL, UBP6, USP14 
5a5b:6    (LYS33) to   (HIS186)  STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX  |   HYDROLASE, CONFORMATIONAL SWITCHING, PROTEIN DEGRADATION, PROTEOSTASIS, QUALITY CONTROL, UBP6, USP14 
5a5b:7    (ARG33) to   (ALA181)  STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX  |   HYDROLASE, CONFORMATIONAL SWITCHING, PROTEIN DEGRADATION, PROTEOSTASIS, QUALITY CONTROL, UBP6, USP14 
5a5b:A    (TYR71) to   (ALA213)  STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX  |   HYDROLASE, CONFORMATIONAL SWITCHING, PROTEIN DEGRADATION, PROTEOSTASIS, QUALITY CONTROL, UBP6, USP14 
5a5b:B    (LYS63) to   (SER199)  STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX  |   HYDROLASE, CONFORMATIONAL SWITCHING, PROTEIN DEGRADATION, PROTEOSTASIS, QUALITY CONTROL, UBP6, USP14 
5a5b:C    (LYS65) to   (THR201)  STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX  |   HYDROLASE, CONFORMATIONAL SWITCHING, PROTEIN DEGRADATION, PROTEOSTASIS, QUALITY CONTROL, UBP6, USP14 
5a5b:D    (LYS63) to   (GLN204)  STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX  |   HYDROLASE, CONFORMATIONAL SWITCHING, PROTEIN DEGRADATION, PROTEOSTASIS, QUALITY CONTROL, UBP6, USP14 
5a5b:F    (LYS62) to   (ILE182)  STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX  |   HYDROLASE, CONFORMATIONAL SWITCHING, PROTEIN DEGRADATION, PROTEOSTASIS, QUALITY CONTROL, UBP6, USP14 
2x1c:C   (THR142) to   (LEU289)  THE CRYSTAL STRUCTURE OF PRECURSOR ACYL COENZYME A:ISOPENICILLIN N ACYLTRANSFERASE FROM PENICILLIUM CHRYSOGENUM  |   ZYMOGEN, TRANSFERASE, NTN-HYDROLASE, PENICILLIN BIOSYNTHESIS, ACYLTRANSFERASE, ANTIBIOTIC BIOSYNTHESIS 
2x1c:D   (THR142) to   (LEU289)  THE CRYSTAL STRUCTURE OF PRECURSOR ACYL COENZYME A:ISOPENICILLIN N ACYLTRANSFERASE FROM PENICILLIUM CHRYSOGENUM  |   ZYMOGEN, TRANSFERASE, NTN-HYDROLASE, PENICILLIN BIOSYNTHESIS, ACYLTRANSFERASE, ANTIBIOTIC BIOSYNTHESIS 
5bou:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, NON-COVALENT LIGAND, BINDING ANALYSIS 
5bou:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, NON-COVALENT LIGAND, BINDING ANALYSIS 
5bou:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, NON-COVALENT LIGAND, BINDING ANALYSIS 
5bou:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, NON-COVALENT LIGAND, BINDING ANALYSIS 
5bou:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, NON-COVALENT LIGAND, BINDING ANALYSIS 
5bou:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, NON-COVALENT LIGAND, BINDING ANALYSIS 
5bou:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, NON-COVALENT LIGAND, BINDING ANALYSIS 
5bou:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, NON-COVALENT LIGAND, BINDING ANALYSIS 
5bxl:E    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME BETA2-G170A MUTANT  |   HYDROLASE, IMMUNODEFICIENCY, PROTEASOME, MUTANT, ASSEMBLY DEFECT 
5bxl:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA2-G170A MUTANT  |   HYDROLASE, IMMUNODEFICIENCY, PROTEASOME, MUTANT, ASSEMBLY DEFECT 
5bxl:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA2-G170A MUTANT  |   HYDROLASE, IMMUNODEFICIENCY, PROTEASOME, MUTANT, ASSEMBLY DEFECT 
5bxl:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA2-G170A MUTANT  |   HYDROLASE, IMMUNODEFICIENCY, PROTEASOME, MUTANT, ASSEMBLY DEFECT 
5bxl:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA2-G170A MUTANT  |   HYDROLASE, IMMUNODEFICIENCY, PROTEASOME, MUTANT, ASSEMBLY DEFECT 
5bxl:S    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME BETA2-G170A MUTANT  |   HYDROLASE, IMMUNODEFICIENCY, PROTEASOME, MUTANT, ASSEMBLY DEFECT 
5bxl:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA2-G170A MUTANT  |   HYDROLASE, IMMUNODEFICIENCY, PROTEASOME, MUTANT, ASSEMBLY DEFECT 
5bxl:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA2-G170A MUTANT  |   HYDROLASE, IMMUNODEFICIENCY, PROTEASOME, MUTANT, ASSEMBLY DEFECT 
5bxl:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA2-G170A MUTANT  |   HYDROLASE, IMMUNODEFICIENCY, PROTEASOME, MUTANT, ASSEMBLY DEFECT 
5bxl:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA2-G170A MUTANT  |   HYDROLASE, IMMUNODEFICIENCY, PROTEASOME, MUTANT, ASSEMBLY DEFECT 
5bxn:E    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, IMMUNODEFICIENCY, PROTEASOME, MUTANT, ASSEMBLY DEFECT 
5bxn:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, IMMUNODEFICIENCY, PROTEASOME, MUTANT, ASSEMBLY DEFECT 
5bxn:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, IMMUNODEFICIENCY, PROTEASOME, MUTANT, ASSEMBLY DEFECT 
5bxn:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, IMMUNODEFICIENCY, PROTEASOME, MUTANT, ASSEMBLY DEFECT 
5bxn:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, IMMUNODEFICIENCY, PROTEASOME, MUTANT, ASSEMBLY DEFECT 
5bxn:S    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, IMMUNODEFICIENCY, PROTEASOME, MUTANT, ASSEMBLY DEFECT 
5bxn:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, IMMUNODEFICIENCY, PROTEASOME, MUTANT, ASSEMBLY DEFECT 
5bxn:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, IMMUNODEFICIENCY, PROTEASOME, MUTANT, ASSEMBLY DEFECT 
5bxn:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, IMMUNODEFICIENCY, PROTEASOME, MUTANT, ASSEMBLY DEFECT 
5bxn:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, IMMUNODEFICIENCY, PROTEASOME, MUTANT, ASSEMBLY DEFECT 
4no9:C    (LYS61) to   (LEU198)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, EPOXYKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no9:E    (SER56) to   (ILE181)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, EPOXYKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no9:I    (LYS41) to   (ASP177)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, EPOXYKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no9:L    (LYS42) to   (ARG194)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, EPOXYKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no9:M    (ARG41) to   (ARG187)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, EPOXYKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no9:N    (LYS33) to   (ASN141)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, EPOXYKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no9:Q    (LYS61) to   (LEU198)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, EPOXYKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no9:S    (SER56) to   (ILE181)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, EPOXYKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no9:W    (LYS41) to   (ASP177)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, EPOXYKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no9:Z    (LYS42) to   (ARG194)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, EPOXYKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no9:a    (ARG41) to   (ARG187)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, EPOXYKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no9:b    (LYS33) to   (ASN141)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, EPOXYKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3jrm:A    (LYS66) to   (LEU201)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR  |   20S PROTEASOME, PA26, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX 
3jrm:B    (LYS66) to   (LEU201)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR  |   20S PROTEASOME, PA26, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX 
3jrm:G    (LYS66) to   (LEU201)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR  |   20S PROTEASOME, PA26, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX 
3jrm:H    (LYS33) to   (ARG165)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR  |   20S PROTEASOME, PA26, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX 
3jrm:I    (LYS33) to   (ARG165)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR  |   20S PROTEASOME, PA26, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX 
3jrm:J    (LYS33) to   (ARG165)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR  |   20S PROTEASOME, PA26, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX 
3jrm:K    (LYS33) to   (ARG165)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR  |   20S PROTEASOME, PA26, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX 
3jrm:L    (LYS33) to   (ARG165)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR  |   20S PROTEASOME, PA26, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX 
3jrm:M    (LYS33) to   (ARG165)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR  |   20S PROTEASOME, PA26, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX 
3jrm:N    (LYS33) to   (ARG165)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR  |   20S PROTEASOME, PA26, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX 
5cgf:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA5-G48C MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
5cgf:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA5-G48C MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
5cgf:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA5-G48C MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
5cgf:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA5-G48C MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
5cgf:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA5-G48C MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
5cgf:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA5-G48C MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
5cgf:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA5-G48C MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
5cgf:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA5-G48C MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
5cz4:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME AT 2.3 A RESOLUTION  |   HYDROLASE-HYDROLASE COMPLEX, UBIQUITIN-DEGRADATION SYSTEM, PROTEASOME, NTN-HYDROLASE, THR-PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
5cz4:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME AT 2.3 A RESOLUTION  |   HYDROLASE-HYDROLASE COMPLEX, UBIQUITIN-DEGRADATION SYSTEM, PROTEASOME, NTN-HYDROLASE, THR-PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
5cz4:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME AT 2.3 A RESOLUTION  |   HYDROLASE-HYDROLASE COMPLEX, UBIQUITIN-DEGRADATION SYSTEM, PROTEASOME, NTN-HYDROLASE, THR-PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
5cz4:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME AT 2.3 A RESOLUTION  |   HYDROLASE-HYDROLASE COMPLEX, UBIQUITIN-DEGRADATION SYSTEM, PROTEASOME, NTN-HYDROLASE, THR-PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
5cz4:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME AT 2.3 A RESOLUTION  |   HYDROLASE-HYDROLASE COMPLEX, UBIQUITIN-DEGRADATION SYSTEM, PROTEASOME, NTN-HYDROLASE, THR-PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
5cz4:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME AT 2.3 A RESOLUTION  |   HYDROLASE-HYDROLASE COMPLEX, UBIQUITIN-DEGRADATION SYSTEM, PROTEASOME, NTN-HYDROLASE, THR-PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
5cz4:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME AT 2.3 A RESOLUTION  |   HYDROLASE-HYDROLASE COMPLEX, UBIQUITIN-DEGRADATION SYSTEM, PROTEASOME, NTN-HYDROLASE, THR-PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
5cz4:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME AT 2.3 A RESOLUTION  |   HYDROLASE-HYDROLASE COMPLEX, UBIQUITIN-DEGRADATION SYSTEM, PROTEASOME, NTN-HYDROLASE, THR-PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
5cz4:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME AT 2.3 A RESOLUTION  |   HYDROLASE-HYDROLASE COMPLEX, UBIQUITIN-DEGRADATION SYSTEM, PROTEASOME, NTN-HYDROLASE, THR-PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
5cz4:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME AT 2.3 A RESOLUTION  |   HYDROLASE-HYDROLASE COMPLEX, UBIQUITIN-DEGRADATION SYSTEM, PROTEASOME, NTN-HYDROLASE, THR-PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
5cz7:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB, PROPEPTIDE EXPRESSED IN CIS  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz7:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB, PROPEPTIDE EXPRESSED IN CIS  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz7:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB, PROPEPTIDE EXPRESSED IN CIS  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz7:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB, PROPEPTIDE EXPRESSED IN CIS  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz7:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB, PROPEPTIDE EXPRESSED IN CIS  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz7:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB, PROPEPTIDE EXPRESSED IN CIS  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz7:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB, PROPEPTIDE EXPRESSED IN CIS  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz7:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB, PROPEPTIDE EXPRESSED IN CIS  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz7:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB, PROPEPTIDE EXPRESSED IN CIS  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz7:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB, PROPEPTIDE EXPRESSED IN CIS  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz8:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz8:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz8:K    (ALA33) to   (HIS166)  YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz8:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz8:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz8:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz8:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz8:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz8:Y    (ALA33) to   (HIS166)  YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz8:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz8:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz8:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz9:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz9:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz9:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz9:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz9:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz9:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz9:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz9:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
1yar:H    (LYS33) to   (ARG165)  STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX  |   PROTEASOME 20S, PA26 PROTEASOME ACTIVATOR 11S, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1yar:I    (LYS33) to   (ARG165)  STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX  |   PROTEASOME 20S, PA26 PROTEASOME ACTIVATOR 11S, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1yar:J    (LYS33) to   (ARG165)  STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX  |   PROTEASOME 20S, PA26 PROTEASOME ACTIVATOR 11S, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1yar:K    (LYS33) to   (ARG165)  STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX  |   PROTEASOME 20S, PA26 PROTEASOME ACTIVATOR 11S, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1yar:L    (LYS33) to   (ARG165)  STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX  |   PROTEASOME 20S, PA26 PROTEASOME ACTIVATOR 11S, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1yar:M    (LYS33) to   (ARG165)  STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX  |   PROTEASOME 20S, PA26 PROTEASOME ACTIVATOR 11S, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1yar:N    (LYS33) to   (ARG165)  STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX  |   PROTEASOME 20S, PA26 PROTEASOME ACTIVATOR 11S, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
4qlv:C    (LYS61) to   (LEU198)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlv:E    (LYS61) to   (ILE181)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlv:L    (LYS42) to   (ARG194)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlv:N    (LYS33) to   (ASN141)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlv:Q    (LYS61) to   (LEU198)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlv:S    (LYS61) to   (ILE181)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlv:Z    (LYS42) to   (ARG194)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlv:b    (LYS33) to   (ASN141)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3bdm:A    (LYS66) to   (VAL202)  YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX  |   PROTEASOME, UBIQUITIN, PROTEOLYSIS, PATHOGEN, VIRULENCE FACTOR, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3bdm:D    (LYS66) to   (TRP180)  YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX  |   PROTEASOME, UBIQUITIN, PROTEOLYSIS, PATHOGEN, VIRULENCE FACTOR, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3bdm:E    (LYS66) to    (ILE18)  YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX  |   PROTEASOME, UBIQUITIN, PROTEOLYSIS, PATHOGEN, VIRULENCE FACTOR, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3bdm:G    (TYR66) to   (GLY202)  YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX  |   PROTEASOME, UBIQUITIN, PROTEOLYSIS, PATHOGEN, VIRULENCE FACTOR, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3bdm:I    (LYS33) to   (ASP166)  YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX  |   PROTEASOME, UBIQUITIN, PROTEOLYSIS, PATHOGEN, VIRULENCE FACTOR, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3bdm:J    (LYS33) to   (ARG165)  YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX  |   PROTEASOME, UBIQUITIN, PROTEOLYSIS, PATHOGEN, VIRULENCE FACTOR, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3bdm:L    (LYS33) to   (ARG165)  YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX  |   PROTEASOME, UBIQUITIN, PROTEOLYSIS, PATHOGEN, VIRULENCE FACTOR, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3bdm:M    (ARG33) to   (ARG165)  YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX  |   PROTEASOME, UBIQUITIN, PROTEOLYSIS, PATHOGEN, VIRULENCE FACTOR, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3bdm:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX  |   PROTEASOME, UBIQUITIN, PROTEOLYSIS, PATHOGEN, VIRULENCE FACTOR, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3bdm:O    (LYS66) to   (VAL202)  YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX  |   PROTEASOME, UBIQUITIN, PROTEOLYSIS, PATHOGEN, VIRULENCE FACTOR, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3bdm:R    (LYS66) to   (TRP180)  YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX  |   PROTEASOME, UBIQUITIN, PROTEOLYSIS, PATHOGEN, VIRULENCE FACTOR, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3bdm:S    (LYS66) to    (ILE18)  YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX  |   PROTEASOME, UBIQUITIN, PROTEOLYSIS, PATHOGEN, VIRULENCE FACTOR, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3bdm:U    (TYR66) to   (GLY202)  YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX  |   PROTEASOME, UBIQUITIN, PROTEOLYSIS, PATHOGEN, VIRULENCE FACTOR, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3bdm:W    (LYS33) to   (ASP166)  YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX  |   PROTEASOME, UBIQUITIN, PROTEOLYSIS, PATHOGEN, VIRULENCE FACTOR, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3bdm:X    (LYS33) to   (LYS164)  YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX  |   PROTEASOME, UBIQUITIN, PROTEOLYSIS, PATHOGEN, VIRULENCE FACTOR, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3bdm:Z    (LYS33) to   (ARG165)  YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX  |   PROTEASOME, UBIQUITIN, PROTEOLYSIS, PATHOGEN, VIRULENCE FACTOR, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3bdm:0    (ARG33) to   (ARG165)  YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX  |   PROTEASOME, UBIQUITIN, PROTEOLYSIS, PATHOGEN, VIRULENCE FACTOR, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3bdm:1    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX  |   PROTEASOME, UBIQUITIN, PROTEOLYSIS, PATHOGEN, VIRULENCE FACTOR, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
4qw3:E    (LYS61) to   (ILE181)  YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw3:I    (LYS41) to   (ASP177)  YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw3:L    (LYS42) to   (ARG194)  YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw3:M    (ARG41) to   (ARG187)  YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw3:N    (LYS33) to   (ASN141)  YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw3:S    (LYS61) to   (ILE181)  YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw3:W    (LYS41) to   (ASP177)  YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw3:Z    (LYS42) to   (ARG194)  YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw3:a    (ARG41) to   (ARG187)  YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw3:b    (LYS33) to   (ASN141)  YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw7:E    (SER56) to   (ILE181)  YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw7:I    (LYS41) to   (ASP177)  YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw7:L    (LYS42) to   (ARG194)  YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw7:M    (ARG41) to   (ARG187)  YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw7:N    (LYS33) to   (ASN141)  YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw7:S    (SER56) to   (ILE181)  YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw7:W    (LYS41) to   (ASP177)  YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw7:Z    (LYS42) to   (ARG194)  YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw7:a    (ARG41) to   (ARG187)  YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw7:b    (LYS33) to   (ASN141)  YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwi:E    (SER56) to   (ILE181)  YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwi:I    (LYS41) to   (ASP177)  YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwi:L    (LYS42) to   (ARG194)  YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwi:M    (ARG41) to   (ARG187)  YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwi:N    (LYS33) to   (ASN141)  YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwi:S    (SER56) to   (ILE181)  YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwi:W    (LYS41) to   (ASP177)  YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwi:Z    (LYS42) to   (ARG194)  YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwi:a    (ARG41) to   (ARG187)  YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwi:b    (LYS33) to   (ASN141)  YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz1:E    (SER56) to   (ILE181)  YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz1:I    (LYS41) to   (ASP177)  YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz1:L    (LYS42) to   (ARG194)  YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz1:M    (ARG41) to   (ARG187)  YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz1:S    (SER56) to   (ILE181)  YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz1:W    (LYS41) to   (ASP177)  YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz1:Z    (LYS42) to   (ARG194)  YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz1:a    (ARG41) to   (ARG187)  YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
5fga:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fga:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fga:J    (LYS34) to   (HIS147)  YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fga:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fga:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fga:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fga:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fga:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fga:X    (LYS34) to   (HIS147)  YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fga:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fga:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fga:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fgg:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgg:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgg:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgg:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgg:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgg:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgg:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgg:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgg:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgg:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgh:E    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgh:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgh:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgh:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgh:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgh:S    (LYS61) to   (ILE181)  YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgh:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgh:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgh:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgh:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgi:E    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgi:I    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgi:L    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgi:M    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgi:N    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgi:S    (SER56) to   (ILE181)  YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgi:W    (LYS41) to   (ASP177)  YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgi:Z    (LYS42) to   (ARG194)  YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgi:a    (ARG41) to   (ARG187)  YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgi:b    (LYS33) to   (ASN141)  YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4r67:D    (LYS61) to   (GLU197)  HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r67:G    (ARG65) to   (ILE199)  HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r67:H    (LYS33) to   (THR142)  HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r67:J    (LYS41) to   (ASP178)  HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r67:K    (LYS34) to   (LYS169)  HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r67:M    (LYS42) to   (ARG185)  HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r67:R    (LYS61) to   (GLU197)  HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r67:U    (ARG65) to   (ILE199)  HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r67:V    (LYS33) to   (THR142)  HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r67:X    (LYS41) to   (ASP178)  HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r67:Y    (LYS34) to   (LYS169)  HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r67:1    (LYS42) to   (ARG185)  HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r67:f    (LYS61) to   (GLU197)  HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r67:i    (ARG65) to   (ILE199)  HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r67:j    (LYS33) to   (THR142)  HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r67:l    (LYS41) to   (ASP178)  HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r67:m    (LYS34) to   (LYS169)  HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r67:o    (LYS42) to   (ARG185)  HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r67:t    (LYS61) to   (GLU197)  HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r67:w    (ARG65) to   (ILE199)  HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r67:x    (LYS33) to   (THR142)  HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r67:z    (LYS41) to   (ASP178)  HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r67:0    (LYS34) to   (LYS169)  HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r67:a    (LYS42) to   (ARG185)  HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3c91:A    (LYS66) to   (SER200)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE  |   PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c91:B    (LYS66) to   (SER200)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE  |   PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c91:C    (LYS66) to   (SER200)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE  |   PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c91:D    (LYS66) to   (SER200)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE  |   PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c91:E    (LYS66) to   (SER200)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE  |   PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c91:F    (LYS66) to   (SER200)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE  |   PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c91:G    (LYS66) to   (SER200)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE  |   PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c91:J    (LYS33) to   (ARG165)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE  |   PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c91:K    (LYS33) to   (ARG165)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE  |   PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c91:L    (LYS33) to   (ARG165)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE  |   PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c91:M    (LYS33) to   (ARG165)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE  |   PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c91:N    (LYS33) to   (ARG165)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE  |   PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c91:O    (LYS66) to   (SER200)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE  |   PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c91:P    (LYS66) to   (SER200)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE  |   PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c91:Q    (LYS66) to   (SER200)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE  |   PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c91:R    (LYS66) to   (SER200)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE  |   PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c91:S    (LYS66) to   (SER200)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE  |   PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c91:T    (LYS66) to   (SER200)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE  |   PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c91:U    (LYS66) to   (SER200)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE  |   PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c91:X    (LYS33) to   (ARG165)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE  |   PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c91:Y    (LYS33) to   (ARG165)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE  |   PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c91:Z    (LYS33) to   (ARG165)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE  |   PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c91:1    (LYS33) to   (ARG165)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE  |   PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c91:2    (LYS33) to   (ARG165)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE  |   PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c92:A    (LYS66) to   (SER200)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE  |   PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c92:B    (LYS66) to   (SER200)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE  |   PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c92:C    (LYS66) to   (SER200)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE  |   PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c92:D    (LYS66) to   (SER200)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE  |   PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c92:E    (LYS66) to   (SER200)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE  |   PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c92:F    (LYS66) to   (SER200)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE  |   PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c92:G    (LYS66) to   (SER200)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE  |   PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c92:J    (LYS33) to   (ARG165)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE  |   PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c92:K    (LYS33) to   (ARG165)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE  |   PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c92:L    (LYS33) to   (ARG165)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE  |   PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c92:M    (LYS33) to   (ARG165)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE  |   PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c92:N    (LYS33) to   (ARG165)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE  |   PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c92:O    (LYS66) to   (SER200)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE  |   PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c92:P    (LYS66) to   (SER200)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE  |   PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c92:Q    (LYS66) to   (SER200)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE  |   PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c92:R    (LYS66) to   (SER200)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE  |   PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c92:S    (LYS66) to   (SER200)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE  |   PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c92:T    (LYS66) to   (SER200)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE  |   PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c92:U    (LYS66) to   (SER200)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE  |   PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c92:X    (LYS33) to   (ARG165)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE  |   PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c92:Y    (LYS33) to   (ARG165)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE  |   PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c92:Z    (LYS33) to   (ARG165)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE  |   PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c92:1    (LYS33) to   (ARG165)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE  |   PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3c92:2    (LYS33) to   (ARG165)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE  |   PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
5fmg:C    (LYS64) to   (ASP201)  STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS  |   HYDROLASE, PROTEASOME, 20S, PLASMODIUM, MALARIA, INHIBITOR, DRUG DESIGN, CRYO-EM 
5fmg:D    (LEU62) to   (ILE193)  STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS  |   HYDROLASE, PROTEASOME, 20S, PLASMODIUM, MALARIA, INHIBITOR, DRUG DESIGN, CRYO-EM 
5fmg:F    (LYS62) to   (GLU180)  STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS  |   HYDROLASE, PROTEASOME, 20S, PLASMODIUM, MALARIA, INHIBITOR, DRUG DESIGN, CRYO-EM 
5fmg:G    (ARG68) to   (ILE187)  STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS  |   HYDROLASE, PROTEASOME, 20S, PLASMODIUM, MALARIA, INHIBITOR, DRUG DESIGN, CRYO-EM 
5fmg:H    (LYS33) to   (GLN190)  STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS  |   HYDROLASE, PROTEASOME, 20S, PLASMODIUM, MALARIA, INHIBITOR, DRUG DESIGN, CRYO-EM 
5fmg:I    (LYS33) to   (ASP166)  STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS  |   HYDROLASE, PROTEASOME, 20S, PLASMODIUM, MALARIA, INHIBITOR, DRUG DESIGN, CRYO-EM 
5fmg:J    (LYS43) to   (ASP191)  STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS  |   HYDROLASE, PROTEASOME, 20S, PLASMODIUM, MALARIA, INHIBITOR, DRUG DESIGN, CRYO-EM 
5fmg:K    (LYS35) to   (TYR146)  STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS  |   HYDROLASE, PROTEASOME, 20S, PLASMODIUM, MALARIA, INHIBITOR, DRUG DESIGN, CRYO-EM 
5fmg:L    (ILE34) to   (ARG166)  STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS  |   HYDROLASE, PROTEASOME, 20S, PLASMODIUM, MALARIA, INHIBITOR, DRUG DESIGN, CRYO-EM 
5fmg:M    (LYS70) to   (ARG212)  STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS  |   HYDROLASE, PROTEASOME, 20S, PLASMODIUM, MALARIA, INHIBITOR, DRUG DESIGN, CRYO-EM 
5fmg:N    (ARG42) to   (ASP217)  STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS  |   HYDROLASE, PROTEASOME, 20S, PLASMODIUM, MALARIA, INHIBITOR, DRUG DESIGN, CRYO-EM 
5fmg:Q    (LYS64) to   (ASP201)  STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS  |   HYDROLASE, PROTEASOME, 20S, PLASMODIUM, MALARIA, INHIBITOR, DRUG DESIGN, CRYO-EM 
5fmg:R    (LEU62) to   (ILE193)  STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS  |   HYDROLASE, PROTEASOME, 20S, PLASMODIUM, MALARIA, INHIBITOR, DRUG DESIGN, CRYO-EM 
5fmg:T    (LYS62) to   (GLU180)  STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS  |   HYDROLASE, PROTEASOME, 20S, PLASMODIUM, MALARIA, INHIBITOR, DRUG DESIGN, CRYO-EM 
5fmg:U    (ARG68) to   (ILE187)  STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS  |   HYDROLASE, PROTEASOME, 20S, PLASMODIUM, MALARIA, INHIBITOR, DRUG DESIGN, CRYO-EM 
5fmg:V    (LYS33) to   (GLN190)  STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS  |   HYDROLASE, PROTEASOME, 20S, PLASMODIUM, MALARIA, INHIBITOR, DRUG DESIGN, CRYO-EM 
5fmg:W    (LYS33) to   (ASP166)  STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS  |   HYDROLASE, PROTEASOME, 20S, PLASMODIUM, MALARIA, INHIBITOR, DRUG DESIGN, CRYO-EM 
5fmg:X    (LYS43) to   (ASP191)  STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS  |   HYDROLASE, PROTEASOME, 20S, PLASMODIUM, MALARIA, INHIBITOR, DRUG DESIGN, CRYO-EM 
5fmg:Y    (LYS35) to   (TYR146)  STRUCTURE AND FUNCTION BASED DESIGN OF PL